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Food addiction (FA) is a contributing factor to obesity. Individuals with similar total body 
fat (BF) %, exhibit a large amount of heterogeneity in how BF is distributed. Certain BF 
distribution (BFD) patterns produce different outcomes regarding metabolic health. Little 
is known about how FA influences BFD and metabolic profiles.  
The study was designed to evaluate the correlation between FA symptom counts and 
metabolic characteristics, the correlation between FA symptoms and BFD patterns with 
emphasis on central obesity and Visceral fat (VF), and the role of android fat (AF) in 
women’s metabolic health. Data from the CODING study was used for analysis. 
FA symptoms are correlated with HOMA-β, triglycerides (TG), inversely correlated with 
high-density lipoprotein (HDL) in men and are correlated with TG in post-menopausal 
women. FA symptom counts were also associated with central obesity markers in men 
and women, including trunk fat (TF) and VF. Women exhibited slightly stronger 
correlations for all BFD measures except for VF and AF than in men. AF to GF ratio 
(AGR) affected metabolic characteristics and metabolic syndrome (MetS) risk in women. 
When separated into AGR tertiles, women in each tertile differed significantly in levels of 
insulin, glucose, TG, HDL, low-density lipoprotein (LDL), total cholesterol (TC), blood 
pressure (BP), and waist circumference (WC). Women in the top tertile exhibited higher 
levels of HOMA-IR and HOMA-β. When women in the top AGR quartile, matched by 
age and body mass index (BMI) with a control group while controlling for VF, were 2.4x 
more likely to have MetS. 
In conclusion, FA symptoms exhibit correlations with markers of metabolic disturbance 
in men and to a smaller degree in women. FA symptoms are also correlated with central 
obesity in men and women. Women with high levels of AF are at increased risk of 
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1.1 Prevalence of Obesity and Comorbidities 
Obesity is a multifactorial disorder characterized by the excessive accumulation of 
adipose tissue and is defined by the World Health Organization (WHO) as having a body 
mass index (BMI) of 30.0 or higher [1, 2]. The severity of obesity ranges from class I 
obesity to class III obesity with class 1 being a BMI of 30.0-34.9, class II is a BMI of 
35.0 to 39.9 and class III is a BMI of 40 or greater [3]. It is associated with the 
development of a number of health issues such as hypertension and high blood sugar. It is 
also considered a risk factor for other illnesses including but not limited to cardiovascular 
disease, type 2 diabetes (T2D), and some forms of cancer such as breast and prostate [4-
10]. The worldwide rate of obesity has been climbing rapidly for the past 3 decades and 
Canada is no exception to this trend. The WHO reported that the prevalence of obesity 
globally, tripled between 1975 and 2016 with the global prevalence of obesity now at 
13%  [2, 11]. Between 1985 and 2011 the prevalence of obesity amongst Canadian adults 
increased from 6.1% to 18.3% [12]. As of 2018, the prevalence of obesity among 
Canadian adults is 18.7% for those ages 18-34, 30.3% for those ages 35-49, 31.3% for 
those ages 50-64, and 28.1% for those ages 65 and over [13]. The obesity trend has been 
accompanied by a similar increase in other chronic diseases such as diabetes and 
cardiovascular disease [14-16]. This is precisely why obesity is considered one of the 
greatest public health issues facing the world today accompanied by the fact that it is a 
significant economic burden and is often associated with a lower quality of life [17, 18]. 
The financial cost of obesity in Canada, according to a 2011 report from the Public Health 





due to both the direct cost of obesity such as surgery and medication as well as the 
indirect cost such as lost working hours and premature death. The population of 
Newfoundland and Labrador (NL) suffer from a high prevalence of obesity unmatched by 
the rest of Canada. Recent reports put the prevalence of adults living with obesity in NL 
at 39.9% [13]. The prevalence of obesity is reported to be as high as 38.94% along NL’s 
East Coast and 42.46% in the region along the Northern Peninsula and Labrador (Fig.1-1) 
with the prevalence of those living with obesity in Canada as a whole at 28.2% [20]. Due 
to the high prevalence of obesity in NL, obesity research is of particular importance to 
this Province’s population. One reason is new information on the causes and 
consequences of obesity may inform health practitioners how to best treat those affected 
by obesity in the future, whether it be through therapy, medication, surgery or a 
combination of all three. Another reason being, information generated by obesity research 
may also help shape public health initiatives as it can reveal information about trends, risk 
factors, the outcomes of previous interventions and patterns of care. Research on the 
underlying causes of obesity may also assist in informing the most economical means of 




















1.2 Etiology of Obesity 
Obesity is a multi-factorial condition with many genetic, environmental, physiological, 
and behavioural factors to be considered and it is important not to overlook how these 
factors affect one another. There are 75 and counting obesity susceptibility loci that have 
been discovered since the employment of genome-wide association studies (GWAS) [21, 
22]. One notable example would be the minor allele of the fat mass and obesity-
associated (FTO) gene which is associated with a 1130g increase in body weight and 
increases the risk of obesity 1.2x [23]. Additionally, a 2009 study confirmed that variants 
of several genes associated with obesity in a Caucasian population such as SEC 16 
homologue B (SEC16B), transmembrane protein 18 (TMEM18), glucosamine-6-
phosphate deaminase 2 (GNPDA2), brain-derived neurotrophic factor (BDNF), fas 
apoptotic inhibitory molecule 2 (FAIM2) and melanocortin-4-receptor (MC4R) were also 
significantly associated with obesity in a Japanese population [24].  
Many of the aforementioned genetic variants which are associated with obesity, code for 
proteins, and hormones essential to the maintenance and performance of energy 
regulation pathways which is why the physiological aspects of obesity and how they 
affect appetite and metabolism must also be considered. Ghrelin, for example, is an 
orexigenic hormone that is reduced in individuals living with obesity and is dependent 
upon body mass and food intake patterns and diet-induced obesity may lead to ghrelin 
resistance  [25, 26]. A study from our lab revealed that a 7-day overfeeding challenge in 
young men increased circulating levels of PYY, an appetite inhibiting hormone which 





secreted primarily by white adipose tissue also play an important role in energy regulation 
and obesity. The discovery of adipokines was quite a milestone in obesity research as 
white adipose tissue was long thought to merely be a site of storage. Visfatin, an 
adipokine which is upregulated by hyperglycemia and downregulated by insulin, was 
found to be significantly higher in a sample of 21 obese women when compared to a 
sample of 16 lean women. Lean, in this case, referred to women with a BMI of 24.9 or 
less. The women chosen for this study had an average age of 29. Visfatin exhibited a 
significant correlation with glucose in obese women and a significant correlation with 
insulin in the lean group. It was concluded that the increase of visfatin in those living with 
obesity may have a counter-regulatory effect to prevent increasing glucose levels. and 
other adipokines such as IL-6, RBP4, and resistin increase inflammation and insulin 
resistance [28].  
Various environmental factors have also been found to correlate with the development 
and maintenance of the obese state.  For example, convenient access to calorie-dense fast 
foods has been shown to correlate with obesity [29]. A 2014 study by Slack and 
colleagues identified several environmental and socioeconomic correlations with obesity. 
The correlations that were observed include a positive correlation between obesity and 
unemployment as well as an inverse correlation with the number of physicians per 1000 
people, education level, and the number of recreational/natural amenities in an area [30]. 
A study by Cooksey-Stowers and colleagues investigated the role of “food swamps” in 





and other fast food establishments. The researchers analyzed 211 food environment 
indicators from 3141 United States counties and the “food swamp” measures that were 
used were the traditional Retail Food Environment Index as well as two expanded forms 
of the Retail Food Environment Index. BMI measurements were calculated from the self 
reported height and weight of over 500,000 respondents aged 20 years or older. The 
Retail Food Environment Index is the ratio of convenience stores and fast food 
establishments to grocery stores and supermarkets. The expanded forms include 
additional food outlets such as farmer markets and super centres. It was reported that 
“food swamps” are indeed significantly associated with obesity in adults. This correlation 
remained significant after controlling for indicators of physical activity such as the 
number of recreational facilities, natural amenities, and means of transportation to work 
in a given county, socio-economic factors such as level of education and income, and 
other variables such as race, age, and gender [31]. Some limitations worth noting in this 
study are the fact that weight and height were self-reported. For example, participants 
were simply asked “About how much do you weigh without shoes?”. Also, one of the 
main measurements, the Retail Food Environment Index, relied on the categorization of 
food as “healthy” or “unhealthy” with the latter being described as foods with high 
amounts of saturated fat, added sugar/sodium, or those that contribute little to meeting 
daily dietary recommendations. This definition is open to some subjectivity and it is not 
made clear if unhealthy food must simultaneously be high in saturated fat, added 
sugar/sodium, and do little to meet dietary recommendations or if a food is categorized as 





milk to soda was used as a proxy for the relative cost of healthy food compared to 
unhealthy food. Why those specific food items (low-fat milk and soda) were chosen is not 
made entirely clear or why that cost ratio made for the best proxy. Another environmental 
factor contributing to obesity may be where an individual works, as certain occupations 
are associated with a higher incidence of obesity. While it has been found that employed 
individuals tend to have lower BMIs than those who are not employed across different 
populations and age groups [32-34], certain occupations may have a higher prevalence of 
obesity when compared to other occupations. One study of 125,992 working adults (aged 
18 years and over) in the United States which collected data on 23 broad occupational 
groups and 93 minor occupational groups found that the highest prevalence of obesity 
among non-Hispanic white males was among those working in health care support 
(36.3%), protective services (34.3%) and transportation and material moving (33.7%). In 
the 2 periods between 2004-2007 and 2008-2011, obesity significantly increased among 
males working in computers, mathematics, legal areas, and protective services. Among all 
individuals, the highest prevalence of obesity was observed for those working as motor 
vehicle operators, construction or construction-related workers, law enforcement, home 
health aides, psychiatric workers, or nurses. The lowest prevalence of obesity was 
observed among those working in health diagnostics and treatment, certain military 
careers, art/design, and post-secondary teachers. Among non-Hispanic white females, the 
highest prevalence of obesity was observed in those working in farming/fishing/forestry, 
transport workers, and production. The lowest prevalence of obesity in this group was 





art/design/entertainment/sports/media, and life/physical/social sciences. Among Non-
Hispanic black females, those working in health care support, transportation, protective 
services, personal care, community/social services, food preparation/serving, and health 
care practitioners/technicians had an age-adjusted prevalence of obesity above 40%. Non-
Hispanic black females tended to have a high prevalence of obesity with the exception of 
those working in computers, mathematics, and legal areas. In non-Hispanic black males, 
those working in protective services, community/social services, production, and 
transportation had the highest prevalence of obesity. Out of the 93 minor occupations 
observed, non-Hispanic black males working in law enforcement and motor vehicle 
operation had the highest prevalence of obesity among that group. Hispanic males 
working in protective services, community/social services, life/physical/social sciences, 
computers, and mathematics had the highest prevalence of obesity. Hispanic males 
working in farming/fishing/forestry, food preparation/serving, building, and ground 
cleaning/maintenance had the lowest rate of obesity among males of this group. Hispanic 
females working in transportation, community/social services, and health care support 
had the highest prevalence of obesity among the minor occupation groups, and Hispanic 
females working in motor vehicle operation had the highest prevalence of obesity within 
that group [35]. While age was adjusted for in this analysis there are several limitations 
present in this study. Height and weight were self-reported which may have affected the 
accuracy of these measurements and there are many other potentially confounding 





socioeconomic factors. These variables could potentially explain some of the variations 
observed among certain ethnic groups, sexes, and occupations. 
While physiological mechanisms are partly responsible for driving eating behaviour as 
previously noted, the reciprocity of eating behaviour on physiology and obesity must also 
be acknowledged because should an individual go on to develop potentially harmful 
eating behaviours, such as binge eating or addictive eating tendencies, obesity and 
obesity-related issues can be far more difficult to manage [36-38]. A study consisting of 
638 healthy, non-smoking women ages 55-65 years examined the relationship between 
eating behaviours with weight and BMI. Eating behaviour was quantified using the 
Eating Inventory questionnaire which quantifies 3 constructs termed restraint and 
disinhibition as it pertains to eating, as well as hunger. Disinhibition, defined as the 
tendency to overeat in the presence of palatable foods or stimuli such as emotional 
distress, was found to be a strong predictor of both current BMI and weight gain. 
Restraint which was described as a tendency to consciously restrict food intake, while not 
a strong independent predictor of BMI did appear to moderate the association of 
disinhibition with weight gain [39]. An important note about this study is that current and 
past weight was self-reported for all participants so it is of course possible that reporting 
may have been incorrect, especially for past weight. The researchers took care to exclude 
smokers and individuals who reported health or eating disorders but there is always the 
possibility of some individuals failing to report health issues as they had not been 





food addiction (FA) symptoms, as defined by the Yale Food Addiction Scale (YFAS) 
Questionnaire which will be covered in much greater detail in later sections, and weight 
loss as well as other behavioural factors was conducted among adults seeking weight loss 
treatment. This study included 57 participants (68.4% female) with an average age of 47.4 
years who were enrolled in an 18-week behavioural weight loss intervention. Behavioural 
and psychological measures included psychological distress, maladaptive eating 
behaviours, weight bias attitudes, and body image/satisfaction. It was reported that higher 
YFAS scores were significantly correlated with higher levels of psychological distress as 
measured by the Center for Epidemiological Studies Depression Scale. YFAS scores also 
exhibited a significant correlation with body image and weight bias. There was a 
significant correlation between YFAS scores and maladaptive eating behaviours such as 
binge eating, emotional eating, and difficulty controlling eating. These behaviours were 
measured using the Binge Eating Scale, the Dutch Eating Behaviour Questionnaire, and 
the Eating Self-Efficacy Scale, respectively. The researchers performed Cronbach’s alpha 
calculations on each of these questionnaires to test internal consistency and each of the 
three maladaptive eating behaviour questionnaires yielded acceptable alpha scores which 
ranged from 0,84 to 0.98. What is most relevant for the purpose of this thesis are the 
correlations observed between YFAS scores and body weight. YFAS scores displayed a 
significant negative correlation with the percentage of weight lost at week 7 of the study. 
It was found that individuals with more FA symptoms lost less weight than those with 
fewer symptoms [40]. While this study helped demonstrate how eating behaviour can 





conducted in a small sample of largely white, female participants actively seeking to lose 
weight so it is difficult to say whether these findings could be applied to a large general 
population. This study is also unable to predict how these eating behaviours might affect 
long term weight loss or weight gain. It was also determined that YFAS scores were no 
better at predicting weight loss than binge eating behaviours. There is some overlap 
between FA and binge eating which makes it difficult to say which of these issues 
accounted for more of the variance in weight loss so it would be premature to conclude 
that FA is the primary reason for lack of weight loss in some of the participants.  
The etiology of obesity is often reduced to simply being a matter of long term, positive 
caloric balance caused by the ingestion of too many calorie-dense foods and lack of 
physical activity, however, as evidenced by the previous examples, the behaviours and 
physiological components that contribute to and sustain an obesogenic environment and 
the maintenance of body fat, are quite intricate. FA and its relationship to endocrine 
function and adiposity are an excellent example of the intricacy of obesity etiology. There 
is a substantial gap in knowledge concerning FA and its relationship to adiposity and 
metabolism which is why we chose to focus on this topic for my graduate work. This 
research made use of the CODING study which consists of over 3000 individuals of the 
general NL population. Our unique cohort has been screened to make sure all participants 
are at least third-generation Newfoundlanders above the age of 19 and not pregnant or 
experiencing serious metabolic disease at the time of taking part in the study. Many 





assess body composition and how body fat is distributed. We chose to make use of dual-
energy x-ray absorptiometry (DXA) scanning technology which is a far superior measure 
of body fat percentage and body fat distribution compared to BMI as demonstrated by 
previous research and shares a good concordance with other imaging technologies such as 
computed tomography (CT) scanning and magnetic resonance imaging (MRI) [41-47]. A 
study in 2009 found that the adiposity status of approximately 1/3 of men and women of 
the NL population was misclassified when relying on BMI [48, 49]. Studies that have 
been performed on several vastly different populations also reported on the accuracy of 
DXA for body composition measurement. These studies range from study populations 
such as the elderly, division 1college athletes, and underweight to individuals with 
chronic intestinal disease [42, 44, 45, 50]. When discussing BFD, the precise definition of 
terms such as upper body fat, lower body fat, central fat, and others can vary greatly from 
group to group depending on the tools of measurement available and/or the personal 
preferences of certain researchers. Due to this variability, I will first define the terms of 
BFD employed by Dr. Sun’s laboratory and the precise definition and anatomical 
locations of these BFD measurements in the following section. 
1.3 Body Fat Distribution Terms and Definitions 
All measures of body fat distribution and body composition, as previously noted, were 
measured using DXA scanning technology. The terms described below are per the 





and technical specifications of our DXA scanner are explained in greater detail in section 
1.4 
Total Body Fat (BF) – This includes all subcutaneous fat storage sites throughout the 
entire body, head to toe, and all extremities, as well as all Visceral fat.  
Trunk Fat (TF) - The trunk consists of the area between the lowest boundary of the pelvis 
to the highest boundary of the neck, just below the chin. It includes the chest, abdominal 
and pelvic areas with perimeters set at the middle of the femoral necks while avoiding 
cutting out the edge of the pelvis.  
Android Fat (AF) – The android area is located within the trunk of the body. This area is 
between the ribs and the pelvis. The chest, neck, head, and arms are all excluded from the 
AF measurement. It is the area ranging from the iliac crest to 20% of the height between 
the iliac crest and the base of the skull (Figure 1-2).  
Visceral fat (VF) – VF refers to the fat depot located behind the abdominal wall within a 
fold of the peritoneum. This area is called the omentum. It also includes the area of the 
mesentery and surrounds organs in that space which include the liver and intestines. This 
area is a 5cm wide region that runs across the entire abdomen just above the iliac crest at 
a level that approximately coincides with the 4th lumbar vertebrae (Figure 1-3).   
Gynoid Fat (GF) – This area includes the hips, upper thighs, and buttocks. It slightly 
overlaps with the leg and trunk region. It is approximately located between the superior 





to twice the height of the AF area. The upper boundary of the gynoid area is located 
below the top of the iliac crest at a distance of 1.5x the height of the android region and 
the total height of this region is 2x that of the android region (Figure 1-2). 
DXA technology allowed a more accurate calculation of specific patterns of body fat 
distribution, including VF deposits, however, DXA is just one of several different 













Figure 1-2 Estimates of Abdominal and Gynoid Region According to DXA 
Wiklund, Peter; Toss, Fredrik, Abdominal and Gynoid Fat Mass Are 
Associated with Cardiovascular Risk Factors in Men and Women, The 
Journal of Clinical Endocrinology & Metabolism, 2008, 93, 4360- 







Figure 1-3 Visceral Fat Region as Determined by DXA 
Kelly, Thomas L. Wilson, Kevin E. Punyanitya, Mark. Et al. Dual‐Energy X‐Ray Performs as Well 
as Clinical Computed Tomography for the Measurement of Visceral Fat. Obesity 2012.20 by 










1.4 Measurements of Body Fat Distribution 
When discussing the health implications of BFD, it is important to consider how certain 
body fat depots or body regions are measured and defined. Upper body fat or central 
obesity is described in many different ways depending on the study in question and the 
tools available to the respective research teams. Some researchers may opt to define upper 
body or central obesity using only waist circumference (WC) or waist to hip ratio (WHR) 
[51-53]. This is perhaps the simplest and most cost-effective method as it only requires a 
measuring tape and takes only seconds to perform. However, one should be aware that 
there is no universally accepted method for the measurement of WC which means there 
will always be a degree of uncertainty with this measurement until it is standardized. One 
study attempted to shine some light on this issue. 528 participants aged 6-78 were 
recruited. Prepubertal children had a BMI range of 12.3-25.7, pubertal children had a 
BMI range of 13.8-38.6 and adults had a BMI range of 16.8-40.2. Weight and height were 
measured using an electronic scale and stadiometer. Individuals who were pregnant, 
lactating, smoking, using anti-hypertensives, lipid-lowering, or hypoglycemic medication 
were excluded as was anyone using drugs that may influence body composition. WC was 
measured at three different points, below the lowest rib, above the iliac crest, and midway 
between both these areas using a non-elastic plastic measuring tape. Measurements were 
taken with the tape parallel to the floor with participants standing erect and those taking 
the measurement avoided compressing the skin with the measuring tape. Visceral and 
subcutaneous fat was measured using MRI. When the measurements at each of the three 





women and 6%-10% in men. Participants were also stratified by sex and BMI class and 
partial correlation analysis between WC, subcutaneous abdominal fat, and VF, adjusted 
for age, was performed. The highest significant correlation observed between any 
measure of WC and VF was 0.67 which was observed in normal-weight women when 
measuring WC from below the lowest rib. Obese women exhibited a similar correlation 
coefficient of 0.66 when WC was measured from the same site. In men, the strongest 
correlation with VF was observed in the normal weight group when WC was measured at 
the midpoint of the lowest rib and iliac crest with a correlation coefficient of 0.61. In 
obese men, no significant correlation was observed between any measure of WC and VF 
and all other significant correlations between WC and VF in men ranged from a 
coefficient of 0.52-0.58. In normal-weight and obese women, the correlation coefficient 
between WC and subcutaneous abdominal fat ranged from 0.70-0.77. The group of 
overweight women exhibited the lowest correlations of all groups with the correlation 
between WC and subcutaneous abdominal fat ranging from 0.30-0.51 depending on 
which of the three WC measurement sites were chosen. In men, the strongest correlation 
between WC and subcutaneous abdominal fat was 0.74 which was observed in 
overweight men when WC was measured from the iliac crest. The lowest correlation 
between WC and subcutaneous abdominal fat was 0.40 when measured in normal weight 
men from the bottom of the lowest rib. In all but two measurements, the correlation 
between WC measured at any site and subcutaneous abdominal fat was higher than the 
correlation observed between WC and VF. The only exceptions were in overweight 





the bottom of the lowest rib and in normal weight men (VF: r=0.52, subcutaneous 
abdominal fat: r=0.40), also when WC was measured from the bottom of the lowest rib. 
Based on these correlation coefficients, the authors concluded that, while WC can be a 
moderately decent indicator of subcutaneous adipose tissue, it is not as reliable for the 
quantification of visceral adipose tissue [54]. This study highlights the shortcomings of 
using WC as a measurement of upper body fat. Depending on sex, precisely where WC is 
measured, the BMI of the individual, and the fat depot of interest (VF stores versus 
subcutaneous abdominal fat stores), WC may exhibit either no significant correlation at 
all or it may yield a significant, moderately good correlation. There is a high degree of 
variability so caution should always be exercised when drawing conclusions from studies 
that employ WC as their only method of upper body fat measurement. Another study 
examined the concordance of WHR with DXA measured central and peripheral fat mass. 
This study was performed in 376 adults, 200 of whom were women, with a mean age of 
36 years. These participants were part of an ongoing longitudinal study that began in 
1976 and participants were recruited from two secondary schools. The average BMI of 
the participants was 24.8. The authors of this paper concluded that WC and skinfolds may 
offer a reliable alternative measurement of fat distribution in a cheap non-invasive 
manner, but WHR does not. WHR was measured using a flexible steel tape. WC was 
measured at the umbilicus and hip circumference was measured at the widest point of the 
buttocks. Central fat mass in this particular study refers to the trunk as defined by the 
factory pre-sets of the DXA machine used. The trunk area, according to this paper, started 





included the hips with cut-off points where the shoulder meets the scapula and at the 
femoral necks. Peripheral fat mass included the subcutaneous fat stores of the arms and 
legs. Skinfolds were measured using Harpenden calipers at several sites which include the 
subscapular, suprailiacal, biceps, triceps, and upper leg. It was concluded that in both men 
and women skinfolds and WC offer a reliable alternative for the measurement of fat 
distribution in a cheap non-invasive manner based on the correlations observed with DXA 
scanning (r ≥ 0.80), however, WHR does not [55]. It should be stated that the current 
study consisted of mostly lean individuals so the accuracy of the method used may vary 
in a mostly overweight or obese sample. Also, all participants were Caucasian and as 
acknowledged by the authors, results are most applicable to a Caucasian population-based 
on previously reported ethnic variations in BFD and body composition. Bioelectrical 
impedance (BIA) is another relatively cost-effective method of measuring body 
composition, however, it is saddled with many limitations when it comes to measuring 
BFD and exhibits variations in accuracy depending on the level of adiposity of the 
individual. Accuracy can also be affected by things such as having recently eaten before 
measurement, exercising, or the environment the measurement is conducted in. This is 
because all these things can affect electrolyte concentration in the body or on the skin 
which can influence the rate at which the current passes through the person being 
measured. BIA works by emitting a very low-level electrical current through the body, in 
most cases, about 50kHz. The current moves faster through hydrated lean body tissues 
and is impeded by the presence of adipose tissue. This allows BIA to calculate body fat 





use of specific equations [56]. A study from Dr. Sun’s research team in 2005 on a group 
of healthy adults revealed that the mean body fat percentage when measured by BIA, was 
consistently lower than when it was measured by DXA. Body fat was overestimated by 
3%-4% in men with less than 15% body fat and women with less than 25%. Conversely, 
body fat was underestimated by 4.32% in men with over 25% body fat and 
underestimated by 2.71% in women with over 33% body fat [57]. Another BIA study was 
performed using a group of 35 men and 37 women aged 60-83 years who were screened 
for dehydration, edema and use of drugs that may alter the body’s electrolyte balance. It 
was found that BIA measurements of fat free mass that were thought to be accurate 
according to an earlier study by this same group in a younger population of men and 
women aged 20-40 years which employed similar methods, overestimated fat free mass in 
an elderly population by approximately 6kg [58]. BIA lacks the precision of DXA and 
other imaging technologies when it comes to measuring actual BFD but can be a quick 
and easy method of measuring whole body composition at the cost of some accuracy. 
Upper body obesity may also sometimes be defined as excessive adipose tissue within the 
trunk of the body [59]. What is known as the “trunk” area consists of the area between the 
lowest boundary of the pelvis to the highest boundary of the neck, which is the operating 
TF definition [60] for the projects this team has completed on BFD. However, this does 
not always account for adipose tissue in the arms, though some researchers have chosen 
to include arm fat in their upper body definition [61]. The term, upper body, has also been 
used to refer to the android region which encompasses an area slightly smaller than what 





The android area consists of the region near the waist, between the middle of the lumbar 
spine and the upper-most part of the pelvis [62]. This area ranges from the iliac crest to 
20% of the height between the iliac crest and the base of the skull [47]. This is definition 
that has been employed for the purposes of these projects as well. It is an accumulation of 
adipose tissue in this area that results in the “apple” shape, more common among men 
[63]. In studies concerning lower body fat, the lower body region is often referred to as 
the gynoid or gluteo-femoral area. This area consists of the hips, buttocks, and thighs. The 
more precise definition, as described in section 1.3, is the area between the superior and 
inferior trochanter major or from the lower boundary of the umbilicus to a line equal to 
twice the height of the AF area. Accumulation of adipose tissue in this area of the body 
creates the “pear” shape, often seen in women who present with smaller upper bodies 
with most of their body fat being concentrated in the hips and thighs [64]. More detailed 
measurements of the mass and area of upper body adipose tissue, whether subcutaneous 
or visceral adipose stores, usually requires advanced imaging technologies. MRI scanning 
is often used for this purpose. This is due to its ability to distinguish between tissue types. 
MRI also provides great resolution and lacks the ionizing radiation associated with x-ray 
technology [65, 66]. MRI scanning relies on the use of extremely strong magnetic fields, 
usually between 1.5-3.0 Tesla (T), for the sake of comparison, the earth's magnetic field 
is about 0.00005T. So how exactly are magnetic fields used to produce images? The 
human body is largely composed of water, approximately 70%. Water also happens to be 
rich in hydrogen nuclei and these nuclei spin on an axis. The axis on which hydrogen 





extremely powerful magnets like those found in MRI machines, they align along the axis 
of the MRI scanner, parallel to the magnetic field, creating a magnetic vector. MRI 
machines consist of a primary magnetic field, radiofrequency coils, receiver coils, 
gradient coils and of course a computer system to store and present the images that are 
produced. The primary magnetic field is responsible for emitting the strong magnetic 
field which forces hydrogen nuclei to align along its axis creating the magnetic vector. 
The radio frequency coils emit a secondary magnetic field in a short pulse which disturbs 
the hydrogen proton alignment. When the radio frequency pulse ends, protons will return 
to their position parallel to the magnetic field emitted by the primary magnet. Based on 
the tissue these protons are in, they will return to their former parallel state at different 
rates. When protons are parallel with the primary magnetic field, they are in what is 
known as the relaxed state. When the radio frequency pulse ends, the time it takes these 
protons to completely relax is measured by 1) how long it takes for the magnetic vector to 
return to its relaxed state and 2) how long the axial spin takes to return to its relaxed state. 
This is known as T1 and T2 relaxation, respectively. Due to different tissues having 
different relaxation times, this can be used to distinguish one type of tissue from another. 
The signal, which is a radio wave, that is emitted upon protons returning to the relaxed 
state is picked up by receiver signals which surround the body part of interest. It is these 
radio waves that are actually responsible for producing the image. The signal is plotted 
along a grey scale and from this, cross sectional images can be constructed. Gradient coils 
are arranged in opposition to each other to produce negative and positive poles. These 





long axis to produce axial images, the Y gradient runs along the vertical axis to produce 
coronal images and the X gradient runs along the horizontal axis, producing sagittal 
images. These gradient magnets can alter the strength of the primary magnetic field in 
small increments which helps with spatial encoding of the image as different slices of the 
body resonate at different frequencies. The radio wave signals undergo an analog to 
digital conversion which are then converted to the final image using a mathematical 
process known as Fourier Transformation [67, 68]. MRI technology is among the most 
advanced available for assessing body composition but due to high cost not just to 
purchase and run the equipment but to simply house it as well, it is not practical to use 
MRI for body composition studies on large numbers of people. Also, due to the use of 
high-powered magnets, it may be unsafe for individuals with metal implants or metal 
prosthetics, especially if they are not secured and anchored into bone. Computed 
Tomography (CT) scans are another method which is sometimes used to assess BFD [69-
71]. CT scans provide excellent contrast and allow for the visualization of the body 
through multiple cross-sectional images. However, like MRI, CT scanning can be quite 
expensive. The other issue with CT scanning, particularly when it used on volunteers for 
research as opposed to diagnostic purposes, is that it emits a high level of ionizing 
radiation the research participant otherwise wouldn’t have been subjected to, which can 
increase an individuals risk of developing cancer [72]. CT makes use of x-ray technology. 
An x-ray being a form of electromagnetic radiation with wavelengths measuring from 
0.01 to 10 nanometers. To put that in perspective, visible light ranges from 400-700 





electromagnetic energy when the electrons are decelerated by interacting with a target 
material which is, in this case, an anode. The x-ray tube, the equipment necessary for x-
ray production, consists of several key components. This is a vacuum tube which houses a 
cathode, an anode and is attached to high voltage cables at the cathode and anode which 
are connected to a generator. The cathode, which is the source of electrons, is heated to a 
temperature as high as ~2200 degrees Celsius, which causes it to release electrons in a 
process known as thermionic emission. These electrons are then accelerated to the 
positively charged anode which is assisted by the large electrical potential difference 
between the cathode and anode (~20,000-150,000 volts). When the electrons collide with 
the target atom, the kinetic energy of the electrons is converted into other forms of 
energy. Most interactions with the target atom simply give rise to heat but a small fraction 
of electrons (about 1%) come within close proximity of the positively charged nucleus of 
the target atom. These electrons will then decelerate and change direction resulting in a 
loss of kinetic energy which is converted into x-ray photons. This is termed 
bremsstrahlung radiation. The energy level of the x-ray is expressed in kiloelectronvolts 
(keV). The energy level is dependent upon how close to the nucleus the electron was 
before slowing down and being redirected. Electrons that reach the K shell, the electron 
shell closest to the nucleus, will eject a K shell electron due to strong repulsive forces 
between the two negatively charged particles. An electron from the neighboring L shell 
will then fill its place and an x-ray photon is emitted whose energy is equal to the 
difference in the binding energies of the two electron shells. The greater the distance 





ray. This is because electrons in the K shell, closest to the positively charged nucleus will 
experience the greatest binding energy due to their proximity to the attractive force 
exerted by oppositely charged proton particles. Tungsten is commonly used as the anode 
in the x-ray tube assembly as the x-ray energy is proportional to the charge on the nucleus 
which is proportional to the atomic number. Tungsten has a high atomic number at 72 and 
it can also withstand incredibly high temperatures before melting [73-75].  CT relies on 
the fact that the density of the tissue being passed through by the x-ray beam can be 
measured using what is known as the attenuation coefficient, which represents how easily 
a material is penetrated by the x-ray beam. Modern CT scanners have an x-ray tube, as 
described above, which rotates around the patient at a high speed while emitting a wedge-
shaped x-ray beam. Directly across from the tube, on the opposite side of the patient, is a 
detector which rotates synchronously with the x-ray tube, although some CT scanners 
have a stationary ring of detectors that surround the patient on all sides. The detector 
measures attenuated and unattenuated x-ray intensity. Attenuated intensity (I) is equal to 
N·hv / S·t  
where N is the amount of photon energy passing through a unit of area (S) in a unit of 
time (t), h is Planck’s constant, and v is the frequency of the photon of the radiation 
emitted. The relationship between attenuated x-ray intensity and unattenuated x-ray 
intensity (I0) is expressed by the equation  
ln(I/I0) = u·x  
where u is the linear attenuation coefficient and x is the thickness of the biological tissue. 





equation is used in the CT reconstruction algorithm in a pre-processing step before image 
reconstruction [74]. Detectors often use either a high-pressure inert gas, most often 
xenon, or a scintillator paired with photodiodes. A scintillator is a material that exhibits 
luminescence when excited by ionizing radiation. In a xenon-based detector, the detector 
is made up of thin tungsten plates with an electrical current applied to every other plate 
(~500 V) while the other plates have no voltage. When an x-ray photon hits the detector, 
the xenon gas is ionized and releases a photoelectron which then ionizes more xenon gas 
ions. The ionized xenon nuclei are drawn to the zero-voltage plate and the free electrons 
are collected by the 500V plate. The quantity of xenon gas that has been ionized is 
proportional to the intensity of the x-ray and as I have previously noted, it is this intensity 
data that is used to construct the image [76]. In scintillator-based detectors, the x-ray 
photon undergoes a photoelectric interaction with the scintillator material. A 
photoelectron is released which then excites electrons in other atoms. When these excited 
electrons return to their ground state, they release light on the spectrum of visible light 
and ultraviolet [76].  The light is then guided to a photocathode of a photomultiplier tube 
which then emits an electron, creating an electric current. Within the photomultiplier tube 
are dynodes that are coated with a material that will create secondary electrons upon 
interacting with the initial electron. The electrons are then directed to a series of dynodes 
that will amplify the electric signal. An electric pulse is emitted at the end of the 
photomultiplier tube whose intensity is proportional to the absorbed energy [77]. Images 
are then constructed from the resulting intensity signals which are proportional to the 





attenuated by the body’s tissues and organs. Each of our research endeavours concerning 
BFD makes use of DXA scanning technology as mentioned in a previous section. DXA 
has been chosen for several reasons. It is far more cost-effective and less time consuming 
than MRI or CT scanning. It can reliably distinguish between bone, lean body mass, and 
fat mass. DXA has often been used clinically for the diagnosis of osteoporosis [41, 78, 
79]. DXA also provides the added advantage of producing highly accurate VF mass and 
area measurements comparable to those produced by CT scanning (r2=0.957) [43]. This 
particular function was crucial to these projects. DXA scanning, like CT, make use of x-
ray technology. I have described above how x-ray radiation is generated and the 
generation of x-rays in a DXA scanner is no different. Our model of DXA scanner makes 
use of the scintillation-based detectors which have also been described, however, several 
features make DXA uniquely suited for a research effort like the CODING study. The 
DXA scanner is only 205cm in length, 109cm in width, 128cm in height, and requires just 
a small desk and a standard consumer brand computer with a minimum of an i3 
processor, 2GB of ram, and 1GB of free space for the accompanying software [80]. This 
makes it not only cost-efficient but size efficient as well. DXA also subjects participants 
to significantly less radiation than a CT scan. A CT scan can expose an individual to as 
little as 2.1mSv for a head and neck scan to as much as 31mSv for an abdomen-pelvic 
scan [81]. Our Lunar Prodigy scanner, made by General Electric [60, 82] exposes 
participants to approximately 0.004mSv for a whole-body scan [83]. Smaller doses of 
radiation are received because DXA scanners use a K-edge filter which is a material used 





specific x-ray energies. This is where the term dual-energy is derived. The K-edge filter is 
usually an element such as gadolinium, samarium cerium, or others that block x-ray 
photons of a particular energy level. The filtration material used depends on the energy 
range you wish to block and the voltage of the x-ray tube. The K-edge refers to the energy 
required to eject a K shell electron [73, 84, 85]. The remaining x-rays are an energy that is 
optimal for absorption by bone and soft tissue. The Lunar Prodigy, for example, produces 
x-rays at two distinct energy peaks of approximately 38keV and 70keV [83]. DXA 
scanning relies on the fact that bone will absorb more x-ray photons than the bodies soft 
tissues and the difference in the attenuation of the x-ray photons is linearly related to the 
proportion of fat in the soft tissues [86]. Another important feature of the DXA scanner is 
the way the x-ray beam is dispersed. There is pencil beam, fan beam and narrow fan beam 
DXA scanners. The DXA scanner used for our projects makes use a narrow fan beam 
scanner. Pencil beam scanners, while limiting radiation exposure, can take quite some 
time to complete a scan (5-10 minutes). Pencil beam detectors used a thin beam with a 
single detector which scans the individual in a rectilinear fashion. Fan beams are much 
faster (about 1 minute per scan) as they scan the entire individual in a single sweep but 
expose individuals to more radiation and have issues with magnifying parts of the body 
closer to the x-ray source. The narrow fan beam is compromise between these two 
methods. This is the beam utilized by the Lunar Prodigy DXA scanner. Narrow fan beam 
technology scans in a rectilinear fashion while using a broader fan beam which decreases 
scan time but still narrower than the original fan beams which reduces the magnification 





laps with the previous pass and these overlapping images are reconstructed resulting in 
more accurate estimations of bone depth [80, 86]. This concludes the review of available 
technologies for the measurement of BFD. Reliable measurements of BFD are incredibly 
valuable to obesity research as simple indexes of obesity such as BMI do not provide 
information on adiposity which can present issues.  
1.5 Body Fat Distribution and BMI 
Many people with similar BMI, the traditional index, or surrogate measure by which 
obesity is diagnosed, may have drastically different levels of BF. BMI is not a measure of 
BF and it cannot assess an individual’s adiposity [48, 87]. BMI is body weight as 
measured in kg divided by height in m2 (BMI=kg/m2) [88]. Again, for reference, the BMI 
classifications are as follows: 
Normal Weight – 18.5-24.9 
Overweight – 25.0-29.9 
Class 1 Obesity – 30.0-34.9 
Class 2 Obesity – 35.0-39.9 
Class 3 Obesity – 40.0 and above  
 At a population level, BMI shares strong correlations with several health indices. For 
example, a study on men and women from 12 European countries found that each 5 unit 
increase in BMI was associated with a 34% increased risk of CVD in men and a 29% 
increased risk of CVD in women.[89]. McLaughlin et al studied the relationship between 





study had to be in good general health which was determined using medical history and a 
physical examination. Participants could not be diabetic nor could they be taking any 
medications for the treatment of BP, hyperglycemia, or dyslipidemia. Participants were 
also subjected to a chemical screening battery. Blood samples were taken following an 
overnight fast. It was reported that 36% of individuals in the highest tertile for insulin 
resistance were BMI defined obese [90]. Another large study of 3981 men and 3099 
women showed that BMI defined overweight and obese individuals experienced far 
worse physical well-being defined by measures such as bodily pain, fatigue, and physical 
functioning, among others. These measures were evaluated using the 12 Item Health 
Status Questionnaire. This questionnaire subjectively evaluates physical, social and 
mental well-being over the past 4 weeks. Participants were asked to rank how severe they 
perceive their bodily pain to be on a scale of 1 (none) to 6 (very severe). They were also 
asked questions regarding fatigue and physical functioning. Physical functioning was 
defined by the participants perceived ability to handle basic daily tasks such as carrying 
groceries, climbing stairs, or walking several blocks, ranked on a scale of 1 (limited a lot) 
to 3 (not limited at all) while fatigue was assessed by asking participants how often they 
feel as though they have “a lot of energy” on a scale of 1 (all the time) to 6 (none of the 
time) [91]. In this study, BMI was calculated from self-reported weight and height so it is 
important to note that some participants may have misreported one or both of those 
measures, possibly resulting in BMI misclassification. Misclassification of adiposity can 
also be quite persistent. A study of 27,000 individuals from 52 countries found that, while 





(MI), this relationship became substantially weaker after controlling for central adiposity 
which was defined in this study using WHR. The risk of MI when comparing the top BMI 
quintile to the lowest, was 44% higher but upon adjusting for WHR the risk was only 
found to be 12% higher [92]. The concern with BMI misclassification in athletic 
individuals or simply those with higher levels of lean body mass was the topic of a study 
by Lambert et al. in 2012. The BMI, fat mass, and fat-free mass of division 1 college 
American football athletes were compared to a group of gender and age-matched 
volunteers. It was concluded that the athletic group was far more like to be classified as 
overweight based on BMI despite having more fat-free mass than the comparison group 
[50]. While this particular study is not representative of the general population, as only an 
incredibly small fraction of individuals will ever compete in Division 1 collegiate sports, 
it does serve to highlight how BMI can at times be an unreliable measure of overall 
health. To further highlight the shortcomings of BMI, a massive study of 15,184 adults, 
published in Annals of Internal Medicine, examined the relationship between common 
anthropometric markers and BMI concerning their relationship with mortality. The study 
consisted of 7249 men and 7935 women with a mean age of 45 years old. WHR was used 
as an index of upper body obesity and was calculated by measuring the WC at the height 
of the iliac crest and hip circumference at the widest point around the buttocks. Women 
with a WHR of 0.85 or greater and men with a WHR of 0.90 or greater were considered 
to have central obesity. There were 3222 deaths, 1413 of which were women in an 
average follow up time of 14.3 years. 1404 were cardiovascular related deaths. The 





greater association with mortality, largely due to cardiovascular related disease, than BMI 
defined obesity in both men and women [93]. As noted in section 1.4, while WHR is a 
cheap, quick way to assess BFD, it comes a large degree of variability depending on the 
expertise of the person taking the measurement and the exact position of the measuring 
tape [54]. Also, while this analysis revealed that normal-weight central obesity shares a 
greater association with mortality than BMI defined obesity, it is important to remember 
that there are levels to the severity of obesity and we cannot conclude that normal-weight 
central obesity may be a greater health risk when compared to individuals living with 
morbid obesity which is a BMI of 40 or greater. As previously noted, many individual's 
adiposity status is often misclassified when relying only on BMI measurements [48] and 
it appears their true risk of any number of health issues may easily be under or 
overestimated as well.  
Furthermore, BMI does provide any information on the heterogeneity of obesity. 
Individuals with similar adiposity levels can exhibit a high degree of heterogeneity in 
how that adipose tissue is distributed throughout their body which in turn can have very 
different metabolic outcomes. For example, individuals who tend to carry the majority of 
their adipose tissue in the trunk or android region of their body are at a significantly 
higher risk of CVD and other metabolic issues than those who are predisposed to carry 
more adipose tissue in the gynoid region of their body. A study on the commingling 
effects of AF and GF on metabolic dysregulation was performed on 1802 adults with 





DXA and all metabolic markers were measured in serum which was obtained from a 
blood sample following an 8 hour fast. The markers that were chosen for this study 
included TG, HDL, LDL, and blood glucose. Height and weight were measured using a 
fixed stadiometer and digital scale while WC was measured using non-elastic tape at the 
height of the right iliac crest at the mid-axillary line. After adjusting for age, sex, smoking 
status, and alcohol intake, it was found that in the full sample of participants android to 
gynoid percent fat ratio exhibited stronger correlations with several cardiometabolic risk 
factors compared to BMI and AF or GF percent alone. This included significant positive 
correlations with systolic/diastolic BP, fasting plasma glucose, TG, LDL, and total 
cholesterol (TC). In men, android to gynoid percent fat ratio exhibited a significant 
negative correlation with HDL and significant positive correlation with systolic/diastolic 
BP, TG, LDL, and TC. In women, android to gynoid percent fat ratio exhibited a 
significant positive correlation with TG and fasting plasma glucose and a significant 
negative correlation with HDL [94]. Odds ratios were also calculated for cardiometabolic 
risk factors of individuals in the highest tertile of android percent fat to gynoid percent 
ratio. While these odds ratios suggested that those in the top tertile were more likely to 
have elevated glucose, BP, TG, LDL, TC and low levels of HDL, the selection of the top 
tertile as the cut-off is an arbitrary designation and there is no clinically defined ideal 
percentage of AF or GF for the maintenance of good health. This was a cross-sectional 
study so the exact cause or directionality of these correlations cannot be concluded. 
Another important factor that is missed when solely relying on BMI without considering 





anthropometric measurements of subcutaneous abdominal fat in a group of 71 men and 
34 women with an average age of 51.5 years and 52.4 years, respectively. Research 
subjects underwent routine abdominal CT scans at a local hospital for diagnosis and 
monitoring of malignancies. Anyone under the age of 19 or anyone presenting with an 
abnormality such as an enlarged liver, that would influence body fat measurements were 
excluded. The subcutaneous fat measurements that were used include waist, hip, and 
thigh circumferences as well as skinfold thickness near the supra-iliac and para-umbilical 
areas. WC was measured at the height of the umbilicus and hip circumference was 
measured at the height of the anterior superior iliac spine. Some of the key findings 
observed in women include a significant correlation between abdominal subcutaneous fat 
and VF (r=0.73) as well as a significant correlation between skinfold measurements and 
VF (r=0.73). In men, abdominal subcutaneous fat and VF also exhibited a significant 
positive correlation (r=0.72) as did WHR and VF (r=0.75). An important note about this 
study is that some of the participants were there to obtain CT scans to monitor disease 
progression so it is possible that either the illness or medication use may have influenced 
the amount of body fat [95]. There are several important differences between abdominal 
subcutaneous and VF depots. First, the anatomical difference between VF and abdominal 
subcutaneous fat is that VF, sometimes called intra-abdominal fat, refers to the adipose 
tissue located behind the abdominal wall within a fold of the peritoneum, known as the 
omentum as well as the area of the mesentery and surrounds organs in the same space 
such as the liver and intestines (Figure 1-4). Abdominal subcutaneous fat is in reference 





fascia to the dermis as well a deeper layer of fat composed of more loosely packed fat 
lobules as described by Markman and Barton following 36 hemidissections of 8 fresh and 
10 preserved cadavers [96]. While the anatomical location is just one distinction, it is an 
important one as VF that accumulates near the liver will undergo lipolysis resulting in 
free fatty acids (FFA) entering hepatic circulation via the hepatic vein. This was 
demonstrated by Nielsen and colleagues. This group investigated whether a larger amount 
of VF would result in more hepatic FFA delivery. The participants consisted of 12 non-
obese men and women, 20 men living with obesity, and 24 women living with obesity. 
Participants were taken off medication for hypertension and lipid-lowering medications 1 
month before the study while diabetic patients were withdrawn from hypoglycemic 
therapy 2 weeks before the study. All meals were consumed at the research centre 3 days 
before the study to ensure that caloric and macronutrient intake were consistent among 
participants. Hepatic FFA delivery from the VF depot was measured using isotope 
dilution to label FFA and catheterization of the hepatic vein. The evening before the 
procedure participants were admitted to the research centre and were intravenously 
administered a 0.45% NaCl saline solution and resting energy expenditure was measured 
using indirect calorimetry. Sheaths were inserted in the right femoral artery and a catheter 
was inserted through the sheath with the tip in the common iliac artery for arterial blood 
sampling and infusion of the medical dye, indocyanine green. A sheath was then inserted 
into the right femoral vein with the distal tip in the external iliac vein. A catheter was then 
inserted with the tip placed in the right hepatic vein. When all catheters were in place [9, 





not reported in this study) and indocyanine green infusions began 30 minutes before 
blood sampling. Arterial, femoral, and hepatic vein samples were taken at 10-minute 
intervals over 30 minutes. Regional body fat was measured using DXA and a CT scan 
between the L2 and L3 vertebrae to measure VF. Plasma FFA concentration was 
significantly greater in men and women of the obese group (663umol/L and 709umol/L, 
respectively) than men and women of the lean group (487umol/L and 587umol/L, 
respectively). VF area was positively correlated with the percent of hepatic FFA delivery 
from VF stores in men and women with correlation coefficients of 0.52 and 0.49, 
respectively. The authors also reported that this effect was more accentuated in women 
than in men. Generally, among lean individuals, 5-10% of hepatic FFA delivery is from 
VF and in obese individuals, over 30% of hepatic FFA delivery is from VF [97]. Several 
of the participants in the obese group were hypertensive, diabetic, or dyslipidemic. While 
this was intentional as the authors wanted to be sure those with obesity-related 
complications were represented, there could be any number of underlying metabolic 
issues that could skew results in a manner not representative of those living with obesity 
yet remain healthy. Those with metabolic disorders were not separated from the otherwise 
healthy obese group though the research team did appear to take measures to account for 
variance due to medication or diet as best they could. There are also important 
biochemical differences between subcutaneous fat and VF. For example, one study that 
analyzed 2 independent cohorts investigated whether there was differential macrophage 
infiltration between subcutaneous and VF samples and see if these differences were 





consisted of 20 lean men and women, 20 subcutaneously obese men and women, and 20 
viscerally or intra-abdominally obese men and women. Each group consisted of 10 men 
and women. Obesity status was determined using BMI, total fat percent was measured 
using DXA, and VF was measured using CT with images taken between the L3 and L4 
vertebrae. Those with a VF to subcutaneous fat ratio above 0.5 were in the intra-
abdominally obese group while those with a ratio below 0.5 were in the subcutaneously 
obese group. Blood samples were taken after an overnight fast and insulin resistance was 
determined using the euglycemic hyperinsulinemic clamp. The second cohort consisted of 
27 severely obese women (BMI >40) who were divided according to whether they had 
normal glucose homeostasis or impaired glucose homeostasis which was determined 
using fasting glucose levels. Insulin resistance in cohort 2 was determined using the 
homeostatic model of assessment-insulin resistance (HOMA-IR) equation. The second 
cohort did not undergo CT or DXA scanning as cohort 1 had. WC was measured in both 
groups either at the point between the iliac crest and lowest rib or, among those living 
with severe obesity, at the point of the largest trunk circumference. Cohort 1 included 
individuals who did not have any acute or chronic inflammatory disease, glycated 
hemoglobin levels below 7.5% and fasting glucose below 180mg/dl, systolic BP below 
160mmHg and diastolic BP below 95mmHg, less 1han 100mg/dl LDL and more than 
35mg/dl HDL, no evidence of CVD or peripheral arterial disease, no medication usage 
with the exception of metformin for the ten type 2 diabetics in the obese groups, no 
history of alcohol or drug abuse and no pregnancy at the time of the study. Cohort 2 was 





subcutaneous and VF depots. Adipose tissue samples were obtained from both groups 
during various abdominal surgical procedures which ranged from exploratory surgeries (if 
findings were negative), weight reduction surgery, or most commonly, gastric banding 
surgery. Expression of chemoattractant protein-1, an inflammatory cytokine, and colony-
stimulating factor-1, which stimulates macrophage colony formation among other 
inflammatory effects, were measured using real-time polymerase chain reaction. When 
compared to abdominal subcutaneous fat tissue samples, VF taken from the omental area 
displayed significantly more macrophage infiltration in all cohort 1 groups, lean controls 
included. Macrophage infiltration was higher among the intra-abdominally obese group 
compared to the subcutaneously obese group. Also, macrophage infiltration demonstrated 
a significant positive correlation with visceral obesity but displayed no significant 
relationship with subcutaneous obesity. The cohort 1 analysis also revealed that 
macrophage infiltration, whether it was in subcutaneous or VF, had a positive correlation 
with BMI, WC, fasting insulin, and systolic BP. Increased macrophage infiltration was 
also significantly associated with mRNA levels of colony-stimulating factor-1 in cohort 1. 
Cohort 2 also exhibited more macrophage infiltration in VF compared to subcutaneous 
fat, in fact, it was 2.5-fold more. Cohort 2 also displayed higher levels of chemoattractant 
protein-1 and colony-stimulating factor-1 in VF samples. A positive correlation was also 
demonstrated between the number of MetS factors as defined by the adult treatment panel 
III (ATPIII) criteria and VF macrophage infiltration but not subcutaneous fat macrophage 
infiltration [98]. An ambitious study such as this one makes it difficult to standardize the 





any number of confounding variables as both cohorts consisted of vastly different people. 
One example of this is the different method of measuring insulin resistance in each 
cohort, one used the highly reliable gold standard euglycemic hyperinsulinemic clamp 
while the other relied upon the HOMA model. HOMA-IR also has limitations that should 
be acknowledged. The first thing to note is the HOMA-IR equation which is 
Glucose (mmol/L) x Insulin (mmol/L)/22.5 
 HOMA-IR has a moderately good correlation with insulin resistance as measured by a 
euglycemic hyperinsulinemic clamp which is the gold standard for measuring insulin 
resistance but it is less reliable in some people including older individuals with impaired 
glucose tolerance and older men and women with diabetes [99, 100]. Also, HOMA-IR 
does not distinguish between hepatic or peripheral insulin resistance. This study did, 
however, demonstrate that, in 2 very different cohorts consisting of healthy individuals 
and those with metabolic disorders with a wide range of obesity phenotypes, VF is 
distinct from subcutaneous fat in the way that it is susceptible to macrophage infiltration 
which can result in inflammation.  Additionally, macrophage infiltration, specifically in 
VF, is associated with a higher number of MetS components. However, there is slight 
controversy surrounding the degree to which VF contributes to metabolic disorders due to 
the finding that upper body subcutaneous fat stores contribute between 60%-78% of FFA 
to systemic circulation, lower body subcutaneous fat stores contribute 16%-20% of FFA 
to systemic circulation while VF store contributes 5%-20% of the FFA in systemic 





makes up, at most, approximately 10% of total fat mass [97, 101]. BFD is an important 
factor in the development of obesity related comorbidities and a shortcoming of BMI is 
that it simply cannot account for this variation. The relationship between BFD and obesity 











Figure 1-4 Visceral Fat Anatomical Location 
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1.6 Body Fat Distribution and Obesity Related Comorbidities 
Obesity, which is a multifaceted disorder, has recently been classified as a “disease” by 
both the American Medical Association and the Canadian Medical Association. However, 
this classification is not without criticism. There are several reasons for this skepticism 
and fair questions have been raised such as the concern of possible financial incentives 
[102]. One primary reason for the hesitancy of some to label obesity as a disease is due to 
the fact that some individuals living with obesity experience no comorbidities or negative 
health effects. This is, in part, because obesity is often diagnosed using BMI which, as 
described above, may be a reliable index at the population level but says nothing of actual 
adiposity. It is understandably difficult to label something a disease when some 
individuals who meet the criteria for said disease are otherwise healthy. This is why the 
matter of BFD and adiposity is so important when discussing obesity as it pertains to 
health outcomes and certain BFD patterns are of unique concern due to the heightened 
risk of developing obesity related comorbidities. The studies reviewed below support this 
claim. 
 A study published in 2017 by Han and colleagues investigated the relationship between 
BFD and CVD risk in a sample of 15,686 (6761 men, 8925 women) adults aged 20 years 
and older with no previous diagnosis of CVD. Many variables were used in this study as 
it is quite comprehensive (ex. muscle distribution kidney disease, albuminuria) but I will 
focus on the measurements relevant to this thesis. BFD was measured using DXA and the 
ratio of leg fat to TF was used as an index of BFD. The metabolic components that were 





insulin, HDL, LDL and TG were all measured following an 8 hour overnight fast. CVD 
risk was assessed using several different criteria which included the atherosclerotic CVD 
risk score from the American College of Cardiology and the American Heart Association, 
the Framingham 10-year CVD risk score, and the Korean coronary heart disease 
prediction model. The atherosclerotic CVD risk score calculates risk based on age, 
ethnicity, TC, HDL, systolic and diastolic BP, and whether not an individual is a diabetic 
or a smoker [103]. The Framingham risk score calculates risk using age, TC, HDL, 
Systolic BP, whether an individual is receiving treatment for high BP, whether they are a 
diabetic or a smoker and how many CVD incidents they’ve had in their lifetime [104]. 
The Korean coronary heart disease prediction model calculates risk using the same 
variables as the Framingham risk score but includes LDL, TG and expands on smoking 
status by asking whether an individual is a former smoker [105]. Individuals were 
separated into sex specific tertiles based on CVD risk score and leg fat to total fat ratio. 
They were also separated by obese or non-obese and then each group was further 
stratified by leg fat to total fat ratio tertiles for analysis. In both the obese and non-obese 
groups, those in the highest tertile of to total BF ratio fat exhibited the lowest prevalence 
of hypertension, diabetes, and MetS. The prevalence of hypertension, diabetes, and MetS 
in the highest leg fat to total fat ratio tertile in the non-obese group was 7.0%, 1.1%, and 
2.4%, respectively. The prevalence of hypertension, diabetes, and MetS in the lowest 
tertile within the same group was 37.5%, 15.2%, and 37.6% respectively. The prevalence 
of hypertension, diabetes, and MetS in the obese group, among those in the highest tertile 





hypertension, diabetes, and MetS in the lowest tertile within the obese group was 53.8%, 
26.4%, and 72.4% respectively. Higher leg fat to total fat ratio was also associated with 
more favorable levels of glucose, insulin, HOMA-IR, LDL, TG, and HDL. Those with 
higher leg fat, after separating by sex, had lower CVD risk scores even when they had 
higher amounts of total fat. Also, a logistic regression analysis which controlled for age, 
sex, obesity, smoking status, alcohol intake, BP, serum glucose, dyslipidemia BMI, 
menopausal status, and kidney function revealed those with the lowest leg fat to total fat 
ratio had significantly higher CVD risk, using the atherosclerotic CVD risk score from the 
American Heart Association, with an adjusted odds ratio of 1.85%. Other risk scores 
showed similar results [106]. One notable limitation of this study, as with any cross-
sectional study, is that the directionality of the association could be not concluded. The 
authors also note that they did not have all the information on medication usage available 
to confirm whether certain medications may have influenced the results. Also, it is 
important to note that, in the Korean population, the BMI cut-off point for obesity is a 
lower than western populations as East Asian populations tend to have more body fat and 
experience obesity related comorbidities at a lower BMI than western populations, 
however, this is a large general population study which demonstrates the important role of 
BFD in obesity related comorbidity, also, many of the criteria used to assess CVD risk are 
the same as those used in western populations. There is some controversy regarding the 
beneficial relationship between measures of metabolic health and GF as other studies 
have found that GF still shares an association with worsening metabolic characteristics. In 





was significantly correlated with impaired glucose tolerance (OR=2,07), 
hypertriglyceridemia (OR=2.10), and hypertension (OR=2.15) in 175 men with an 
average age of 45.3 and an average BMI of 25.7, whereas the ratio of GF to BF mass 
exhibited a protective effect against hypertriglyceridemia (OR=0.42) and hypertension 
(OR=0.61) while controlling for age, physical activity, and smoking status. Among the 
417 female participants with an average age of 46.8 and an average BMI of 24.8, GF was 
associated with an increased risk of hypertension (OR=1.57) while gynoid to total fat 
ratio decreased the risk of hypertriglyceridemia (OR=0.49) and hypertension (OR=0.62), 
emphasizing the importance of fat distribution as opposed to fat accumulation in any one 
region [107]. Other studies highlight the role of sex on BFD. Wiklund et al performed a 
longitudinal study on 3258 individuals with a follow-up period of approximately 8 years 
that found in women, abdominal to GF ratio was the best predictor of MI while the ratio 
of gynoid to total fat mass was protective after adjustment for age and smoking status. 
There was no significant difference in total fat mass between women who did or did not 
experience a MI (26.2kg vs 27.5kg, respectively) and there was no significant difference 
in BMI (25.5 vs 26.4). However, there was a significant difference with respect to 
abdominal to GF mass (0.56 vs 0.66) and GF to total fat mass ratio (0.11 vs 0.01). In men, 
no significant results were observed suggesting higher gynoid to total fat mass ratio 
offered any protective effects against MI [108].  
Another study that highlights the importance of BFD as it pertains to obesity related 





1138 men aged 30-65 years sought to assess the relative contribution of BF and BFD to 
the components of MetS. The sample population consisted of individuals enrolled in the 
Dallas Heart Study. Those with diabetes mellitus were excluded from the analysis. Body 
fat and BFD were measured using DXA and the authors used the ratio of TF to lower 
body fat as their BFD measurement. The authors defined lower body fat as all fat below 
the oblique lines. The components of MetS that were measured include TG, HDL, 
HOMA-IR which is a measure of insulin resistance and systolic BP. Participants were 
separated into tertiles based on their ratio of TF to lower body fat and grouped by sex. In 
men, BFD exhibited a stronger correlation with TG than BF percent, but BF had a 
stronger correlation with HOMA-IR. There was not a significant difference in the 
correlation coefficients for systolic BP or HDL. In women, BFD had a stronger 
correlation with TG and a stronger negative correlation with HDL. There was not a 
significant difference between correlation coefficients for systolic BP or HOMA-IR. 
Based on this study, it appears that markers of insulin resistance were more attributable to 
BF while markers of dyslipidemia and higher TG levels were more attributable to the 
ratio of TF to what the authors defined as lower body fat. One thing to note about this 
study is that it was composed of individuals of Caucasian, African American, and 
Hispanic ethnicity proportional to the population of the city in which it took place and 
while there were differences among these ethnicities in regards to BFD and BF, the level 
of association between these variables and components of MetS were consistent among 
these groups which is why the authors pooled them together. As this study was meant to 





it is possible that the strength of these correlations may differ in a more homogenous 
population. While this study was chosen for this review because it highlights how BFD 
and total BF may differentially affect different obesity related comorbidities in a wide age 
range of men and women from a general population, it is important to note the factor of 
ethnicity that may make it less generalizable to some populations [109]. Another large 
general population study that highlights the role of BFD in the development of obesity 
related comorbidities was published in BMC Public Health by Lukacs. This study 
examines the relationship between BFD and metabolic risk factors in a sample of non-
obese participants. 2082 men and 3146 women aged 18 years and older with no history of 
diabetes, hypertension, ischemic heart disease, or chronic obstructive pulmonary disease. 
All measurements were performed on-site by a community nurse and a public health 
practitioner. The metabolic variables that were measured include blood glucose, TC, 
LDL, HDL, and TG. WC was used as an index of abdominal obesity and this 
measurement was made at the halfway point between the lowest rib and iliac crest. 
Participants were divided into a high WC group and a normal WC group with a high WC 
being defined as having a WC above 102cm in men and above 88cm in women. Those in 
the high WC group had a significantly higher occurrence of high systolic BP, high fasting 
blood glucose, high cholesterol, and high TG based on the cut-off points set by the 
ATPIII criteria of MetS. A subsequent logistic regression analysis adjusted for age and 
gender showed that the high WC group had a significantly higher risk of having high BP, 
low HDL, and high TG as the odds ratios were 1.53, 2.06, and 1.65, respectively. The 





compared to those ages 20-31 [110]. This study demonstrates the impact specific BFD 
patterns can have on health even in a normal weight, general population, however, there 
are some limitations to note in this study. The issue of using WC as an index of adiposity 
has been mentioned before. It can vary quite a bit and is dependent on the skill of the 
individual taking the measurement. It is also important to note that the sample population 
also skews a little younger with the majority of participants between the ages of 18-44. 
Another limitation is that information on medication usage is not provided or adjusted for. 
It is possible that some participants may have been using medications that may have 
affected the outcomes of this study, especially among older participants, and of course, as 
this is a cross-sectional study, cause and effect cannot be discerned. It is apparent BFD 
patterns are important for determining the risk of obesity related comorbidities, it is 
imperative that the factors which influence BFD patterns are thoroughly researched and 
well understood. The factors that contribute to BFD patterns are no less complex than the 
factors that contribute to obesity as a whole. There are a plethora of aspects to be weighed 
and considered. The next section explores these factors beginning with a review of the 
underlying genetic factors and building outwards to physiological, environmental factors, 
and behavioural factors. 
1.7 Factors Influencing Body Fat Distribution 
1.7.1 Genetics and Body Fat Distribution 
There are a large number of genetic factors that have been shown to influence BFD and 
with the advances in GWAS, more are being found. A large collaborative effort to 





found 44 loci associated with WHR adjusted for BMI (WHRadjBMI). Of the 44 loci 
identified, 17 were novel. 28 of the 44 showed larger effects in women while only 5 
exhibited a larger effect in men and perhaps most interestingly, 11 showed opposite 
effects between sexes. The genes exhibiting sex-dependent opposite effects were CECR2, 
PTPRD, RXRA, TTN, IRS1, SLC2A3, IQGAP2, SGCZ, GNPNAT1, SIM1, and NMU. 
These genes control a very diverse role of functions ranging from chromatin remodeling, 
to lean muscle development, insulin receptor substrates, and hypothalamic mediators of 
stress [111]. Another study concerning WHRadjBMI conducted a GWAS meta-analysis of 
224,459 individuals. This revealed 49 loci, 33 of which were new, associated with WHR, 
and 19 novel loci associated with waist or hip circumference alone. 20 loci displayed sex-
dependent effects, 19 of which appeared to be much more pronounced in women. 
Additional pathway analysis identified many possible physiological mechanisms by 
which these genes operate including adipogenesis, angiogenesis, and insulin resistance 
[112]. Follow up studies to further investigate the functionality of these genetic loci as 
they pertain to BFD could offer great insight into potential therapies in the future and it 
would also be beneficial to better understand the underlying mechanism of the sex-
dependent effects that were observed as sex is an important BFD factor 
1.7.2 Sex and Body Fat Distribution 
Another more noticeable observation concerning BFD patterns is the stark difference 
between many men and women. In men, the accumulation of truncal or android and 
visceral adipose tissue is far more common than gynoid adipose tissue accumulation. 





is far more common in women than men. This sexual dimorphism of BFD has long been 
observed [113-115]. The BFD differences between men and women may largely be 
influenced by sex hormones. Estrogens have been repeatedly shown to decrease appetite 
and therefore caloric intake. Animal studies on estrogens have been shown to decrease 
appetite by potentiating the effects of anorectic hormones such as cholecystokinin and 
leptin while decreasing the effects of orexigenic hormones such as ghrelin [116-118]. 
Studies on women have also found that energy intake tends to be at its lowest during the 
late ovulation phase of the menstrual cycle when estradiol levels are at their peak [119, 
120]. However, the effects of sex hormones on BFD go well beyond appetite control. 
Testosterone, growth hormone, and estrogen are thought to combat central fat 
accumulation by mobilizing fat stores while hormones such as cortisol and insulin 
promote fat accumulation. Furthermore, visceral adipose tissue tends to have more 
cortisol and androgen receptors than adipose tissue elsewhere in the body which explains 
why these hormones appear to wield so much influence over the deposition of VF while 
estrogen receptors do not appear to be present on this particular type of adipose tissue 
[121, 122]. A study aimed to better elucidate the role of estrogen in fat accumulation by 
obtaining subcutaneous abdominal adipose tissue samples from two groups of women via 
liposuction. One group of women were an average age of 55.8 years, had an average BMI 
of 25.5, and were reported to be healthy and not receiving any hormone replacement 
therapy treatment. The other group of women were an average age of 53.7 years, had an 
average BMI of 24.8, and were receiving hormone replacement therapy but were reported 





days of taking a tablet containing 2mg of estradiol, 10 days of taking a tablet containing 
2mg of estradiol and 1mg norethisteronacetate, and 6 days of taking a tablet containing 
1mg of estradiol. The authors defined the in vivo portion of their study as the research that 
was performed on the isolated adipocytes of this group of women. The authors described 
the in vitro portion of the study at the research that was performed on cultured adipocytes. 
All liposuction procedures were for cosmetic reasons and all women had received 
hormone replacement therapy for 3 years. In addition to this, samples of subcutaneous 
abdominal and visceral adipose tissue were obtained from 5 women living with obesity 
with an average BMI of 45.2 who underwent gastric banding surgery for severe obesity. 
This is a procedure that involves placing an adjustable, inflatable band around the upper 
portion of the stomach which induces feelings of fullness without consuming as much 
food as the patient would have previously consumed. The purpose of this procedure is to 
achieve weight-loss via caloric restriction [123]. Lipolysis, lipoprotein lipase, hormone-
sensitive lipase, α2-adrenergic receptor mRNA, and α2-adrenergic receptor activity were 
measured from isolated adipocytes as well as cultured adipocyte samples. It was found 
that estradiol directly increases the number of antilipolytic α2A-adrenergic receptors in 
subcutaneous adipocytes thereby lowering the subcutaneous lipolytic response whereas 
estradiol appeared to exhibit no control over intra-abdominal or VF adipocytes. This 
would suggest that the typically female BFD pattern is maintained by way of female sex 
hormones, specifically estradiol, inhibiting lipolysis in certain subcutaneous fat regions 
thereby favoring subcutaneous fat accumulation rather than VF accumulation [124]. 





lean muscle mass and mobilizes fat stores in this area [125, 126]. This section concerns 
the differences in BFD attributable to sex and as the previous research explored the role 
of female sex hormones the next study that is cited will explore the role of male sex 
hormones. A study published in 2006 by Derby and colleagues investigated the 
association between BMI, BFD and changes in sex hormones in a group of 942 men who 
were randomly recruited to take part in the Massachusetts Male Ageing Study. All men 
were between the ages of 40 and 70 at the time of recruitment between 1987-1989 and 
follow up measurements were completed in 1995-1997. The anthropometric 
measurements included height, weight, and WHR. BP was also measured. Height and 
weight were measured by a trained interviewer while participants were in socks and light 
clothing. A non-fasting blood sample was obtained by a trained phlebotomist for the 
measurement of sex hormones between 9am and 11am. Two blood samples were taken 30 
minutes apart to account for episodic hormone secretion. WC and WHR were used as an 
index of abdominal adiposity which was defined as a WC above 100cm or a WHR above 
0.95.  Men who were diagnosed with prostate cancer or had outlying hormone 
concentrations were excluded. The hormonal measurements that were taken included total 
testosterone, free testosterone, Dehydroepiandrosterone, and sex hormone-binding 
globulin. Covariates included age, follow up levels of smoking, alcohol intake, diabetes, 
heart disease, cancer, physical activity levels, and general health status. The baseline 
levels of all measured hormone concentrations were inversely correlated with WC. 
Baseline levels of total testosterone, dehydroepiandrosterone, and sex hormone-binding 





concentrations with the exception of dehydroepiandrosterone were inversely correlated 
with BMI. Free testosterone, total testosterone, and sex hormone-binding globulin 
concentrations were all lowest among men who were classified as obese at baseline and 
follow up and those who became obese at follow up. Levels of total testosterone at follow 
up were highest among men who were never obese by any of the 3 indices used and the 
lowest follow up concentrations were reported for men who were obese at both baseline 
and follow up. It should be noted that the use of waist and hip measurements and as an 
index of abdominal adiposity is subject to error and can vary based on the exact location 
of the measurement. Also, this study was completed in a group of men ranging in age 
from 40-70 so it is best to be cautious if generalizing these results to much younger men. 
While this study demonstrates a relationship between sex hormones and BFD, the design 
of the study does not allow one to conclude the directionality of the correlations between 
BFD and sex hormones. While the sex-related variation of BFD is well researched and 
easily observed, another sex-related aspect that should not be overlooked when 
researching BFD and obesity is that of menopausal status in women. 
1.7.3 Menopause and Body Fat Distribution 
In women, reproductive stages may also influence BFD. Before menopause, 
subcutaneous fat stores tend to build in the gynoid area as opposed to the abdominal area 
while this balance seems to shift to store more abdominal fat after menopause [127]. This 
was demonstrated in a study that examined 12 perimenopausal women and 12 post-
menopausal women. Perimenopause describes the 2 to 8 year period before menopause as 





race. All women were described as sedentary meaning no more than 20 minutes of 
exercise weekly, had stable weight meaning less than 2 kg in weight change over the last 
year and none reported smoking within the last 5 years. Women were also screened to be 
sure no participants were using birth control, hormone replacement therapy, or drugs that 
could influence lipid metabolism. Several measurements of body composition were taken 
including waist and hip circumference, DXA scanning, and a single slice abdominal CT 
scan taken between the L4 and L5 vertebrae of the spine. Follicle-stimulating hormone, 
estradiol, free testosterone, and sex hormone-binding globulin were measured from serum 
samples. Adipose tissue samples were obtained for measurement of lipoprotein lipase 
activity from the abdominal and gluteal regions by aspiration using a 16-gauge needle 
following an overnight fast. Participants were also put on a controlled diet for 2 days 
before the study which consisted of 50-55% carbohydrates, 15-20% protein, 30% fat, 
200-400mg cholesterol, and polyunsaturated to saturated fat ratio of 0.6-0.8. Basal 
lipolysis in adipose tissue cells from the gynoid region, referred to in this paper as the 
gluteal region, was significantly higher in perimenopausal women. Adipose tissue 
lipoprotein lipase activity was reported to be significantly lower in perimenopausal 
women in samples obtained from both the gluteal and abdominal area. This was 
expressed as the nanomoles of FFA produced per gram of tissue in 1 min. In 
perimenopausal women, this number was 2.0 nmol FFA/g.min and 1.3 nmol FFA/g.min 
in the gluteal and abdominal region, respectively. In postmenopausal women, lipoprotein 
lipase activity was reported to be 4.9 nmol FFA/g.min and 3.2 nmol FFA/g.min in the 





significantly higher in the gluteal region compared to the abdominal region in both 
groups. When lipoprotein lipase activity was expressed per 1 million cells, it was reported 
to be significantly lower in the abdominal region of the perimenopausal group but was not 
significantly different for the gluteal region [127]. The strength of this study lies in the 
fact that the researchers managed to obtain adipose tissue samples from living subjects in 
two groups of women matched for BMI and body fat percentage. It was also wise to 
control the women’s diet leading up to the sampling. It would’ve been helpful to know if 
all blood samples were taken at approximately the same time as some hormone’s 
concentrations can vary throughout the day. It is, of course, difficult to say how strictly 
each participant adhered to the controlled diet as well. Abdominal fat accumulation may 
increase after menopause as a result of the change in lipoprotein lipase activity explored 
in the previously described study and this is preceded by lowering estrogen levels, but it 
has been shown that estrogen substitution via hormone replacement therapy can reduce 
abdominal fat storage in postmenopausal women [128, 129].  
To clarify, it appears that estrogen promotes fat storage in the lower body while 
testosterone systemically combats any fat accumulation and uniquely influences VF 
accumulation. It is when estrogen and testosterone are diminished in women and men 
respectively, that central or VF accumulation may begin to increase. This is further 
substantiated by studies that have shown that in pre-menopausal women when estrogen 
levels are higher, body fat tends to accrue around the hips, buttocks, and thighs but as 





towards abdominal fat storage [130, 131]. While the underlying cellular mechanisms for 
these effects are not well understood and there is still much to be learned, here is what is 
currently known of the sexual dimorphism of BFD at the cellular level. Visceral and 
subcutaneous adipose tissue contains both estrogen and androgen receptors, however, VF 
tends to have more androgen receptors as noted above in section 1.7.2. Androgens such as 
testosterone inhibit preadipocyte differentiation and maturation. The presence of 
androgen receptors in adipocytes appears to be upregulated in the presence of 
testosterone. When bound, androgen receptors interact with co-activators which may up 
or down-regulate transcription of genes that contain androgen response elements. It has 
been proposed that β-catenin nuclear translocation is triggered by the androgen receptor 
which is a downstream effector of the Wnt signaling pathway, Wnt proteins then 
inactivate glycoprotein kinase 3β which represses phosphorylation of β-catenin, an 
important pathway for cellular differentiation and proliferation. Also, in preadipocytes, 
expression of Wnt protein represses adipogenesis via the inhibition of PPARγ 
transcription factors [132]. Androgens may also upregulate adrenoceptors which are g-
protein-coupled receptors for catecholamines such as norepinephrine and are important 
for the activation of lipolysis. Lipolytic effects on adipose tissue are mediated through the 
activation of β-adrenoceptors which subsequently activates adenylyl cyclase, signaling an 
increase in intracellular cAMP levels. cAMP then phosphorylates Protein-Kinase A 
which in turn phosphorylates hormone-sensitive lipase and lipid droplet binding proteins. 
Fatty acids are then released, bound by chaperone proteins, and transported out of the cell 





through various estrogen receptors (ER), for example, ERβ4 and ERβ5 expression are 
higher in gynoid adipose tissue than subcutaneous abdominal adipose tissue [134]. Also, 
activation of ERα increases the expression of anti-lipolytic α2 adrenergic receptors in 
subcutaneous but not VF stores. The activation of α2 adrenergic receptors inhibits 
adenylyl cyclase activity which decreases cAMP levels resulting in a decrease in the rate 
of lipolysis [135]. 
Sexual and menopausal factors account for a great deal of the variability in BFD, 
however, other factors have been shown to have an association with BFD that should not 
be overlooked. This includes ethnicity, environmental factors, and dietary behaviour 
which are explored in the subsequent sections. 
1.7.4 Ethnicity and Body Fat Distribution 
Ethnicity is yet another factor that may also play a role in body composition and BFD 
patterns. Slight variations among different ethnicities within the same geographical area 
have been observed and used as reference data [136]. Differences in body composition 
and BFD have even been observed in young children in various stages of life ranging 
from infancy, childhood, and puberty [137]. Ethnic differences in BFD are explored in the 
studies cited below in several different age groups to support the previous claim that 
ethnic differences in body composition and BFD are observable at different life stages. 
A study of 332 term infants recruited within 1-3 days of birth investigated the relationship 
between race and body composition. The race of the infants was based on the report of 





congenital disorders, infections, or non-singleton birth were excluded. Infants were also 
excluded if the mother was diabetic, had pre-eclampsia, or were admitted to the neonatal 
ICU. Infant length and crown to rump length were measured using an infant length board. 
Weight was measured using an electronic scale. Fat mass was calculated using air 
displacement plethysmography. To sum this method up briefly, an individual is placed in 
a chamber, and body volume is calculated based on pressure changes that occur between 
the testing chamber and reference chamber with corrections made for thoracic gas 
volume. This is calculated using Boyles Law (P1V1=P2V2) [138]. Body density is 
calculated by dividing body mass by body volume and fat mass is calculated using Siri’s 
equation (% Body Fat=[(4.95/body density-4.50)x100] [139]. The authors reported that 
African American and Caucasian females had higher fat mass than African American and 
Caucasian males, however, Caucasian males had less fat mass than Asian and Hispanic 
males but there was no significant difference observed between Caucasian and African 
American males [140]. Air displacement plethysmography is a reliable means of 
measuring fat mass in infants [141], results can be affected by the hydration levels of the 
participant and it does not provide regional body composition data the way other 
measures of body composition could. It should also be mentioned that the researchers had 
no information on maternal nutrition or access to nutrition so they are unable to correct 
for these variables that could influence birthweight and infant body composition. This 
study, though not without some limitations, demonstrates that there are possible ethnic 
differences in body composition from birth, but how do these differences extend to BFD 





composition and BFD) among 176 girls and 182 boys ages 5-12 years who were either 
Caucasian (n=120), African American (n=95), or Asian (n=143). The ethnicity of all four 
grandparents was used to confirm the ethnicity of the child and medical history along 
with a physical examination was used to confirm normal health status. This study 
measured body composition and BFD using skin-fold thickness measured by calipers and 
DXA. Skin-fold measurements were taken at the tricep, bicep, chest, subscapular, 
abdomen, suprailiac, calf and thigh area. Among male participants, according to skin-fold 
measurements, Asian children had significantly more GF than African Americans but did 
not differ significantly in extremity fat from either African American or Caucasian 
children. According to DXA based BFD measurements, Asian boys had significantly less 
extremity fat than Caucasian boys. Among female participants, Asians had significantly 
less extremity fat and GF than Caucasians when using skin-fold measurements. 
According to DXA based measurements, Asians had significantly less extremity fat than 
both Caucasians and African Americans. Asian girls also significantly less GF than 
African American girls [142]. One possible issue with this study is that pubertal status 
was not confirmed biochemically in all children, just a small sample of them, which could 
have affected body composition among some of the older children. It is also important to 
note that information on socioeconomic status (SES), diet or exercise was not available 
for this analysis. Each of the previously described studies examined BFD differences 
among several ethnicities early in life and demonstrated that some differences among 
ethnicities may be present from birth. However, these results would carry more weight 





variations among different ethnicities was performed by Stults-Kolehmainen and 
colleagues. This study consisted of 852 men between the ages of 18 and 30. The 
participants were 50.7% Caucasian, 17.7% Hispanic, 23.7% Asian, and 7.9% African 
American. Height and weight were measured using a stadiometer and physician scale. 
BFD was measured using DXA. Individuals were excluded if they had any metal or rods 
in their bodies or if they were unable to fit their entire body in the DXA scanner. All 
participants filled out health questionnaires and were reported to be free of any chronic 
disease before taking part in the study. Hispanics had a higher fat percentage than 
Caucasians for every region and a higher fat percentage than African Americans in every 
region but the arms. Hispanics had more fat in the trunk and android region than Asians, 
though Asians had higher TF and AF than African Americans. Asians also had more TF 
than Caucasians [143]. Some important notes about this study are that participants were 
recruited from an exercise class and while none of the participants were college-level 
athletes at any point, they may be much more active than the average person. Also, the 
average BMI among each group ranged from 23.9 to 26.5 meaning the majority of 
participants were not obese so it cannot be assumed that similar ethnic BFD differences 
would be observed among those living with obesity. Though there were no significant 
BFD differences between African American and Caucasian men in the study, other 
studies have found that Caucasian men of a similar BMI have a greater amount of VF 
than African American men and women after controlling for age, sex hormone levels and 
total BF [144]. There have been many reported observations of differences in BFD and 





and access to nutrition are important factors that should be considered as environmental 
aspects could be potential confounders.  
1.7.5 The Environment and Body Fat Distribution 
Living in environments of lower SES can affect dietary behaviours which have been 
shown to be largely mediated by the food environment in low SES areas [145]. 
Additionally, lack of fruit/vegetable consumption in low SES areas and the consuming of 
certain foods that are eaten more frequently in low SES areas such as soft drinks, 
processed meats, pizza, chips, table sugar, and other savory snack foods [146] have been 
shown to increase central adiposity [147, 148] whereas healthier diets such as the 
Mediterranean diet have been shown to decrease central adiposity. A study of 25 males 
and 34 females living with obesity and MetS investigated the benefits of dietary 
intervention, using a hypocaloric Mediterranean diet, on body composition and 
cardiometabolic health. Patients were followed for 6 months and had assessments every 4 
weeks. Those who did not comply with the dietary regimen were excluded. Other 
exclusion criteria included T2D, coronary or peripheral artery disease, heart failure, renal 
or hepatic disease, and smoking. None of the participants reported using any lipid-
lowering, anti-diabetic, insulin, nitro derivatives, or systemic corticosteroid medications 
at the time of the study. The total caloric intake recommended for each participant was 
calculated individually with resting metabolic rate accounted for. The mean energy value 
was around 1500 kcal. Height and weight were reported to have been performed 
according to the standard procedure after a 12 hour fast without clothes or shoes. WC was 





circumference was measured at the widest point. Body composition was determined using 
DXA. Blood samples were taken following a 12 hour fast between 7:00 am and 9:00 am 
and used to measure glucose, TC, HDL, LDL, and TG. It was reported that adherence to 
the Mediterranean diet resulted in a significant decrease in WC, total BF, TF, and AF. 
Adherence to the diet also resulted in a 56% decrease in MetS for men and a 47% 
decrease in MetS for women [149]. While the outcomes for participants were great, this 
study was conducted with consistent support from nutritional experts so it is hard to say 
how likely someone would be to adopt and adhere to this diet long-term without access to 
such guidance. Additionally, while the Mediterranean diet is a healthy, nutrient-dense 
diet, this study intentionally decreased daily caloric intake for each participant by about 
500 calories a day. It is difficult to say, to what extent the promising results are 
attributable to the content of the diet as opposed to merely decreasing caloric intake. This 
finding has been mirrored in other studies as well [150, 151]. While there are dietary 
factors to be considered such as whether a meal induces satiety thereby decreasing the 
need to consume more or the glycemic index of a food which will influence the insulin 
response, ultimately, weight-loss requires creating a calorie deficit. Some disordered 
eating behaviours such as BED or FA may make it much more difficult for individuals to 
even attempt creating a calorie deficit with the goal of losing weight. However, before the 
role of FA, as defined by the YFAS, in BFD patterns can be discussed, a foundational 
understanding of FA and how it is measured must first be understood. 





Simply overeating is not necessarily indicative of disordered eating however, some 
individuals may begin compulsively eating to an obsessive degree. This type of behaviour 
goes well beyond normal indulgence or homeostatic eating and self-reported food addicts 
display behaviours consistent with the criteria for substance abuse disorders as described 
in the DSM-IV TR [152]. Food addicted individuals will continue to eat certain foods far 
beyond the appropriate amount required to merely maintain health. Individuals who 
display these addictive eating behaviours have been found to display less impulse control, 
higher emotional reactivity, significantly greater food cravings, and the tendency to self-
soothe with food [153].  
Several overlaps have been identified between addictive eating behaviour and other forms 
of substance addiction. Highly palatable foods have been found to share many similarities 
with nicotine regarding how the brain’s reward pathways, such as the mesolimbic 
dopamine system, are activated and behavioural overlaps have been observed as well 
[154]. Another example of this overlap was demonstrated by a study that examined the 
relationship between maternal nicotine exposure, food preferences, and dopaminergic 
pathways in rats. It was reported that adult rats that were subjected to maternal nicotine 
exposure had lower dopamine receptors and dopaminergic transporters in the nucleus 
accumbens and lower dopamine receptors in the arcuate nucleus, which coincided with a 
higher ad libitum intake of the provided high sugar diet [155]. The relationship between 
lower dopamine receptor content, binge eating, and increased sugar intake has also been 





between abusing addictive substances such as nicotine and the consumption of highly 
palatable foods such as those rich in sugar and fat have also been observed using rodent 
models. Studies have found that rats have exhibited signs of tolerance, sensitization and 
even withdrawal symptoms such as anxiety, teeth chattering, forepaw tremors and head 
shakes in several studies concerning FA and binge eating behaviours [157, 158]. Further 
evidence of the neurobiological overlap between FA and substance abuse and how FA 
symptoms fit into the criteria for other substance abuse disorders are explored in sections 
1.8.1 and 1.8.2 
1.8.1 Neurobiological Correlates of Food Addiction and Substance Abuse 
Both highly palatable foods and nicotine have been found to evoke similar reward 
pathway activation patterns, as noted in the previous section. The similarities between FA 
and substance abuse are further illustrated by the following study. A study of 48 young 
women with an average age of 20.8 years, ranging from lean to obese were subjected to a 
between-subject functional magnetic resonance imaging (fMRI) study. Lean or obese 
status was determined using BMI classification and height and weight were directly 
measured by researchers using a digital scale and stadiometer. Participants were asked not 
to ingest any food or beverages 4-6 hours before the imaging session which allowed 
researchers to assess the participants in the state of hunger experienced as individuals 
approach their next meal. This is also the time when differences in behaviour as it 
pertains to food reward would be most pronounced. Most participants completed the 
paradigm between 10:00 am and 1:00 pm, though some completed it between 2:00 pm 





themselves with the fMRI paradigm on a separate computer. FA was measured using the 
YFAS. Patients were divided into two groups, a high FA group with 3 or more FA 
symptoms and a low FA group with 1 or no symptoms. The researchers excluded those 
with only 2 FA symptoms to make sure there was an adequate separation between the two 
groups. Participants were randomly presented with an image of either a chocolate 
milkshake or a glass of water which was followed by the administration of either the 
milkshake or a solution designed to mimic the taste of saliva as actual water can also 
activate the taste cortex. In 40% of the trials, the taste was not delivered as anticipated to 
avoid confounding the neural response to the anticipation with the response to ingesting 
the substance in question. It was found that FA scores correlated with increased activation 
in the anterior cingulate cortex, the medial orbitofrontal cortex, and the left amygdala, all 
of which are involved in the brain's reward pathways, and those women with higher FA 
scores exhibited greater activation in areas associated with reward circuitry when they 
anticipated that they would be receiving food [159]. One limitation of this study was that 
it was performed in a small group of young women so the conclusions should not be 
carelessly generalized to men or a large general population. Also, only two participants 
met the criteria for FA “diagnosis” so individuals with severe FA are not necessarily well 
represented in this study. Also, hunger was not measured in this study. A measurement of 
the participant's hunger may have been helpful here as this may also affect the response to 
the presentation and administration of the milkshake. Neuroimaging studies have also 
revealed differential activity in the brain based on obesity status in response to highly 





oxygenation level-dependent activation in the dorsal striatum, an area related to reward 
circuitry, dopamine receptors, and BMI. BMI was calculated by measuring height and 
weight using a mechanical scale. Blood oxygenation level-dependent response was 
measured in 29 individuals aged 19-39 years. All participants were screened for any 
serious medical conditions, psychiatric disorders, neurological disorders as well as any 
history of head trauma or loss of consciousness. Participants were asked to arrive feeling 
neither hungry nor full and to avoid eating 1 hour before the session. They were also 
asked to rate their hunger upon arrival by selecting a number from visual analog scales 
ranging from -100 (“I am not hungry at all” or “I am not full at all”) to +100 (“I have 
never been more hungry” or “I have never been more full”) with 0 being “neutral”. 
Participants were also allowed to participate in a mock trial to familiarize themselves with 
the procedure. The training and scanning sessions were performed on different days and 
all scans took place between 11:00 am and 3:00 pm. Blood oxygenation level-dependent 
response was measured using susceptibility-weighted single-shot echoplanar imaging. 
Susceptibility-weighted imaging is a neuroimaging technique that makes use of a tissue 
magnetic susceptibility to enhance contrast in MRIs, magnetic susceptibility being the 
degree of magnetization of a material when a magnetic field is applied. A single-shot 
echoplanar image is a very fast MRI technique capable of capturing an entire image in 
only a fraction of a second using only a single radio-frequency excitation [160]. 
Dopamine receptor availability was measured using positron emission tomography. 
During the fMRI, participants were administered either a tasteless solution or a Nestle 





until it was fully administered, and a tasteless rinse was administered 3-10 seconds after 
the milkshake. It was found that there was an inverse relationship between the blood 
oxygenation level dependent response in the dorsal striatum to the milkshake and BMI. 
The availability of the dopamine receptors, D2R and D3R, exhibited a positive correlation 
with BMI, however, there was no clear connection observed between the blood 
oxygenation level-dependent response to palatable food and dopamine receptor 
availability [161]. The echoplanar imaging techniques used in this study allowed the 
researchers to collect highly detailed information on how the brain's reward systems 
respond to palatable food. A limitation of this study is the small sample size (n=29). The 
authors of the paper acknowledge that this may have contributed to a false negative 
regarding the relationship between dopamine receptor availability and the blood 
oxygenation level dependent response. The authors of the paper also note that the 
availability of dopamine receptors appeared to decrease as age increased which may 
suggest one be cautious if trying to generalize these results to a senior population. Many 
of these same brain areas, including the anterior cingulate cortex and the orbitofrontal 
cortex, are associated with cravings in individuals with substance abuse disorders such as 
those addicted to cocaine [162]. Some of these areas show increased activation by simply 
recalling past experiences with drug use [163]. It was demonstrated quite some time ago 
that food elicits a short term increase in dopamine in the nucleus accumbens, which 
connects multiple components of the brain's reward pathways, in a way similar to other 
addictive substances [164]. It has also been found that consuming food items such as 





[165]. It has been reported that not only drugs but also drug-related stimuli can produce 
increased activation in the mesolimbic dopamine system which plays a role in cravings 
and eventual relapse and more recently, an fMRI study by Rothemund and colleagues 
found that images of highly palatable, high-calorie food can have the same effect in a 
sample of obese patients. This study was conducted with 13 obese female subjects and 13 
normal-weight female subjects with an average age of 31 and 29 years, respectively. Each 
participant was screened for neurological and psychiatric illness as well as diabetes, 
stroke, a history of substance abuse, or eating disorders. Obesity status was defined as a 
BMI of 31.0 or greater. All participants also had normal or corrected to normal vision 
which was important in this particular study as participants are subjected to a series of 
visual stimuli. Participants were also excluded if they reported being hungry before 
testing as this study aimed to measure an individual’s response to food-related visual cues 
and hunger would of course influence this response. No subject had been eating within 
1.5 hours of fMRI scanning. Mean calorie intake was also reported before taking part in 
the study. Participants were hooked up to an fMRI scanner with a vacuum pad to 
minimize head movement and shown 40 images for 3 seconds at a time. The images 
consisted of high-calorie foods (ex. Hamburgers), low-calorie foods (ex. vegetables), 
eating-related utensils (ex. Forks, spoons, etc.), and neutral images such as flowers and 
rocks. It was reported that visual cue-induced food motivation resulted in differential 
activation of the dorsal striatum in women living with obesity compared with normal-
weight women. A proportional increase between BMI and activity in the dorsal striatum 





this paper acknowledge that the handedness of 3 of the control group participants may 
have affected stimulus processing and that differences in the educational background may 
have also influenced food preferences. Another limitation of this study is of course the 
fact that this was conducted on a small group of women so we cannot conclude that we 
would reliably see similar results in men. Participants are said to not have eaten 1.5 hours 
before testing but it is not made clear if they also abstained from drinking any beverages. 
This would have been helpful to know as consumption of beverages, especially sugar-
sweetened or fatty beverages may have influenced response to visual food cues. 
Participants were reported to have been screened for addictions but confirming that 
individuals abstained from smoking anything prior to testing would have been ideal as 
substances such as nicotine may also influence response to food related stimuli since 
nicotine can affect appetite. Also, it is not made entirely clear if weight and height are self 
reported or if the research team weighed participants at the study site. The numerous 
similarities between food and addictive substances as it pertains to activation in the brains 
reward and motivation centres lend to the development of the idea of FA and tools by 
which to measure or diagnose FA.  
1.8.2 Diagnosis of Food Addiction 
The YFAS is a validated tool that is used to diagnose FA and measure the severity of FA 
in an individual. In addition to the brain imaging research described in the previous 
section, there were other keen observations made by various researchers that preceded the 





noted that there were similarities between the diagnostic criteria for substance 
dependence and the diagnostic criteria for binge eating disorder (BED). The symptoms 
that Gold and colleagues noted specifically are 1) tolerance or the need for an increased 
amount to achieve the desired effect, 2) substance is taken in larger amounts of or over a 
larger period than intended 3) persistent desire of unsuccessful attempts to cut down or 
control use 4) a great deal of time is spent obtaining, using or recovering from the 
substance, 5) important activities are reduced or given up because of the substance and 6) 
continued use despite adverse consequences. Gold and colleagues go on to note other 
similarities between those living with BED and those with substance abuse disorders such 
as compulsive thoughts and obsession. They also note that much like alcohol or tobacco 
addicts, an individual with BED cannot merely “take it or leave it” [167]. This particular 
article is not original research nor is any formal experiment conducted,  however the 
creators of the YFAS mention this piece of work as a notable contribution to the larger 
body of work that preceded the creation of the YFAS [168]. Another paper that lent to the 
rationale behind the YFAS comes from Volkow and O’Brien who noted similarities 
between symptoms of substance abuse and the broader issue of obesity rather than BED. 
They reported that these corresponding obesity-related behaviours were 
-tolerance: increasing amounts of food to maintain satiety  
-distress and dysphoria during dieting 
-larger amounts of food being eaten than intended 
-persistent desires for food and unsuccessful attempt to curtail the amount eaten 





-activities are given up for fear of rejection because of obesity 
-overeating is maintained despite knowledge of adverse physical and psychological 
consequences [169] 
One symptom of substance abuse for which there is little evidence of a corresponding 
behaviour in FA is that of withdrawal. There is one case study reported by Ehrenreich in 
2006 where a woman with a previously controlled panic disorder experienced the return 
of her symptoms after starting a high protein low carbohydrate diet. The symptoms upon 
diagnosis of the panic disorder at age 37 included chest pain, dizziness, and an 
overwhelming sense of fear without depression, among others. This was largely under 
control until she began her low carbohydrate diet at the age of 47 in an effort to lose 
weight as she weighed 252 pounds at the time. One day after starting this diet she 
experienced shakiness which turned into full-blown panic attacks that reportedly 
improved within the first day of resuming carbohydrate consumption and resolved within 
several days [170]. Of course, this is a case study so there are a number of factors that 
may be unaccounted for and withdrawal-like symptoms would have to be observed in a 
larger number of people before any conclusions could be made. It is also possible that this 
withdrawal-like behaviour was unique to this woman as her panic disorder was a pre-
existing condition. The very idea that certain foods may have addictive properties goes 
back as far as 1956 when Randolph suggested that frequently consumed foods such as 
maize, wheat, potatoes, and several others, relieve symptoms of “malaise” and that this 
may result in sensitization to these foods, leading to obesity [171]. Earlier research on 





recruited 50 participants who were self-described “chocoholics”.  The aim was to 
quantify chocolate intake and investigate their beliefs, feelings, and attitudes about their 
supposed addiction to chocolate using the Dutch Eating Behaviours Questionnaire, the 
Eating Attitudes Test, the Eating Inventory, the Body Shape Questionnaire and the Beck 
Depression Inventory. These questionnaires assess disordered eating, restrained eating, 
body dissatisfaction and depression. The average age of participants was 39.8 years and 
92% were women with a mean BMI of 25.3. The mean number of self-reported chocolate 
cravings per month was 24.2 times with an average consumption of 12.5 bars of chocolate 
a week (1 bar=60g). Other foods that were commonly craved included confections, cake, 
ice cream, bread, pasta, and pizza. 86% of participants said they indulged their food 
cravings 75% of the time and of those who reported giving in to these cravings, 49% 
reported that it made them feel guilty, dissatisfied, and unattractive. When trying to 
reduce chocolate consumption 66% reported feelings of irritation while most participants 
(86%) reported feeling positive while eating chocolate. 76% reported being unable to 
resist urges to eat chocolate while 72% said that even the sensory features of chocolate 
caused cravings. There are several important limitations to note in this study. First, the 
majority of participants were women and of these women, 58% reported increased 
cravings during pre-menstruation. This is an important sex-specific effect that makes it 
difficult to say how applicable these findings are to men. Second, they mentioned the age 
range is 14-83 years old. Questions on body image and guilt related to eating may be 
perceived very differently by such a young individual and eating habits may be very 





what and when they eat. Due to a lack of information, we cannot be absolutely sure there 
aren’t other young teens included in this study. It also appears as though height and 
weight were self-reported in this study so the BMI calculation may also be inaccurate, 
and it is not clear exactly how many of the participants were obese, merely overweight or 
normal weight. Lastly, according to the Beck Depression Inventory 84% of participants 
reported mild depression and 30% reported moderate depression. With so many 
participants experiencing depressive symptoms it also makes it difficult to say how 
representative this sample is of the average population. While there has been some solid 
research on the neurobiological correlates of the addictive potential of food as described 
in section 1.8.1, early research on addictive eating behaviours had many limitations such 
as those noted in the above study. Before the YFAS there were tools that measured 
disordered eating such as the Dutch Eating Behaviour Questionnaire which measures 
emotional eating, external eating (eating simply due to the sight or smell of food), and 
restrained eating [172]. There was also the Eating Self-Efficacy Scale which measures 
difficulty controlling eating in various social situations or when experiencing feelings 
such as depression, anxiousness, or nervousness [173], however, there was no dedicated 
tool to assess specifically addictive eating. The YFAS is a tool for diagnosing FA and 
providing a means of measuring the severity of FA in an individual [168]. It has been 
employed as a method of measuring FA in studies of several different populations 
including but not limited to adults seeking weight loss treatment [40], obese individuals 
with BED [174], and bariatric surgery patients [175]. The YFAS is a 25-item 





25 questions make up the 7 possible symptoms of FA. Some of these questions ask about 
the frequency of a specific behaviour. For example, the first item on the YFAS states “I 
find that when I start eating certain foods, I end up eating much more than planned” and 
asks how often this behaviour has occurred over the last year with the options being 
“never”, “once a month”, “2-4 times a month”, “2-3 times a week”,  or “4 or more times 
or daily”. Other questions simply require the individual to answer yes or no. An example 
of this type of question would be “My food consumption has caused significant physical 
problems or made a physical problem worse” [168, 176].  If an individual answers 
affirmatively to certain questions or indicate a problematic degree of frequency of certain 
behaviours, they are said to have the symptom corresponding to that collection of 
questions. There are two methods of scoring with the YFAS.  
The first method is simply dichotomous and is used to make a diagnosis of FA. In order 
for an individual to be diagnosed with FA, they must have 3 or more of the 7 possible 
symptoms and answer affirmatively to one or both of the questions indicating clinically 
significant impairment or distress. These questions are as follows; 
- “My behavior with respect to food and eating causes significant distress” 
- “I experience significant problems in my ability to function effectively (daily routine, 
job/school, social activities, family activities, health difficulties) because of food and 
eating” 





 1. Substance taken in larger amount and for longer period than intended 
2. Persistent desire or repeated unsuccessful attempts to quit 
3. Much time/activity to obtain, use, recover 
4. Important social, occupational, or recreational activities given up or reduced 
5. Use continues despite knowledge of adverse consequences (e.g., failure to fulfill role 
obligation, use when physically hazardous) 
6. Tolerance  
7. Characteristic withdrawal symptoms; substance taken to relieve withdrawal.  
The second method of scoring using the YFAS is the Likert scoring method which counts 
how many symptoms (from 0 to 7) are present in any one person, in order to assess the 
severity of an addictive tendency towards food [176].  
1.8.3 Eating Behaviours and Body Fat Distribution  
Highly processed foods, especially those high in fat with a high glycemic load such as 
soft drinks, potato chips, and refined grains, tend to be among the foods most commonly 
referred to as addictive [148, 177, 178]. Research in animal models supports the notion 
that high sugar, high-fat foods can produce addictive-like behaviours [156, 158, 179, 
180]. Fascinatingly, these same types of foods consistently show a relationship with 
abdominal obesity while food items lower in saturated fats and with higher fiber content 





western-style diet high in processed meat and refined grains also tend to have higher 
WHR and overall waist girth suggesting increased abdominal or central obesity [182]. 
Given what we know about the metabolic implications of high amounts of abdominal fat, 
coupled with the knowledge that the food items that contribute to abdominal obesity may 
elicit addictive eating patterns is especially concerning. However, to date, the research on 
addictive eating patterns and fat distribution, particularly VF, is scarce. Dr. Pedram and 
colleagues of Dr. Sun’s laboratory published a paper in 2013 which demonstrated the 
relationship between YFAS symptom counts with obesity, BF percent, and TF percent in 
a general population [183]. However, at that time, the laboratory did not possess the 
necessary tools to accurately measure VF. Dr. Sun’s laboratory would not gain the ability 
to perform research on VF until 2015. At the time of writing, only one study besides our 
own (Chapter 3) had investigated the relationship between FA, as defined by YFAS, and 
VF. The sample that was used in that study, unfortunately, does not compare very well to 
the general NL population so results are poorly generalized to our population. The sample 
used in this study was largely Caucasian but that is where the similarities end. That study 
was performed on only 93 young adult females from Australia between the ages of 18 and 
35 with an average of 24.3 years. This is generally, much younger and leaner than the 
general NL population. The authors of that paper mention that the reason for studying 
exclusively females was to eliminate any variation attributable to sex hormones that may 
influence BFD and described the participants as a “convenience sample”. The only noted 
exclusion criteria was pregnancy or living outside of Australia. The YFAS and other 





reported to a physical testing location to measure height, weight, body composition and 
BFD. Height was measured using a stadiometer. Weight, body composition, and BFD 
were measured using BIA. It was found that YFAS symptom counts were positively 
associated with VF area and that YFAS symptom scores predicted an increase in VF area 
(β=1.17, p<.001) [184]. While this study was the first to demonstrate that the number of 
YFAS symptoms were associated with increased visceral adiposity, there are several 
limitations to address. First, this study consisted of a small sample size from a narrow 
demographic. It was exclusively young women who were, for the most part, normal 
weight according to BMI (72%). This makes it difficult to say how applicable these 
results are to men, individuals living with obesity or a general population. Furthermore, 
there are a number of potentially confounding variables not accounted for such as caloric 
intake, physical activity, eating disorders, or medication usage. Also, BIA is not quite as 
accurate as other methods of BFD measurement. While this may be a good starting point 
for this research, it leaves many gaps to be filled on the matter of FA and visceral 
adiposity. Dr. Pedram previously demonstrated 1) the prevalence of FA, as defined by 
YFAS, in a general population 2) those who met the YFAS criteria for FA are more obese 
than those that are non-food addicted, and 3) YFAS symptom scores are associated with 
several adiposity measures that are often used as an index of visceral adiposity and share 
a good correlation with visceral adiposity such as WC, WHR, and TF. One objective of 
ours, now that Dr. Sun’s laboratory had the requisite technology, was to investigate 
whether YFAS symptom scores shared a correlation with VF. We hypothesized that, 





TF in our population, VF would also display a correlation with YFAS symptom scores. 
Both men and women had similar correlation coefficients for each of these BFD measures 
except for GF mass and percent which was understandably higher in women (r=0.30, 
r=0.23, and r=0.24, r=0.15, respectively) and AF percent (r=0.31, r=0.25) which was also 
higher in women, although AF mass exhibited a similar correlation coefficient among 
sexes. The main finding of our study was the significant association observed between 
symptoms of FA and VF mass and percent in men and women. As VF tends to increase 
the risk of many metabolic issues, the finding that addictive eating symptoms contribute 
to visceral adiposity may suggest that an individual’s eating patterns should be factored 
into any efforts to make lifestyle modifications to reduce the risk of obesity, T2D, or 
CVD. 
1.8.4 Disordered Eating Behaviour and Metabolic Characteristics 
Eating disorders are broadly defined by irregular eating habits that result in either an 
insufficient caloric intake or excessive caloric intake [185]. The more pervasive and 
commonly known disorders include anorexia nervosa, bulimia nervosa, and BED. 
Anorexia nervosa is defined as a preoccupation with maintaining low body weight, 
possibly due to a fear of “fatness” or an unhealthy obsession with “thinness”. Bulimia 
nervosa is characterized by episodic binge eating followed by compensatory behaviour 
such as self-induced vomiting to restrict weight gain. There is also BED which is similar 





compensatory behaviours [186]. BED is defined as the presence of three or more of the 
following symptoms as described by the DSM-IV 
-eating much more rapidly than normal 
-eating until feeling uncomfortably full 
-eating large amounts of food when not physically hungry 
-eating alone through embarrassment at the amount one is eating 
-feeling disgust or extreme guilt after overeating 
The consequences of these disordered eating behaviours go well beyond an individual’s 
weight. There is ample evidence that there are significant metabolic consequences for 
individuals who suffer from eating disorders. A research effort consisting of 2342 eating 
disorder patients and 9368 matched controls compared these two groups at three stages. 
Those three stages were before entering the treatment for an eating disorder, after the 
entrance until the end of the study period, combining any time before or during, and after 
the treatment. The aim was to examine the prevalence of T2D in a patient cohort being 
treated for BED, bulimia nervosa, and anorexia nervosa. T2D was diagnosed by linking 
the study population with the oral TSD medication data of 17 years from The Medical 
Reimbursement Register. The first incidence of a participant redeeming a TSD 
medication was used as a proxy for T2D. The time of the onset of T2D was based on the 
date of the first time a medication was redeemed. Men and women with BED or bulimia 





women. The prevalence of T2D in patients was 5.2% and only 1.7% in controls. 
Approximately every third individual with BED went on to develop T2D by the end of 
the study period, while 4.4% of bulimia nervosa patients would go on to develop T2D. 
Among women living with BED, the lifetime prevalence of T2D was 30.9% and among 
men living with BED, it was 54.5%. Among women living with bulimia nervosa, there 
was no significant difference in lifetime T2D prevalence compared with controls. Among 
those treated for anorexia, the prevalence of T2D barely differed from the control group 
(0.8% vs 0.9%)  [187]. One limitation of this study is the lack of information on the BMI 
of the patients. Obesity and T2D often go hand in hand and the ability to control for BMI 
would’ve been quite helpful in understanding how much of a factor disordered eating was 
in the development of T2D. Another limitation is that there was a lack of information on 
possible comorbidities that may have influenced some of the observations made during 
this study. Another study by Barnes et al revealed that 43% of obese BED patients (66% 
of men and 35% of women) collected from 2 primary care facilities in a large urban 
setting also met the criteria for MetS. There was no significant difference observed in 
BED patients with and without MetS in terms of ethnicity, BMI, the severity of eating 
disorder, or depression. Patients were recruited from physician referrals in a primary care 
clinic and by flyers posted in primary care clinics targeted at individuals who wished to 
stop binge eating and lose weight. Participants were excluded if they were experiencing 
significant psychiatric diagnoses such as bipolar disorder or schizophrenia. Other 
exclusion criteria included uncontrolled hypertension, cardiac issues, neurologic history, 





and use of medication such as selective serotonin reuptake inhibitors that are 
contraindicated with sibutramine. The diagnosis of MetS was based on the ATPIII 
definition of MetS  [188]. It is important to note that due to this being a cross-sectional 
study no conclusions can be made regarding cause and effect or the directionality of the 
findings. The authors also acknowledge potential sampling bias as the participants were 
actively seeking treatment and do not, as stated in the paper represent “a consecutive 
series of primary care patients”. The average age of participants was 43.2 years and given 
that some of the markers that were measured using this particular MetS diagnosis criteria 
tend to increase with age (ex. Cholesterol) it is difficult to say if these conclusions can be 
generalized to younger BED patients. A 2015 study compared the metabolic and 
inflammatory profiles of 30 individuals living with both obesity and BED (8 men, 22 
women) to 85 individuals (32 men, 53 women) living with obesity who do not have BED. 
The average age of the BED group was 36.8, the average age of the non-BED group was 
41.8 and the average BMI of these groups was 43.7 and 37.2, respectively. All research 
participants were between the ages of 20 and 65. Patients were excluded if they were 
pregnant, have recently given birth, had a history of diabetes mellitus, inflammatory 
disease, malignant disease or pathologies, or using any drugs that alter glucose 
metabolism. No significant difference in age or sex between the two groups was reported. 
After a 12 hour fast, patients underwent a 75g oral glucose test with blood draws at 
baseline, 30, 60, 90, and 120 minutes. Height and weight were measured using a portable 
stadiometer and balance scale while participants wore light clothing with shoes removed. 





mass, lower percent lean mass, higher HDL, higher glycated hemoglobin, higher C-
reactive protein, higher fasting insulin, and increased insulin resistance, when measured 
using HOMA-IR, than those in the obese group without BED. Initially, no significant 
difference was seen between the two groups for fasting or 2-hour glucose levels, however 
after adjustments were made for BMI, this too became significant [36]. This was a cross-
sectional study which means any conclusion on the long-term relationship between BED 
and markers of inflammation and insulin resistance cannot be made. The research team 
also noted that they measured fat mass using BIA. While BIA has its limitations, 
adjusting for fat mass either in place of or along with BMI would have been ideal as they 
are looking at several markers that have been demonstrated to have correlations with fat 
mass. Also, as noted earlier, there are limitations to be mindful of when using HOMA-IR 
to measure insulin resistance, one of which is the lack of accuracy when used for older 
individuals. Since this study does include individuals as old as 65, this is a limitation is 
worth noting. 
While BED has been the subject of many research efforts, there has been little research 
into the association and implications of FA in metabolic characteristics and obesity. It 
should be noted that BED has previously been shown to share overlap with addictive 
eating behaviours as defined by the YFAS. One such study by Gearhardt and colleagues 
found that the prevalence of FA in obese patients with BED was reported as 57% [174]. 
This particular study consisted of participants ages 28-64 (average age of 47.5 years), 





via newspaper advertisements aimed at individuals living with obesity who felt as though 
their eating was out of control and who wanted to lose weight. Another study by this 
same group of researchers consisted of a more racially diverse group of 96 BMI defined 
obese BED patients ages 19-65 years (average age of 44.9 years), 75.8% were female and 
only 45.3% were Caucasian while the rest were 32.6% African America, 12.6% Hispanic, 
7.4% other and 2.1% Asian. This time, it was reported that the prevalence of FA was 
41.5% [189]. Each of the aforementioned studies reported quite a large difference in the 
prevalence of FA (57% vs. 41.5%). The authors note that age, race, sex, and education 
status did not differ significantly among those who were classified as having FA. One 
thing noted in the methodology that might account for this difference is that the second 
took extra steps to screen out all individuals who reported having severe psychiatric 
problems or substance dependence. Those with severe medical issues such as cardiac 
disease, liver disease, uncontrolled hypertension, thyroid conditions, or diabetes were also 
excluded in the second study. The enforcement of stricter screening requirements, 
particularly those concerning issues with addiction, may have accounted for the large 
drop off in the prevalence of FA reported in the second group. As noted earlier in this 
section, BED has been associated with T2D, components of MetS and shares a sizeable 
overlap with FA, however, there has been little research into the association and 





1.8.5 Food Addiction, Obesity, and Metabolic Characteristics 
FA, like other disordered eating behaviours, can have serious implications in one’s health 
and contribute to the development and maintenance of the obese state. A study by Dr. 
Sun’s research team revealed that the prevalence of FA in the general NL population was 
5.4% (6.7% in women and 3.0% in men). In the same study, the total number of FA 
symptoms an individual had, as defined by the YFAS, were found to share a significant 
association with all the obesity and body composition measurements used. When 
compared to a control group, those diagnosed with FA were on average 11.7 kg heavier, 
4.6 BMI units higher, had 8.2% more body fat, and 8.5% more TF [183]. While a 
significant correlation between the number of FA symptoms and obesity was 
demonstrated, this study did not investigate exactly which FA symptom(s) correlated with 
obesity or body composition measurements or if certain symptoms exhibit stronger 
correlations with measures of obesity and body composition than other symptoms. The 
author of this paper proposed that “food addiction may represent a distinct etiology of 
human obesity in the general population”. However, such a claim would at the very least 
require a demonstration that there were measurable differences between those who were 
food addicted and living with obesity and those living with obesity who are not food 
addicted. Another paper published by Dr. Pedram and colleagues of Dr. Sun’s Laboratory 
compared a group of twenty-nine food addicts living with obesity (FAO), as defined by 
the YFAS, to a group of non-food addicted individuals living with obesity (NFO). These 
two groups were matched for age, sex, physical activity, and BMI. This comprehensive 





polypeptides. Glucose, TC, TG, HDL, LDL, and insulin were also measured following a 
12 hour fast but there was no significant difference observed between the FAO and NFO 
group for any of the six aforementioned metabolic factors. The FAO group had lower 
levels of thyroid stimulation hormone (TSH), tumour necrosis factor-alpha (TNF-α), and 
amylin but higher levels of prolactin. The FAO group also consumed more dietary fat per 
g/kg of body weight. Macronutrient consumption was presented as g/kg in this study as 
Dr. Pedram and colleagues had previously demonstrated that those with FA consume a 
higher percentage of calories in the form of fat [183], however, as this group is BMI 
matched and a goal of the study was to investigate differences in diet among the FAO and 
NFO group, g/kg is more informative of just how much the consumption of each 
macronutrient is related to a unit of body weight. Expressing as only a percentage of total 
calories can result in very different absolute amounts of each macronutrient depending on 
how many calories each participant consumes in a day whereas expressing in only grams 
isn’t as helpful at drawing distinctions between the FAO and NFO group as those in the 
FAO group may simply consume more calories on average and by extension consume 
more of every macronutrient compared to the NFO group. Another reason for the use of 
g/kg is that fat and lean tissue differ in how they affect metabolism. The FAO group also 
consumed a higher percentage of their calories from fat and carbohydrate sources [190]. 
The first of my three manuscripts, which is currently published in Frontiers in 
Endocrinology, examined the association between FA symptom counts and a panel of 
metabolic variables including glucose, insulin, HOMA-IR, HOMA-β, TC, TG, HDL, and 





by the YFAS, with lipid profiles and markers of insulin resistance in 739 participants 
from a general NL population. Much of the existing FA research is in specific subgroups 
of the population such as individuals with T2D, bariatric surgery patients, or individuals 
with eating disorders. Furthermore, even fewer research efforts explore the metabolic 
effects of FA. We know, from previous reports that FA is much more prevalent among 
those living with obesity and those living with T2D, both of which are known to have 
strong associations with lipid profiles and insulin resistance but we did not know if FA 
symptom scores have any correlation whatsoever with lipid profiles or insulin resistance 
in an otherwise healthy general population. We sought to address this gap in knowledge 
and though the body of FA research is still quite sparse, we hypothesized that, given the 
previously reported relationship between FA as measured by YFAS with obesity and 
adiposity, that YFAS symptom scores would exhibit a correlation with markers 
commonly associated with obesity comorbidity in the general population. We took care to 
control for confounding variables such as age, sex, menopausal status, physical activity, 
caloric intake, body fat percentage and excluded any individuals who reported to be using 
anti-dyslipidemic or anti-hyperglycemic medications. We showed that there were several 
modest but significant correlations between FA symptom counts and several metabolic 
characteristics in men and post-menopausal women. In men, FA symptoms were 
significantly correlated with HOMA-β, Triglycerides, and inversely correlated with HDL 
cholesterol. In post-menopausal women, FA symptoms were found to be significantly 
correlated with triglycerides [191]. One research group investigated the prevalence of FA 





met the criteria for FA. They also reported that FA, according to the YFAS criteria 
accounted for greater BMI variance than measures of depression, anxiety, or stress [192]. 
The authors reported good internal consistency for the YFAS (α=0.86). This study, 
however, relied only on surveys administered online which means that BMI was self-
reported and subject to error. Another limitation is that there does not appear to be any 
information regarding the ethnicity or medication usage of participants. Medications 
meant to treat mood or anxiety disorders could have affected some of the variables 
measured in this study, as would medications that may result in weight gain or weight 
loss. In 2017, another research group also examined the prevalence of FA in, who they 
described as, “newly diagnosed” T2D patients, meaning individuals who were outpatients 
at a local hospital who received T2D diagnosis between February 2014 and January 2015. 
The prevalence of FA in T2D patients was 8.6% compared to only 1.3% in a BMI and 
age-matched control group. T2D patients with and without FA were also compared. 
Despite being on average 11 years younger than the non-food addicted T2D patient 
group, T2D patients with FA had significantly higher BMI, WHR, fasting blood glucose, 
HOMA-IR, and uric acid levels than T2D patients who did not meet the YFAS criteria for 
FA [193]. , Also, as noted earlier, HOMA-IR may be less reliable in some people 
including older individuals with impaired glucose tolerance and older men and women 
with diabetes While the prevalence of FA among T2D is quite high, it’s not nearly as high 
as the 70% that was reported in the previously mentioned 2015 study. This may be due in 
part to much better screening to control for possible confounders. The 2017 study 





hyperthyroidism, hypothyroidism, eating disorders, psychiatric disorders, those who were 
required to adhere to certain eating patterns due to pregnancy or operations and anyone 
with what the authors described as a major disease that affects quality of life. Also, while 
the 2017 study was performed on a single population, the 2015 study collected surveys 
from individuals primarily living in Australia, the UK, USA, New Zealand, and other 
living in Germany, Ireland, Norway, Spain and Malaysia. Such as widespread, 
multinational survey-based research effort is sure to have a number of confounding 
variables that are difficult to control for. While our findings and the findings of other 
research groups suggest that addictive eating behaviours can play a role in metabolic 
disorders, research in this area is still quite limited and of course it is only one piece of a 
complex issue.  
1.9 Rationale 
Due to the complexities surrounding the causes and consequences of obesity and by 
extension BFD, coupled with evidence supporting the role of FA in the obesity 
phenotype, this thesis attempts to address questions surrounding these complexities and 
better understand to what degree FA plays a role in obesity and obesity-related 
comorbidities from a behavioural and endocrinological standpoint. Furthermore, we 
aimed to elucidate the impact of central adiposity on women as it relates to a host of 
metabolic characteristics and incidence of MetS. 
FA research in humans remains relatively sparse, particularly as it pertains to the 





that obesity is more prevalent among those with FA. Given this, we sought to explore the 
role of addictive eating tendencies in metabolic markers commonly associated with 
obesity related comorbidities in 710 individuals (435 women, 275 men) from the general 
population recruited through the CODING study.  
Research participants who had previously been diagnosed with FA were excluded from 
analysis so we could capture the extent of the relationship between symptoms of FA and 
metabolic health in a general population. Our cohort was subdivided into men and 
women. Women were then further subdivided into pre-menopausal and post-menopausal 
status, given the role of sex and menopausal status on a number of metabolic markers. 
Furthermore, to identify potential differences between FA and non-FA individuals, we 
also performed a comparative analysis between these two groups in the total population, 
as well as in men and women independently of one another. The objectives of the study 
detailed in chapter 2 were to 1) assess the impact of FA symptom counts, as defined by 
the YFAS, on metabolic characteristics 2) assess sex-specific effects of FA symptoms 
counts on metabolic characteristics 3) compare the metabolic characteristics of FA and 
non-FA individuals. We hypothesized that there would be a positive correlation between 
the number of YFAS symptoms and markers of metabolic disturbance. We also 
hypothesized that those with FA would have a less healthy lipid profile and more insulin 
resistance when compared to those who do not have FA. 
The study in chapter 3 examined the correlation between FA symptom counts and 





The purpose of this study was to understand the role of addictive eating behaviours on 
specific BFD patterns shown to be associated with metabolic disturbance. As previously 
mentioned, individuals with similar adiposity can vary in how their body fat is distributed 
which can greatly affect metabolic health, therefore, it is essential to understand how 
certain eating behaviours, specifically addictive eating behaviours, might influence BFD. 
We analyzed the relationship between FA symptom counts with total, truncal, android, 
gynoid, and VF in terms of both total fat mass and percentage fat mass.  
We examined this relationship in our total cohort, as well as men and women separately. 
The goals of this study were to 1) evaluate the correlation between FA symptom counts 
and measures central adiposity and VF 2) evaluate the correlation between FA symptoms 
counts and gynoid adiposity 3) note any differences between men and women regarding 
how FA symptom counts influence BFD. We hypothesized that a significant correlation 
would be observed between YFAS symptoms and measures of central adiposity, 
particularly VF and that this relationship would be more pronounced in women given that 
women tend to have more body fat. 
Given the important role of BFD as it pertains to metabolic health, understanding the 
metabolic implications of different BFD patterns and how one’s sex may mediate these 
effects, was another effort of Dr. Sun’s research team. Previously, I have discussed the 
role of sexual dimorphism in BFD and obesity related comorbidities, noting that women 
tend to accumulate body fat in the lower body or gynoid area while men tend to 





more common in men, it is far from exclusive to men. Other studies have produced 
evidence that not only have the increases in obesity been more prevalent in women, but 
increases in abdominal obesity have been more prevalent in women as well [194, 195]. 
Furthermore, MetS and its correlation with visceral adiposity has been found to be higher 
in women in other populations [196-198]. It is not at all uncommon for women to exhibit 
upper body obesity along with the accumulation of VF [199-201]. Women with upper 
body obesity still experience a host of metabolic issues as a result of this. A study 
published by Wolhfahrt et al investigated the difference in the association between long 
term changes in weight, abdominal obesity, and ventricular-arterial health. A group of 
375 men and 413 women aged 45 years or older with an average age of 60 were used in 
the analysis. All measurements were taken at baseline and 4 years later at follow up. 
Height and weight were measured using a wall-mounted stadiometer and electronic scale, 
respectively. WC was measured using non-elastic tape at the top of the umbilicus and hip 
circumference was measured at the area of the maximal circumference. WHR, WC, neck 
circumference, and neck to height ratio were used as indices of abdominal obesity. Left 
ventricular structure and function were assessed using echocardiography. 
Echocardiographs were performed by the same 3 sonographers at baseline and follow up. 
The echocardiographs were then reviewed by 2 cardiologists. BP was measured using a 
sphygmomanometer. The analysis revealed, after controlling for age. arterial elastance 
and sex, that all measures of abdominal obesity were associated with age related increases 
in ventricular stiffness in women but not men [202]. The issues and limitations of WC 





acknowledged in the other indices of abdominal obesity that were used. The authors 
suggest that neck circumference is a better indicator of visceral adiposity and metabolic 
disorder but further reading revealed that this was only the case in a group of individuals 
living with class III obesity (BMI > 40). The average BMI range of the participants in this 
study ranged from 27.9 at baseline to 28.1 at follow up. The authors acknowledge that 
echo-doppler data has greater variability than more invasive methods and that they could 
not conclude whether some of the weight changes that were observed between baseline 
and follow-up were a result of diet/exercise, muscle wasting, or other health issues. While 
upper body fat accumulation tends to be more common in post-menopausal women which 
has been touched on previously [130], there appear to be health risks women are exposed 
to as a result of their central adiposity regardless of menopausal status. One comparison 
of middle aged premenopausal women and early post-menopausal women found that 
postmenopausal women had up to 49% greater intra-abdominal or VF [203]. However, 
due to the aforementioned controversy surrounding the true magnitude of the role of VF 
in metabolic issues, we have controlled for VF in our comparative analysis of women 
with and without android obesity which is described in chapter 4 of this thesis. This was 
done to better understand the true contribution of subcutaneous AF to metabolic 
disturbance and the risk of developing MetS. Other studies have also found that in some 
populations, AF may play a larger role in metabolic disturbances than VF [204]. Given 
the wealth of data available regarding the sexual dimorphism of BFD and the relationship 
between abdominal adiposity and metabolic disease which is elaborated upon in much 





1) the true impact of female android obesity on markers of insulin resistance and lipid 
profiles and 2) the MetS risk in women with high levels of android adiposity independent 
of VF stores. While there are many association studies that have examined the correlation 
between central adiposity and various markers of metabolic health in women, there is 
little research that offers a direct comparison of women with similar BMIs and age with 
differing BFD patterns. Also, much of the existing literature draw conclusions on the 
impact of abdominal or truncal fat but fails to control or account for VF storage. We 
hypothesized that a higher AGR would be associated with a significantly higher risk of 
having MetS 
The methods that were employed to achieve each of the objectives outlined above for 
each manuscript chapter are described below. 
1.10 Methods/Protocols 
Participants 
All participants and participant data used in chapters 2,3, and 4 were recruited through 
the CODING study. All participants were recruited for this study through the use of 
advertisements, flyers, and word of mouth. The eligibility requirements for all CODING 
study participants are as follows: 
1. 19 years of age or older 
2. The participant must have been born in NL and the participant’s family must have been 





3. Healthy with no serious metabolic, endocrine, or cardiovascular conditions. 
4. Participants must not be pregnant at the time of the study.  
Additional exclusion criteria were used for the research projects described in chapter 2. 
The additional exclusion criteria were that participants could have not been found to have 
“food addiction” in a previous study by Dr. Sun’s research group and secondly, 
individuals who self-reported having diabetes or hypertension were also excluded from 
this analysis. 
Anthropometric Measurements: 
All measurements were taken with participants wearing only a standard hospital gown, 
socks, and underwear. Height was measured using a fixed stadiometer to the nearest 0.1 
cm. Weight was measured to the nearest 0.1 kg using a platform manual scale balance 
(Health O Meter, Bridgeview, IL). Both hip circumference and WC were measured using 
a flexible non-elastic measuring tape. Hip circumference was measured at the level of the 
largest circumference between the waist and thighs to the nearest 0.1 cm. WC was 
measured using the same method at the level of the umbilicus, between the lowest rib and 
iliac crest. 
Body Composition Measurements 
Body composition measurements which included TF, AF, GF, and VF were assessed 
using DXA (Lunar Prodigy; General Electric Medical Systems, Madison, WI, USA). The 





described in detail in sections 1.3 and 1.4. Measurements were taken while the patient 
lied horizontally on the DXA scanner. Female participants were also asked to remove 
their bra if it contained any metal clips or metal wire since metal objects can interfere 
with the accuracy of the DXA scan.  
Metabolic Marker Measurements 
Serum concentrations of glucose, TC, HDL cholesterol, and TG were measured using the 
Lx20 analyzer (Beckman Coulter Inc., Fullerton, CA) with Synchron reagents. Serum 
insulin was measured using the Immulite Immunoassay analyzer. Insulin resistance and 
beta cell function were calculated using the HOMA equations.  
Food Addiction Symptom Count Measurement: 
Symptoms of food addiction were assessed using the YFAS. The full version of the 
YFAS questionnaire can be viewed in appendix 1. The YFAS has been described in 
much greater detail in previous sections but, to briefly re-iterate, it is a 25 item 
questionnaire that assesses the last 12 months of eating patterns. It is based on the criteria 
used for substance dependence in the DSM-IV TR. This criterion includes symptoms 
such as tolerance, withdrawals, anxiety in social situations, and difficulty lowering or 
quitting the use of the substance. YFAS. symptoms were counted using the Likert scoring 
method which ranges from 0 to 7. Each symptom on the YFAS represents a collection of 
questions from the questionnaire concerning that behaviour. If an individual answers 





Some of these questions are based on the frequency of the behaviour (ex. once a month, 
2-4 times a month, etc.) and some are binary yes or no questions.  
Calorie intake and Physical Activity Assessment: 
Calorie intake was measured using the Willett Food Frequency Questionnaire (FFQ) 
which measures the last 12 months of dietary habits. The quantity of each food item was 
converted into a daily average intake value. This value was then entered into Nutribase 
Clinical Nutrition Manager (software version 9.0; Cybersoft inc. Arizona). To measure 
physical activity, we used the Baecke physical activity questionnaire. This questionnaire 
measures physical activity using three categories which are work, sport, and leisure. The 
full version of this questionnaire can be viewed in appendix 2 and the limitations of these 
questionnaires are acknowledged and described in chapter 5.  
Statistical Analysis: 
All statistical analysis in chapters 2, 3, and 4 was completed using SPSS ver.23. The 
level of statistical significance was set at alpha=0.05. In chapters 2 and 3 Pearson 
correlation analysis was used to evaluate potential relationships between YFAS symptom 
counts with measures of adiposity, insulins resistance, and lipid profiles. Partial 
correlation analysis was also performed which allowed us to control for age, total calorie 
intake, and physical activity levels. A one-way ANOVA was used to measure the 
difference in body fat levels between food addicted obese (FAO), non-food addicted 





All correlations from the study described in chapters 2, 3, and 4 have been controlled for 
sex, age, physical activity, and caloric intake.  
In chapter 4 we divided all women into tertiles based on AGR and compared endocrine, 
anthropometrical, and vital measures between these groups using a one-way ANOVA. 
We then compared a group of women from the highest quartile of AGR to an age and 
BMI matched control group and noted the incidence of MetS in each group using the 
ATPIII criteria. We also controlled for calories, physical activity, and VF percentage to 
assess the true risk associated with excess subcutaneous abdominal obesity in women.  
MetS is a collection of symptoms that increase the risk of CVD and diabetes. There are 
several criteria available for the diagnosis of MetS and for my manuscript we have chosen 
to use the ATPIII criteria. Diagnosis of MetS using this particular set of criteria requires 
that an individual have 3 out of 5 of the following symptoms [205]. 
i. Waist circumference >35 inches (88.9cm) 
ii. Fasting glucose >100mg/dl 
iii. TG >150mg/dl 
iv. HDL <50mg/dl 
v. Systolic blood pressure >130mmHg or diastolic blood pressure >85mmHg 
This criterion was selected based on the physical and metabolic data made available by 
the CODING study up to the conception of this specific research project and not 
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2.1 Introduction 
Obesity rates have been climbing for the last three decades and according to a report from 
Statistics Canada, in Newfoundland and Labrador (NL), 31% of adult women and 27.3% 
of men are obese [2, 206]. It follows that the population of NL also exhibits some of the 
highest rates of obesity-related health issues in Canada such as type II diabetes (TIID) and 
cardiovascular disease (CVD) which makes obesity research within this population so 
vital. Recent reports put the rate of TIID in this Province at 11.2% with CVD contributing 
to 20%-38% of total deaths in adults aged 35 years or older [207-209]. The development 
of obesity is highly complex and is comprised of a number of interacting genetic, 
environmental, and behavioural factors [210-213]. One issue that highlights this intricate 
balance of factors is that of an addictive tendency towards food. This is characterized by 
an obsessive consumption of foods known to be highly palatable with the corresponding 
activation of the bodies reward systems and significant difficulty controlling this 





neural correlates in the way of dopaminergic circuitry activity and it has drawn 
comparisons to nicotine addiction in regards to how the body’s reward systems are 
effected [154, 214].  
Symptoms of an addictive tendency towards food are quantified using the Yale Food 
Addiction Scale (YFAS) which has been adapted from the criteria for substance abuse 
from the DSM-IV TR [168]. Foods that display addictive qualities are those that are high 
in simple sugars, saturated fat, and are heavily processed. One study revealed that the 
processing of food was a strong predictor of it possessing addictive qualities [178]. There 
is substantial evidence that these very same types of foods can have a significant negative 
impact on health. Foods high in fructose can be highly lipogenic and could lead to an 
increased risk of developing non-alcoholic fatty liver disease and consequently, TIID 
[215]. A study concerning the consumption of sugar-sweetened beverages effects on 
health examined over 310 000 individuals and over 15 000 TIID patients and found that 
those in the highest quartile of sugar-sweetened beverage consumption had a 26% higher 
risk of developing TIID [216]. Excessive sucrose intake has also been found to be 
associated with a 37% increased risk of having a coronary event [217]. Furthermore, a 13 
year follow up study performed on 4 999 individuals found that consumption of milk fats, 
various sweets, and cake was associated with increased CVD risk in women [218]. In 
addition to the behavioural and neurological evidence supporting the role of addictive 
food tendencies in health, we have recently found that there are different hormonal 





We have previously reported that those living with obesity who has been diagnosed with 
food addiction, had lower levels of thyroid-stimulating hormone (TSH), tumor necrotic 
factor-alpha (TNF-α), and amylin but higher levels of prolactin compared to non-food 
addicted obese individuals [190]. TSH levels have previously been implicated in the 
development of insulin resistance (IR) and diabetes while TNF-α has been shown to 
decrease appetite, therefore, lower levels of TNF-α may exasperate obesity-related 
comorbidities by lending to increased positive energy imbalance [219-221]. Amylin is 
known to be associated with the development of type 1 and TIID and increased prolactin 
levels have been shown to be a cardiovascular risk factor with correlations to diabetes as 
well [222-225]. However, our previous study was performed with only 58 individuals (29 
FA obese, 29 NFA obese). Many studies in the field of “food addiction” focus on specific 
sub-populations such as the obese, bariatric surgery patients or those with an eating 
disorder [174, 175]. What remains to be seen is whether or not an addictive tendency 
towards food displays an association with metabolic markers and hormones in the general 
population, specifically IR and lipid profiles as these metabolic characteristics play a role 
in the development of TIID and CVD [226, 227]. 
The very same types of foods that possess addictive qualities are demonstrably dangerous 
to an individual’s overall health when frequently consumed. It is therefore essential that 
the association between addictive tendencies towards food and metabolic markers of TIID 
and CVD be studied in the general population. Our investigation was performed in a sub-





and Genetics) study which consists of biochemical and body composition data from over 
3200 men and women from the general NL population.  
2.2 Materials and Methods 
Ethics Statement 
This study was approved by the Health Research Ethics Authority (HREA), Memorial 
University of Newfoundland, St. John’s, Canada with project identification code 10.33. 
Written consent was provided by all who participated. 
Participants 
710 Adults (435 women, 275 men) from the Province of Newfoundland and Labrador 
were recruited for this study through the use of advertisements, flyers, and word of 
mouth. Eligibility requirements are as follows: 
1. 19 years of age or older 
2. The participant must have been born in NL and the participant’s family must have been 
in NL for at least 3 generations 
3. Healthy with no serious metabolic, endocrine, or cardiovascular conditions. 
4. Participant must not be pregnant at time of study.  
5. participants have not been found to have “food addiction” in our previous study 






Individuals who had been previously diagnosed with food addiction were later included 
for additional comparative analysis. 
Food Addiction Symptom Count Measurement 
Symptoms of food addiction were assessed using the YFAS. This is a 25-item 
questionnaire that assesses the last 12 months of eating patterns. The YFAS is based on 
the criteria used for substance dependence in the Diagnostic and Statistical Manual IV-TR 
(DSM-IV TR). This criterion includes symptoms such as tolerance, withdrawals, anxiety 
in social situations, and difficulty lowering or quitting the use of the substance. 
Symptoms were counted using the Likert scoring method which ranges from 0 to 7 [168]. 
Each symptom on the YFAS represents a collection of questions concerning that 
particular behaviour. If a participant answers affirmatively to certain questions, they are 
said to have the corresponding symptom. Some of these questions are based on the 
frequency of the behaviour (ex. once a month, 2-4 times a month, etc.) and some are 
binary yes or no questions [176]. In our comparison of individuals with or without a 
diagnosis of FA, those classified as food addicts were required to have at least 3 
symptoms and answer affirmatively to one of the two questions from the YFAS which 
indicates clinically significant dependence. 
Caloric Intake and Physical Activity Assessment  
Calorie intake was measured using the Willett Food Frequency Questionnaire (FFQ) 





was converted into a daily average intake value. This value was then entered into the 
Nutribase Clinical Nutrition Manager (software version 9.0; Cybersoft inc. Arizona). We 
employed the use of the Baecke physical activity questionnaire to assess physical activity 
levels. This questionnaire measures physical activity using three categories which are 
work, sport, and leisure. 
Body Composition and Metabolic Marker Measurements 
Body composition measurements, which in this study included total body fat, were 
assessed using dual-energy x-ray absorptiometry (DXA; Lunar Prodigy; GE Medical 
Systems, Madison, WI, USA). Measurements were taken while the patient lied 
horizontally on the DXA scanner following a 12 hour fast. Serum concentrations of 
glucose, TC, HDL cholesterol, and triacylglycerols were measured using the Lx20 
analyzer (Beckman Coulter Inc., Fullerton, CA) with Synchron reagents. LDL cholesterol 
was calculated using the following formula: (total cholesterol) − (HDL cholesterol) − 
(triacylglycerols/2.2). Serum insulin was measured using the Immulite Immunoassay 
analyzer. Insulin resistance and beta cell function were calculated using the homeostasis 
model assessment (HOMA) [229].  
Statistical Analysis 
All statistical analysis was completed using SPSS ver.23. The level of statistical 
significance was set at P-Value <0.05. Statistical tests were run on men and women 
separately. Pearson correlation analysis was used to evaluate potential relationships 





was also performed which allowed us to control for age, total calorie intake, physical 
activity levels, and total body fat % as necessary. An independent t-test was run between 
BMI matched food addicts and a control group to assess the difference of mean in the 
metabolic markers that were measured. Control variables were selected for each gender 
dependent on whether the potentially confounding variable in question shared a 
significant association with both dependent and independent variables. Following this 
method, we chose to control for age, physical activity, total body fat %, and calories. In 
order to better normalize the distribution of the data, HOMA-IR, and HOMA-β were 
square root transformed. 
2.3 Results 
Physical Characteristics and Adiposity Measures  
The age, gender, BMI and anthropometric data of all men and women who participated in 
this study are presented in Table 2-1 as mean ± standard deviation. The average age of 
female participants was 45.4 years and the average age of male participants was 42.9 
years. There was a significant difference observed between men and women for height, 
weight, BMI, total % body fat, waist, and hip measurements with men being higher for 
each measure. There was also a significant difference observed between pre and post-
menopausal women for age, height, waist, and hip circumference as well as total body fat 






Men had much higher levels of glucose and triglycerides compared to women. Women, 
however, had significantly higher levels of HDL cholesterol (Table 2-3). All other 
markers including insulin, HOMA-IR, HOMA-β, LDL, and total cholesterol were not 
significantly different between men and women. Metabolic characteristics were also 
compared between pre and post-menopausal women (Table 2-4). Post-menopausal 
women had notably higher levels of insulin, glucose, and triglycerides in addition to 
higher levels of both LDL and total cholesterol.  
Correlations Between YFAS Symptoms and Metabolic Markers 
The Pearson and partial correlation coefficients as well as p-values are presented in tables 
2-5 to 2-8. Men exhibited significant positive correlations between YFAS symptoms and 
HOMA-β, TG as well as a significant negative correlation with HDL cholesterol (Table 
2-5). In men, the correlation between YFAS symptoms and HOMA-IR just barely missed 
the cut-off of for statistical significance at α=0.05 (r=0.164 p=0.053). These correlations 
remained significant after controlling for age, physical activity, total body fat %, and 
calories. YFAS symptoms counts in women exhibited no significant correlations (Table 
2-6) however, when separated by menopausal status, post-menopausal (table 2-7) women 
showed a significant correlation with TG (r=0.198) after controlling for age, physical 
activity, total body fat %, and calories. Pre-menopausal women exhibited no significant 
correlations after controlling for all confounding variables (Table 2-8). The correlation 
between YFAS symptoms and HOMA-β was strongest for men and TG exhibited the 





Comparison of Food Addicts and Non-Food Addicts 
No significant difference was observed between BMI matched FA and NFA individuals 
from the general population for markers of IR or lipid profiles. These groups consisted of 
obese, overweight, and normal weight individuals. When separated by sex, there were 
still no statistically significant differences observed in men or women (table 2-9). FA men 
















Table 2-1 Physical Characteristics of Participants 
 Female Male 
 Mean ± SD Mean ± SD 
 n=479 n=298 
Age* 45.5 ± 13.1 43.0 ± 12.7 
Height (cm)* 163.3 ± 6.0 177.6 ± 6.7 
Weight (kg)* 70.8 ± 14.8 90.8 ± 17.3 
BMI* 25.8 ± 5.0 29.9 ± 4.9 
BF%* 37.0 ± 8.7 26.3 ± 8.4 
Waist (cm)* 91.2 ± 13.8 101.2 ± 13.6 
Hip (cm)* 99.8 ± 12.8 101.7 ± 10.8 
Waist/Hip (cm)* 0.9 ± 0.05 1.0 ± 0.05 
*-significant difference between men and women (p<0.05) 
Mean ± Standard Deviation (SD), BF%- Total Body Fat Percent 
 
 
Table 2-2 Physical Characteristics of Pre and Post-Menopausal Women 
 Pre Post 
 Mean ± SD Mean ± SD 
 n=282 n=179 
Age* 37.3 ± 9.4 57.8 ± 8.4 
Height (cm)* 164.2 ± 6.07 161.8 ± 5.65 
Weight (kg) 70.5 ± 15.7 71.9 ± 14.9 
BMI 26.3 ± 5.79 27.4 ± 5.51 
BF%* 35.6 ± 9.17 39.4 ± 7.45 
Waist (cm)* 89.2 ± 14.5 94.6 ± 12.6 
Hip (cm)* 98.1 ± 12.8 102.8 ± 10.8 
Waist/Hip (cm) 0.91 ± 0.08 0.92 ± 0.06 
*-significant difference between pre and post menopausal and women (p<0.05) 










Table 2-3 Metabolic Characteristics of Men and Women 
 Female Male  
 Mean ± SD Mean ± SD  
 n=435 n=275  
Insulin 77.8 ± 94.1 79.3 ± 53.7  
HOMA-IR 2.90 ± 5.50 3.20 ± 3.30  
HOMA-β 136.9 ± 123.8 122.8 ± 78.1  
Glucose* 5.06 ± 0.60 5.55 ± 1.52  
Triglycerides* 1.09 ± 0.69 1.35 ± 1.00  
HDL* 1.51 ± 0.37 1.23 ± 0.29  
LDL 2.98 ± 0.89 3.13 ± 1.00  
Cholesterol 5.05 ± 0.96 5.06 ± 1.08  
*-significant difference between men and women (p<0.05) Mean ± Standard Deviation (SD), 
HOMA-IR-Homeostatic Model of Assessment-Insulin Resistance, HOMA-β-Homeostatic 




Table 2-4 Metabolic Characteristics of Pre and Post Menopausal Women 
 Pre Post  
 Mean ± SD Mean ± SD  
 n=277 n=158  
Insulin* 66.0 ± 50.6 92.4 ± 127.9  
HOMA-IR 2.23 ± 1.62 3.68 ± 7.86  
HOMA-β 139.4 ± 139.1 134.8 ± 104.2  
Glucose* 4.93 ± 0.46 5.28 ± 0.74  
Triglycerides* 0.98 ± 0.61 1.27 ± 0.77  
HDL 1.52 ± 0.36 1.51 ± 0.38  
LDL* 2.74 ± 0.78 3.38 ± 0.90  
Cholesterol* 4.80 ± 0.83 5.51 ± 0.99  
*-significant difference between pre and post menopausal and women (p<0.05) 






Table 2-6 Correlations between YFAS Symptom Counts and Metabolic Characteristics in 
Women 
YFAS Symptom Counts  
Women (n=435) 
  
r1(P) r2(P) r3(P) r4(P) r5(P)   
Insulin (pmol/L) .084 (.221) .086(.209) .069 (.319) .011 (.880) .021 (.766)   
HOMA-IR .066 (.355) .064 (.370) .054 (.458) .049 (.496) .036 (.624)   
HOMA-β .071 (.319) .064 (.372) .052 (.468) .005 (.947) .021 (.777)   
Glucose (mmol/L) -.039 (.423) -.024 (.622) -.042 (.388) -.080 (.102) -.085 (.081)   
TG (mmol/L) .122 (.011)* .131 (.007)* .110 (.023)* .059 (.224) .065 (.152)   
HDL (mmol/L) -.112 (.020)* -.110 (.022)* -.082 (.092) -.010 (.841) -.010 (.835)   
LDL (mmol/L) -.015 (.750) .004 (.940) -.001 (.980) -.028 (.567) -.030 (.537)   
Cholesterol (mmol/L) .011 (.824) .035 (.465) -.032 (.514) .018 (.714) .017 (.732)   
*-p-value <0.05, r1-pearson correlation, r2-controlled for age 
r3-controlled for age, physical activity, r4-controlled for age, physical activity, total % body fat, r5-controlled 
for age, physical activity, total % body fat, calories 





r1(P) r2(P) r3(P) r4(P) r5(P)     
Insulin (pmol/L) .248 (.001)* .248 (.001)* .231 (.002)* .140 (.064)* .135 (.080)     
HOMA-IR .262 (.001)* .271 (.001)* .255 (.002)* .167 (.048)* .164 (.053)     
HOMA-β .316 (.000)* .302 (.000)* .283 (.001)* .201 (.016)* .196 (.021)*     
Glucose (mmol/L) -.075 (.217) -.040 (.511) -.048 (.440) -.075 (.224) -.070 (.260)     
TG (mmol/L) .205 (.001)* .222 (.000)* .203 (.001)* .137 (.026)* .140 (.025)*     




(.033)*     
LDL (mmol/L) -.031 (.614) .004 (.947) -.005 (.935) -.059 (.342) -.055 (.378)     
Cholesterol (mmol/L) -.006 (.917) .040 (.511) .020 (.640) -.025 (.683) -.019 (.756)     
*-p-value <0.05, r1-pearson correlation, r2-controlled for age 
r3-controlled for age, physical activity, r4-controlled for age, physical activity, total % body fat, r5-controlled 










                                        Females (n=277) 
  
r1(P) r2(P) r3(P) r4(P) r5(P)   
Insulin (pmol/L0 .141 (.120) .142 (.119) .113 (.227) .052 (.571) .053 (.572)   
HOMA-IR .087 (.366) .087 (.369) .071 (.468) .073 (.455) .059 (.546)   
HOMA-β .097 (.314) .103 (.285) .076 (.432) .031 (.753) .037 (.709)   
Glucose (mmol/L) -.012 (.843) -.017 (.784) -.032 (.602) -.073 (.234) -.079 (.201)   
TG (mmol/L) .078 (.200) .077 (.204) .049 (.418) -.016 (.790) -.012 (.842)   
HDL (mmol/L) -.162 (.007)* -.163 (.007)* -.128 (.035)* -.054 (.377) -.047 (.441)   
LDL (mmol/L) .066 (.277) .064 (.288) .066 (.282) .017 (.778) .017 (.788)   
Cholesterol (mmol/L) .038 (.528) .036 (.556) .036 (.559) -.001 (.985) .001 (.990)   
*-p-value <0.05, r1-pearson correlation, r2-controlled for age 
r3-controlled for age, physical activity, r4-controlled for age, physical activity, total % body fatr5-controlled 
for age, physical activity, total % body fat, calories 
        






r1(P) r2(P) r3(P) r4(P) r5(P)   
Insulin (pmol/L) .021 (.841) .013 (.913) .020 (.853) -.027 (.803) .009 (.936)   
HOMA-IR .015 (.889) .014 (.899) .018 (870) -.024 (833) .015 (.897)   
HOMA-β .032 (.763) .016 (.880) .033 (.763) -.009 (.934) .032 (.778)   
Glucose (mmol/L) -.047 (.557) -.035 (.664) -.058 (.477) -.087 (.920) -.089 (.223)   
TG (mmol/L) .227 (.004)* .226 (.004)* .216 (.007)* .191 (.019)* .198 (.016)*   
HDL (mmol/L) -.029 (.715) -.010 (.902) .008 (.922) .064 (.438) -.032 (.701)   
LDL (mmol/L) -.098 (.218) -.086 (.285) -.089 (.274) -.084 (.303) -.098 (.235)   
Cholesterol (mmol/L) .024 (.765) .045 (.577) .040 (.626) .059 (.475) .041 (.619)   
*-p-value <0.05, r1-pearson correlation, r2-controlled for age 
r3-controlled for age, physical activity, r4-controlled for age, physical activity, total % body fat, r5-
controlled for age, physical activity, total % body fat, calories 






















 Total Population Men            Women    
 FA NFA FA NFA FA NFA 
 
 





















96.4±33.9 81.9±35.4 84.4±45.0    
HOMA-
IR  
0.75±1.40 0.45±0.20 1.99±2.85 0.50±0.15 0.40±0.22 0.43±0.22    
HOMA-β  2.14±0.24 2.13±0.17 2.20±0.40 2.15±0.18 2.12±0.18 2.12±0.18    
Glucose 
(mmol/L) 
5.44±1.20 5.14±0.41 6.37±2.09 5.29±0.36 5.14±0.50 5.09±0.42    
TG 
(mmol/L) 




1.36±0.35 1.37±0.31 1.06±0.17 1.12±0.26 1.46±0.34 1.44±0.29    
LDL 
(mmol/L) 




5.19±1.23 5.00±0.91 4.80±1.52 4.88±0.74 5.32±1.14 5.04±0.97    
*significant difference between FA men and women at p<0.05 Mean±standard 
deviation(SD) FA-Food Addict, NFA-Non-Food Addict, HOMA-IR-Homeostatic 
Model of Assessment-Insulin Resistance  HOMA-β-Homeostatic Model of 
Assessment-Beta Cell, TG-Triglyceride, HDL-High Density Lipoprotein LDL-Low 
density Lipoprotein 
 
HOMA-β-Homeostatic Model of Assessment-Beta Cell, TG-Triglyceride, HDL-High 

















2.4 Discussion  
In 2018 the prevalence of obesity among Canadian adults ages 18-34 was 18.7%, it was 
30.3% among those aged 35-49, 31.3% among those aged 50-64, and 28.1% for 
individuals age 65 and over [13]. The global rate of obesity reported by WHO is 13% [2]. 
Not surprisingly, the rapid rise in obesity over the same period is paralleled by a 
substantial rise in diabetes both in Canada and globally [14, 15]. There is evidence 
supporting the role of processed and fast foods as one contributor to the obesity epidemic 
and it is worth noting that these same types of foods may override the body’s normal 
satiety signals leading to overconsumption [29, 230-233]. The very same foods which 
possess addictive qualities can lead to a cascade of metabolic disturbances if frequently 
consumed [216, 217, 234, 235] which contribute to the development of diabetes and CVD 
[236-238]. This marks the need for more exploration of the relationship between an 
addictive tendency towards food and health. No study, to our knowledge, has explored the 
association between an addictive tendency toward food and metabolic characteristics in 
the general population. A better understanding of how symptoms of food addiction are 
associated with insulin resistance and lipid profiles would help us better comprehend the 
impact of specific eating behaviours on health.  
The main finding produced from our study was that in adult males, despite not meeting 
the criteria for a “food addiction” diagnosis, YFAS symptom counts were still 
significantly, associated with HOMA-β and TG levels as well as inversely associated with 





past [239]. HOMA-β, a measure of insulin secretion, has also been found to initially 
parallel rising TG levels in newly diagnosed type 2 diabetics only to decrease as TG 
levels continued to rise higher [240]. Interestingly, HOMA-β levels tend to be lower in 
individuals with a family history of diabetes due to lower levels of insulin secretion as a 
result of an impaired β-cell function [241]. The aforementioned studies demonstrate the 
complexity of the relationship between insulin secretion and metabolic health. In the 
current study, there was a significant positive correlation between HOMA-β and YFAS 
symptom counts which may suggest that food addicted behaviours result in higher insulin 
secretion as a compensatory mechanism. This could potentially be problematic as 
consistently high insulin levels can often precede diabetes which can eventually damage 
the β-cell to the point where the cell can no longer produce sufficient levels of insulin to 
combat hyperglycemia. This is evidenced by the enlargement of β-cells observed in obese 
individuals and those in the pre-diabetic phase [242-244]. HOMA-β measurements, 
therefore, must be interpreted cautiously as high insulin secretion can suggest an 
individual is at risk of developing diabetes and low insulin secretion may suggest that the 
damage has already been done to the β-cell. A study by the Canadian Heart Health 
Surveys Research Group found that in a sample of over 29 000 Canadians, high TG and 
low HDL levels were common among diabetics and those with hypertension [245]. 
Elevated TG levels have also been associated with atherosclerotic CVD and all cause 
mortality in a study comprised of over 15 000 patients [246, 247]. It stands that 
behaviours that may influence TG and HDL levels may also increase the risk of CVD. 





symptoms, and their relationship with these metabolic characteristics, however, one study 
did find that food addiction was significantly more prevalent in newly diagnosed type 2 
diabetics when compared to a control group. This same study also compared the 
metabolic characteristics of FA and NFA diabetics and found that those who were food 
addicted had a substantially higher HOMA-IR value [193]. However, our results 
indicated that there was no significant difference in HOMA-IR or other metabolic 
characteristics between FA and NFA individuals when matched for BMI. Food addiction 
has also been found to account for a large portion of BMI variance among T2D patients 
[192]. This may suggest that an addictive tendency towards food is not only a risk factor 
for T2D but could in fact exasperate the condition since patients will have greater 
difficulties adhering to dietary recommendations that may improve their health and help 
manage their condition. As previously noted, some of the hormones associated with 
addictive behaviours also share associations with a number of health risks which may 
further compound the effects of an addictive tendency towards food. 
In females, Pearson correlation analysis revealed no significant correlations between 
YFAS symptoms and any of the metabolic markers measured. However, after women 
were separated according to menopausal status to further elucidate the potential effects of 
sex hormones on these outcomes, post-menopausal women exhibited a significant 
correlation between YFAS symptoms and TG after correcting for age, physical activity, 
total body fat percent, and calories. While there are currently no past studies investigating 





studies on disordered eating patterns such as binge eating have been found to have 
signification associations with T2D [248]. The role of addictive food tendencies in T2D 
has also been found to be harmful. Varying levels of food addiction based on YFAS 
symptom counts were associated with a significant increase in BMI among T2D patients 
in a sample that was 67.4% women, however, there was no adjustment for menopausal 
status [249]. The limited associations seen in our female population may be due to the 
protective effects of lower body fat common among women which may help keep blood 
glucose and lipid profiles within a normal range despite problematic eating behaviours 
[250-252]. However, this effect could be somewhat diminished in post-menopausal 
women as decreasing estrogen levels have been shown to influence central fat 
accumulation and TG levels [128, 253] 
The greatest strength of our study is the large number of individuals successfully 
recruited from the general population in conjunction with good screening efforts to 
control for potential confounders such as health disorders that could influence an 
individual’s dietary habits or result in them presenting with addictive behaviours beyond 
that which is seen a general population. We have also benefitted from the ability to collect 
blood samples from every participant for reliable measurement of hormones and lipid 
profiles. Our extensive list of questionnaires to collect details on physical activity and 
dietary history adds strength to the validity of our results as they allowed us to effectively 
control for these confounders. The use of DXA scanning to measure total body fat % 





methods available [86]. One possible limitation present in our study could be that caloric 
intake and physical activity levels were self reported, both of which were controlled for in 
this study. self-reporting bias is another factor that researchers must be cognizant of when 
dealing with self-administered questionnaires. The number of food addicts used in the 
comparative analysis. Although this was a large sample size, food addiction was present 
in only about 5% of participants [183]. It should also be noted that the exclusion of 
previously diagnosed food addicted individuals contributed to the modest correlation 
coefficients produced from the partial correlation analysis. However, exclusion of these 
outliers allowed us to better capture the true contribution of addictive eating tendencies to 
metabolic disturbance in a general population. Replications of this study would greatly 
benefit from a larger number of individuals diagnosed with food addiction. It is also 
possible that with a larger overall sample size, the correlation between YFAS symptoms 
and HOMA-IR in men may reach the required cut-off for statistical significance as it was 
narrowly missed in this analysis (Table 2-5). Future studies could also benefit from 
measuring a larger number of metabolic markers or health outcomes and their association 
with an addictive tendency toward food. Finally, an intervention study measuring 
metabolic characteristics in individuals living with food addiction before and after 
treatment to address addictive eating behaviours would better highlight the impact these 
behaviours have on health and whether meaningful improvements in IR and lipid profiles 
can be achieved through this. In conclusion, we have demonstrated that an addictive 
tendency towards food is associated with several metabolic characteristics that may 





lesser extent, post-menopausal women. Our findings help elucidate the role of addictive 
food tendencies in metabolic disturbance in a general population and how this may 
impact men and women differently. A proper, standardized assessment of FA is an 
important first step to address these behaviours. These symptoms must be managed and 
treated appropriately, ideally, through education and guidance by nutritionist and therapist 
as it may require both dietary intervention and knowledge of effective coping strategies to 
combat urges and recognize detrimental behaviours. Furthermore, efforts to control 
addictive eating behaviours could potentially become a factor in preventative efforts 
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3.1 Introduction 
Obesity is one of the most ubiquitous public health problems in Canada as well as most 
developed and even developing countries [1]. The Province of Newfoundland and 
Labrador (NL), Canada, has the highest prevalence of obesity at 35.2% [2]. Residents of 
this province also exhibit high rates of obesity related health disorders such as type II 
diabetes which affects 11.2% of the provincial population [3] and cardiovascular diseases 
which results in nearly 202.3 deaths per 100,000 individuals yearly which ranks the worst 
among all provinces in Canada [4]. It is clear that the issue of obesity must be addressed 
in this population. The etiology of obesity is highly complex with the interaction of many 
environmental, genetic, and psychological factors involved [5, 6]. The overconsumption 
of calorie dense foods is one of these factors and it has been found that high calorie, 
highly palatable foods may have addictive qualities that promote frequent consumption in 





addictive and it has recently been shown that an addictive tendency toward food is, in 
fact, an important factor contributing to the development of obesity [10].  
Food addiction, not to be confused with the occasional overindulgence, is defined as an 
obsessive consumption of highly palatable foods that trigger the body’s reward systems, 
despite adverse health effects. This phenomenon is supported by a collection of 
physiological evidence in the way of dopaminergic circuitry activation correlating with 
food addictive behaviours in both human and animal studies [11-13]. Similarities have 
been drawn between food addiction and nicotine addiction regarding the way each 
influences the body’s reward systems [14]. Chronic intake of certain foods has even been 
compared to cocaine and opioid use [15, 16]. Despite this evidence, food addiction is not 
yet recognized by clinicians but the quantification of food addictive behaviours is made 
possible through the Yale Food Addiction Scale (YFAS) which was developed in 2009 
[17]. The YFAS has been used and studies among bariatric surgery patients, adults 
seeking weight loss treatment, and eating disorder patients [18-20]. As one might 
imagine, the types of food that are normally found to have addictive qualities are those 
which are high in sugar, fat and are heavily processed. A study by Schulte and colleagues 
revealed that whether or not a food was processed, was a strong predictor of its 
possessing addictive- like qualities [21]. Although the prevalence of obesity in Canada 
has tripled in the past 30 years, fast foods make up only 6.3% of total calorie intake in the 
Canadian diet [22] so it may be possible that food choices at home may be a larger factor. 





comorbidities, there are many individuals who, in spite of maintaining high levels of body 
fat, barely exhibit any signs of metabolic disturbance [23, 24]. This might be partly due to 
the heterogeneity of how different individuals can accumulate body fat and how it is 
distributed within the body [25] which brings us to a more specific concern, the issue of 
fat distribution. 
One way of framing the issue of body fat distribution is the classic apple vs. pear shape 
example. The “apple” shape, otherwise known as central obesity, is often used to refer to 
excessive fat in the android and trunk region of the body with a high waist to hip ratio and 
is far more common in males. The “pear” shape, is characterized by more body fat in the 
hips, thighs, and buttocks, known as the gynoid region, with a lower waist to hip ratio and 
is more often observed in women [26-28]. The way in which an individual accumulates 
body fat in terms of both mass and distribution can result in very different 
cardiometabolic outcomes [29]. Evidence indicates that the often male associated central 
and android obesity defined as excess adipose tissue in the abdominal region and intra-
abdominal or visceral cavity is more important in the association with the prevalence of 
diabetes and cardiovascular diseases than overall subcutaneous fat [30]. Visceral 
adiposity has also been found to increase arterial inflammation and serve as a predictor of 
future cardiovascular events [31]. Conversely, the relationship between gynoid or gluteo-
femoral fat with favorable metabolic profiles has been a consistent finding in many 
studies [32-34]. Body fat distribution appears to play an important role in overall health. 





toward food and its relationship to specific body fat distribution patterns remains to be 
seen.  
We have previously demonstrated that the severity of food addiction is strongly correlated 
to the degree of adiposity in the NL population [10]. However, it is unclear if an addictive 
tendency towards food is associated with an increase in specific fat distribution patterns 
such as an excess of fat in the android region, gynoid region, or visceral cavity. VF is of 
unique concern as it has been shown to increase circulating free fatty acids and 
inflammatory adipocytokines which may contribute to insulin resistance [35, 36]. A 
recent study has suggested that YFAS symptom counts may in fact be associated with 
visceral adiposity in young females [37]. This study, however, was performed with only 
female participants of a relatively small range of ages, which makes it difficult to apply to 
a general population. Furthermore, bioelectrical impedance (BIA) was the method by 
which adiposity measures were taken [38] which may lack accuracy regarding the 
measurement of visceral adiposity. The study did, however, take into consideration other 
potential confounding factors that may influence body fat measures such as physical 
activity and total caloric intake. These factors are highly variable between individuals and 
can easily mask the true contribution of food addiction symptoms to body fat distribution 
if not properly controlled for in the statistical analysis. Physical activity levels exhibit 
significant influence on adiposity and it has been consistently shown that individuals who 
regularly engage in some form of exercise have lower body fat than those who do not [39-





Due to the dangers surrounding certain patterns of body fat distribution, for example, the 
“apple” shape or central obesity as mentioned above, more specific investigations 
concerning factors that contribute to this issue are warranted. We have performed an in-
depth analysis of YFAS symptom count correlations with several measures of body fat 
distribution in men and women of a general NL population using DXA and controlled for 
major confounding factors such as age, physical activity, and caloric intake. To the best 
of our knowledge, no study to date has assessed this relationship in such detail or in such 
a large sample size.  
3.2 Materials and Methods 
Ethics Statement 
This study was approved by the Health Research Ethics Authority (HREA), Memorial 
University of Newfoundland, St. John’s, Canada with project identification code 10.33. 
Written consent was provided by all who participated. 
Study Sample: 
777 adult volunteers (479 women, 298 men) from the Province of NL were recruited for 
this study through the use of advertisements, flyers, and word of mouth. Eligibility for the 
study required that all participants be 





2. The participant must have been born in NL and the participant’s family must have been 
in NL for at least 3 generations 
3. Healthy with no serious metabolic, endocrine, or cardiovascular conditions. 
4. Participant must not be pregnant at time of study.  
Anthropometric Measurements: 
Height, weight, waist, and hip circumference were measured following a fasting period of 
12 hours. All measurements were taken with participants wearing a standard hospital 
gown. Weight was measured to the nearest 0.1 kg using a platform manual scale balance 
(Health O Meter, Bridgeview, IL). Height was measured using a fixed stadiometer to the 
nearest 0.1 cm. Hip circumference was measured using a flexible measuring tape at the 
level of the largest circumference between the waist and thighs to the nearest 0.1 cm. 
Waist circumference was measured using the same method at the level of the umbilicus, 
between the lowest rib and iliac crest. 
Body Composition Measurements and Definitions: 
Body composition measurements which included trunk fat, android fat, and VF were 
assessed using dual-energy x-ray absorptiometry (DXA; Lunar Prodigy; GE Medical 
Systems, Madison, WI, USA). Measurements were taken while the patient lied 
horizontally on the DXA scanner following a 12 hour fast. The trunk region is defined as 
the area from the lowest boundary of the pelvis cut to the highest boundary of the neck. 





20% of the distance between the pelvis and neck cuts. The gynoid region, also within 
DXA software definitions, is defined as the lower boundary of the umbilicus to a line 
equal to twice the height of the android fat distribution [43, 44]. 
Food Addiction Symptom Count Measurement: 
Symptoms of food addiction were assessed using the Yale Food Addiction Scale. This is 
a 25 item questionnaire that assesses the last 12 months of eating patterns. The YFAS is 
based on the criteria used for substance dependence in the Diagnostic and Statistical 
Manual IV-TR (DSM-IV TR). This criterion includes symptoms such as tolerance, 
withdrawals, anxiety in social situations, and difficulty lowering or quitting the use of the 
substance. Using the YFAS. symptoms were counted using the Likert scoring method 
which ranges from 0 to 7 [17]. Each symptom on the YFAS represents a collection of 
questions from the questionnaire concerning that particular behaviour. If an individual 
answers affirmatively to certain questions, they are said to have the corresponding 
symptom. Some of these questions are based on the frequency of the behaviour (ex. once 
a month, 2-4 times a month, etc.) and some are binary yes or no questions [45]. 
Calorie intake and Physical Activity Assessment: 
Calorie intake was measured using the Willett Food Frequency Questionnaire (FFQ) 
which measures the last 12 months of dietary habits [46]. The quantity of each food item 
was converted into a daily average intake value. This value was then entered into 
Nutribase Clinical Nutrition Manager (software version 9.0; Cybersoft inc. Arizona). We 





levels. This questionnaire measures physical activity using three categories which are 
work, sport, and leisure [47]. 
Statistical Analysis: 
All statistical analysis was completed using SPSS ver.23. The level of statistical 
significance was set at alpha=0.05. All statistical tests were run on the entire cohort as 
well as men and women separately. Pearson correlation analysis was used to evaluate 
potential relationships between YFAS symptom counts and measures of adiposity. Partial 
correlation analysis was also performed which allowed us to control for age, total calorie 
intake, and physical activity levels. A linear regression analysis was also performed to 
assess the variance of each fat distribution measure attributed to YFAS symptom counts. 
A one-way ANOVA was used to measure the difference in body fat levels between food 
addicted obese (FAO), non-food addicted obese (NFO), and normal weight controls. FAO 
and NFO were matched by age and BMI.  
3.3 Results 
Physical Characteristics and Adiposity Measures  
The age, gender, BMI, and anthropometric data of the entire cohort, as well as men and 
women separately are presented in Table 3-1 as mean ± standard deviation. Table 3-1 also 
contains all adiposity measures expressed as mean ± standard deviation. The average age 





significant difference between men and women for all anthropometric and adiposity 
measures.  
The Correlation Between YFAS Symptom Counts and Measures of Fat Distribution 
Both men and women showed highly significant correlations between YFAS symptom 
counts and all measures of fat distribution (table 3-2) including total body fat (men: 
r=0.30, women: r=0.33), trunk fat (men: r=0.30, women: r=0.31) android fat (men: 
r=0.34, women: r=0.33), gynoid fat (men: r=0.23, women: r=0.30) and VF (men: r=0.32, 
women: r=0.31). These measures are expressed in percentages as well. Women showed 
slightly higher correlations than men in all measures except for VF and android fat, for 
which men showed slightly higher correlations. Women exhibited a much higher 
correlation between gynoid fat and YFAS symptom counts. All partial correlation 
analysis has been controlled for age, physical activity, and total calorie intake 
Comparison of Body Fat Distribution Measures for FAO, NFO and Control Groups 
An ANOVA was performed between FAO, NFO, and normal weight controls with FAO 
and NFO groups matched by sex and BMI. The control group was also matched by sex. 
There were 21 individuals in each group. ANOVA revealed that all measures of body fat 
distribution differed significantly between the obese groups and the controlled groups as 
expected, however, a significant difference was not observed for FAO and NFO 
individuals. The F value, which is a measure of the variation between samples divided the 
variation within samples, was highest for trunk percent fat and android percent fat. The 





Table 3-1 Characteristics of Participants    
 
Female Male  
 
Mean ± SD Mean ± SD  
  n=479 n=298 P-value 
Age* 45.3 ± 13.1 42.8 ± 12.7 0.011 
Height (cm)* 163.3 ± 6.0 177.6 ± 6.7 <0.001 
Weight (kg)* 70.8 ± 14.8 90.8 ± 17.3 <0.001 
BMI (kg/m2)* 25.8 ± 5.0 29.9 ± 4.9 <0.001 
BF%* 37.0 ± 8.7 26.3 ± 8.4 <0.001 
TF%* 38.4 ± 10.0 31.9-10.1 <0.001 
GF%* 44.0 ± 7.3 28.9 ±7. 8 <0.001 
AF%* 42.6 ± 11.7 36.9 ± 11.5 <0.001 
VF%* 2.0 ± 1.5 4.8 ± 2.5 <0.001 
Waist (cm)* 91.2 ± 13.8 101.2 ± 13.6 <0.001 
Hip (cm)* 99.8 ± 12.8 101.7 ± 10.8 0.019 
Waist/Hip* 0.9 ± 0.05 1.0 ± 0.05 <0.001 
*significant difference of means between men and women Mean ± standard deviation (SD), 
BMI–Body mass index, BF% Percent body fat, TF%–Percent trunk fat, AF%-Percent android 





Table 3-2 Partial Correlations of YFAS Symptom Counts with Measures of Body 
Fat Distribution Controlled for Age, Physical Activity and Caloric Intake 
 





Total Body Fat (g)* r=0.32 (p<0.001)   
r=0.33 
(p<0.001)   
r=0.30 
(p<0.001) 





















Gynoid Fat r=0.29 (p<0.001)   
r=0.30 
(p<0.001)   
r=0.23 
(p<0.001) 







Android Fat(g)* r=0.31 (p<0.001)   
r=0.33 
(p<0.001)   
r=0.34 
(p=0.002) 













VF (g)* r=0.21 (p<0.001)   
r=0.31 
(p<0.001)   
r=0.32 
(p<0.001) 
VF %* r=0.08 (p=0.039)   
r=0.23 
(p<0.001)   
r=0.19  
(p=0.001) 











Table 3-3 ANOVA for Body Fat Differences Between Sex and BMI matched Food 
Addicted Obese, Non-Food Addicted Obese and Control groups 
n=21 in each group F P 
BF (g) 14.8 <0.001* 
BF% 25 <0.001* 
TF (g) 11.5 <0.001* 
TF% 44.5 <0.001* 
AF (g) 15.6 <0.001* 
AF% 44.4 <0.001* 
GF (g) 10 <0.001* 
GF% 7.8 0.001* 
VF (g) 15.3 <0.001* 
VF% 4.38 0.017* 













  Obesity has become one of the widest spread and burdensome health issues facing us 
today. Some studies suggest it may be equally, if not more destructive than cigarette 
smoking [48]. Chronic positive energy balance, whether it’s due to excessive caloric 
intake or lack of physical activity, continues to be the driving force of the obesity 
epidemic [49-51]. It follows that the consumption of highly palatable, calorie dense foods 
only exasperate this problem. Our previous studies have indicated that food addiction or 
an addictive tendency towards food is an independent contributing factor to the 
development of obesity [10, 52]. However, the relationship between symptoms of “food 
addiction” and body fat distribution remains unclear. We have shown that YFAS 
symptom counts exhibit a highly significant correlation with not only total body fat 
percent, which has been highlighted in previous studies of ours [10], but with several 
measures of fat distribution which are far more sensitive indicators of future obesity 
related health issues [53-56]. A better understanding of how an addictive tendency 
towards food contributes to specific body fat distribution patterns could aid in 
understanding how compulsive eating patterns contribute to overall health. To date, no 
other study has performed such a detailed investigation of the relationship between YFAS 
symptoms and body fat distribution, in a large general population. 
We measured body fat distribution in 777 men and women in the general NL population 
using DXA, which allowed us to safely and accurately measure both subcutaneous and 





DXA also provides a much more complete assessment of body composition than BMI 
[59]. The first and most significant finding of the present study is the correlation that was 
observed between VF mass and YFAS symptom counts in both men and women. VF 
percentage was also found to be significantly associated with YFAS symptoms in men 
and women. This is the first time this relationship has been reported in men and women 
of a general population. The present study is an important addition to the current body of 
knowledge on the relationship between YFAS symptoms and BFD and how it applies to a 
general population. Our findings are particularly important as they suggest that food 
addiction plays a significant role in, not only the accumulation of peripheral adipose 
tissue but could have serious metabolic implications as well since VF is a risk factor of a 
number of health issues. These issues include but are not limited to diabetes and high 
blood pressure, additionally, an addictive tendency toward food has recently been found 
to be much more prevalent in a cohort of recently diagnosed type II diabetics [60-63]. 
Excess adipose tissue in the visceral cavity has also been found to exhibit an association 
with arterial stiffness among other cardiometabolic risk factors and all-cause mortality 
[50, 64, 65]. This finding is also reinforced by a study that found many of the same foods 
that have been shown to influence addictive like behavior are also associated with 
visceral adiposity [21, 66]. The correlation of YFAS symptoms with VF percentage was 
higher in women (table 3-2). This particular finding is concurrent with other measures of 
adiposity in women, as they generally have higher body fat percentages [67]. This finding 
highlights the potentially detrimental effects an addictive tendency towards food can have 





dietitians to take a more complete assessment of individual eating habits to address health 
issues that can be exasperated by or are associated with excessive VF. 
A significant correlation between YFAS symptom counts with both total mass and 
percentage of the trunk and android fat was also observed in both men and women. A 
correlation between trunk fat and YFAS symptoms counts had been previously reported 
by our lab but subjects were grouped as either food addicted, or non-food addicted and 
not by gender thereby masking gender specific effects. The number of subjects in the 
previous study was also much smaller [52]. Therefore, this is the first time that the sex 
specific relationship between YFAS symptoms, trunk fat, and android fat has been 
reported in the general population. While men normally tend to carry more weight in this 
region of the body, the association between trunk fat and dietary patterns in women has 
been observed in a recent study [68], so it may stand that addictive eating behaviours in 
women are likely to lend themselves to the development of truncal obesity. A large 
population study also reported that foods with addictive qualities may contribute to 
excessive truncal fat [69] Trunk and android fat, much like VF, has been shown time and 
time again to exhibit strong associations with insulin resistance, diabetes, high 
cholesterol, and metabolic syndrome [43, 70-75]. Our finding, in conjunction with the 
growing body evidence that truncal obesity can be dangerous for the long-term health of 
an individual, indicates a need for a greater understanding of the factors that contribute to 
this particular body fat distribution pattern [70, 76-79]. A significant correlation between 





although this association was much more pronounced in women (table 3-2). It has long 
been observed that women tend to exhibit gynoid obesity far more than men and our 
results are in agreement with this trend [80, 81]. Gynoid fat is thought to be protective 
against metabolic illnesses such as diabetes and CVD [82-86]. While gynoid fat does 
exhibit a positive correlation with YFAS symptoms, additional endocrinological studies 
are required to uncover the metabolic implications of this relationship and whether the 
same protective factors are present in food addicted obese women. Lastly, we compared 
FAO, NFO, and control groups (table 3-3) which revealed that all measures of body fat 
distribution were significantly different between these groups. The body fat regions that 
exhibited the greatest variation between groups was VF mass, trunk fat mass, android fat 
%, and trunk fat %. While differences in body fat measures between healthy controls and 
obese individuals differed greatly, as can be reasonably expected, the post-hoc analysis 
revealed the differences in body fat measures between FAO and NFO groups were not 
statistically significant. However, the prevalence of food addiction among obese 
individuals remains to be much higher than in non-obese individuals as indicated by 
recent studies. Food addiction has also been investigated and validated as a phenotype of 
obesity [10, 87, 88]. This serves to highlight the complexity of obesity and provide 
evidence of the heterogeneity of this disease.  
This study revealed many unique findings; however, potential limitations would be that 
the YFAS questionnaire may be susceptible to self-reporting bias and there is always the 





the time of data collection. This study also could have benefitted from the inclusion of 
hormonal characteristics to further highlight the effects that food addiction can have on 
components of metabolic syndrome such as triglycerides, blood pressure, or fasting 
glucose. In the future, it would be a worthwhile endeavor to examine the correlation 
between specific symptoms of food addiction and measures of adiposity, as well as 
hormonal characteristics. A longitudinal study would also be helpful in documenting the 
relationship between food addiction and body composition at different stages in life, 
although it should be noted that cross-sectional studies such as this cannot determine 
causality or directionality of the correlation that is observed. 
This association study has successfully demonstrated that YFAS symptom counts are 
significantly correlated with multiple measures of fat distribution in both men and women 
of a large, general, NL population even after controlling for several confounding factors. 
It is the first to demonstrate the gender specific association of YFAS symptom counts 
with visceral, trunk, and total fat in such a large cohort. It is also the first to demonstrate 
the correlation between YFAS symptom counts with android and gynoid fat. This is the 
most comprehensive study to date, that highlights the relationship between symptoms of 
food addiction and body fat distribution patterns that are consistently shown to be 
sensitive indicators of diabetes and CVD risk. Additional research is required to reveal 
direct cause and effect relationships between these variables. Our analysis indicated that 
YFAS symptom scores are associated with several measures of adiposity in both men and 





significantly associated with measures such as total BF% (men=0.24 women=0.30), AF% 
(men=0.25 women=0.31) and VF% (men=0.19 women=0.23). The variance in regional 
fat percentage attributable to symptoms of FA ranges from 3.6% to 9.6%, suggesting that 
FA is a factor to consider in obesity treatment and prevention. Perhaps individuals 
seeking weight-loss treatment should also be evaluated for symptoms of FA and/or the 
severity of FA based on YFAS symptom scores so that dietitians are able to better 
understand the challenges individuals face when attempting to lose weight. This can assist 
dietitians in making more informed recommendations as to what types of food their 
clients are struggling with and the behaviors that make weight-loss a more challenging 
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4.1 Introduction 
Obesity is among the most challenging public health issues facing the world today, 
particularly in the Canadian Province of Newfoundland and Labrador where 35% of 
residents are obese [1, 2]. There is a large body of evidence that suggests that 
comorbidities often associated with obesity such as diabetes and cardiovascular disease 
(CVD) exhibit higher correlations with specific body fat distribution (BFD) patterns, as 
opposed to overall body fat percentage [3-8]. BFD can vary greatly between different 
individuals and certain sites of body fat storage are more metabolically active as they are 
more sensitive to lipase activity, the enzyme responsible for the hydrolysis of 
triglycerides, which can lead to an increased risk of metabolic dysfunction [9-14]. The 
way in which individuals store body fat is also modified by sex hormones such as 
estrogen [15-17]. This accounts for some of the variations in BFD between men and 
women, as men tend to store fat in the android or central region and women more 
commonly store fat in the gynoid or gluteal-femoral region [18, 19]. This is why men and 
women often present with what is commonly known as the “apple” and “pear” shape, 
respectively, which can have serious implications in an individual's health [20, 21]. The 





thought to be protective and the “apple” shape may increase an individual's risk to a 
number of health issues [22-24]. Women can also exhibit the android obesity more 
commonly seen in men, however, there is limited data directly comparing the metabolic 
characteristics of women with android obesity to those without in a large general 
population. The role of lower body fat in metabolic health is also in need of further 
clarification because, despite numerous studies that suggest it is protective, a loss in leg 
fat has been found to be equally important to the improvement of insulin sensitivity when 
compared to a loss in trunk fat [25]. 
Many of the existing studies on this topic have limited sample sizes, examine only certain 
subsets of the population (ex. diabetics, elderly), or fail to control for sex specific effects 
[26-32]. Those that do include the general population test only a small number of 
metabolic markers or use less accurate means of measuring BFD compared to imaging 
technologies such as magnetic resonance imagery and dual energy x-ray absorptiometry 
(DXA), that is capable of providing highly accurate BFD data [33-37]. Therefore, we 
have designed a study that compares a large panel of metabolic characteristics in 2323 
women with and without android obesity as measured by DXA scans from the general NL 
population. DXA scanning technology offers a significant advantage as it is a safe, 
efficient, and highly accurate method of assessing body fat distribution and is often 
described as the “gold standard” of performing such measurements. It also allows a 
detailed look at the actual body shape of research participants [38-42]. Furthermore, DXA 





subcutaneous android fat as visceral adipose tissue is independently associated with a 
number of metabolic issues and is located within the android region [43-47]. The inability 
to control for VF is another limitation that is common among many studies on this topic.  
This paper describes the comparison of a wide range of metabolic and anthropomorphic 
measurements between women with different BFD patterns recruited through the 
CODING (Complex Disease in the Newfoundland Population: Environment and 
Genetics) study which has generated several papers in the field of obesity research [38, 
48-50]. We have also included an analysis of a sub-group of 470 BMI matched women of 
similar age with and without upper body obesity which has been adjusted to control for 
VF. Using the same BMI matched sub-group, we have additionally calculated the risk of 
metabolic syndrome (MetS) for women with upper body obesity in the NL population as 
defined by the Adult Treatment Panel III (ATP III) which was designed by the National 
Cholesterol Education Program (NCEP) [51]. MetS is a collection of symptoms that often 
occur together in clusters that significantly increase an individual’s risk of developing 
CVD or other serious illnesses [52]. A better understanding of the relationship between 
female android obesity and MetS could prove extremely helpful to clinicians and public 
health efforts to mitigate the risk of CVD. 






This study was approved by the Health Research Ethics Authority (HREA), Memorial 
University of Newfoundland, St. John’s, Canada with project identification code 10.33. 
Written consent was provided by all who participated. 
Study Sample 
2323 adult women from the Canadian Province of Newfoundland and Labrador were 
recruited for this study through the use of advertisements, flyers, and word of mouth. 
Eligibility requirements are as follows: 
1. 19 years of age or older 
2. The participant must have been born in NL and the participant’s family must have been 
in NL for at least 3 generations 
3. Healthy with no serious metabolic, endocrine, or cardiovascular conditions. 
4. Participant must not be pregnant at time of study.  
Metabolic Marker Measures 
Serum concentrations of glucose, total cholesterol, HDL cholesterol and triacylglycerols 
were measured using the Lx20 analyzer (Beckman Coulter Inc., Fullerton, CA) with 
Synchron reagents. LDL cholesterol was calculated using the following formula: (total 
cholesterol) − (HDL cholesterol) − (triacylglycerols/2.2). Serum insulin was measured 
using the Immulite Immunoassay analyzer. Insulin resistance and beta cell function were 






Height, weight, waist, and hip circumference were measured following a fasting period of 
12 hours. All measurements were taken with participants wearing a standard hospital 
gown. Weight was measured to the nearest 0.1 kg using a platform manual scale balance 
(Health O Meter, Bridgeview, IL). Height was measured using a fixed stadiometer to the 
nearest 0.1 cm. Waist circumference was measured using the same method at the level of 
the umbilicus, between the lowest rib and iliac crest. 
Body Composition Measurements and Definitions 
Body composition measurements which included android fat, gynoid fat, and VF were 
assessed using dual-energy x-ray absorptiometry (DXA; Lunar Prodigy; GE Medical 
Systems, Madison, WI, USA). Measurements were taken while the patient lied 
horizontally on the DXA scanner following a 12 hour fast. The android region as defined 
by the DXA software runs from above the pelvis cut by 20% of the distance between the 
pelvis and neck cuts. The gynoid region, also within DXA software definitions, is defined 
as the lower boundary of the umbilicus to a line equal to twice the height of the android 
fat distribution [43, 54-57]. 
Metabolic Syndrome Diagnosis 
MetS was diagnosed according to the NCEP ATP III criteria. Diagnosis in females 
requires that individuals have at least 3 out of 5 of the following symptoms [51] 





ii. Fasting glucose >100mg/dl 
iii. TG >150mg/dl 
iv. HDL <50mg/dl 
v. SBP >130mmHg or DBP >85mmHg 
Statistical Analysis 
All statistical analysis was completed using SPSS ver.23. The level of statistical 
significance was set at alpha equal to or less than 0.05. Women were separated into 
tertiles and quartiles based upon android: gynoid (AGR) ratio. Metabolic and 
anthropometric characteristics between tertiles were compared using one-way ANOVA. 
Women in the top quartile were compared to a control group of BMI matched women of 
similar ages using multivariate testing controlled for VF percentage. Odds ratio (OR) was 
calculated to determine the risk of metabolic syndrome among women in the top quartile 
of AGR. 
4.3 Results 
Comparison of AGR Tertiles 
Females in the lowest, middle and highest tertile of AGR all differed significantly from 
one another in mean insulin, glucose (figure 4-1), triglycerides (TG), high density 
lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol (TC) (figure 4-2), 
systolic blood pressure (SBP), diastolic blood pressure (DBP), and waist circumference 





between each other for HOMA-IR or HOMA-β, although HOMA-IR did not come quite 
close to reaching the appropriate p-value for statistical significance (p= 0.055). The 
highest tertile was significantly higher than both the lowest and middle tertile for HOMA-
IR and HOMA-β. 
Comparison of Top AGR Quartile with BMI Matched Women  
After controlling for VF percent, women in the top AGR quartile, when compared to a 
BMI matched group of women who populated the lower quartiles of AGR, there was no 
significant difference observed for any of the markers that were studied (Table 4-3). 
However, women in the top quartile were found to be 2.4x more like to have metabolic 
syndrome compared to their BMI matched counterparts of a similar age which may be 













Table 4-1 Physical Characteristics of Participants 
 Mean ± SD 
  n=2323 
Age  44 ± 12.7 
Min-max 19-90 
Height *cm) 163 ± 6.0 
Min-max 158-196 
Weight (kg) 70 ± 14.4 
Min-max 47-157 
BMI (kg/m2) 30.8 ± 5.4 
Min-max 16-48 
BF% 37 ± 7.9 
Min-max 5-59 
GF% 44 ± 6.8 
Min-Max 7-63 
AF% 43 ± 10.9 
Min-max 4-66 
A:G Ratio 0.45 ± 0.16 
Min-max <0.001-1.29 
VF% 2 ± 1.5 
Min-max <0.001-14.7 
Mean ± standard deviation (SD), (Maximum – Minimum), BMI–Body mass index, BF%  Total 
Percent body fat, GF%- Percent Gynoid Fat, AF%-Percent android fat, A:G Ratio- 














Table 4-2 Characteristics of BMI Matched 
Participants 
 
A:G Ratio Top 
Quartile Control 
 Mean ± SD Mean ± SD 
  n=235 n=235 
Age 50.8 ± 9.2 49.3 ± 9.0 
Min-max 24-76 20-70 
Height (cm) 161.2 ± 5.5 162.0 ± 6.3 
Min-max 135-179 140-187 
Weight (kg) 80.1 ± 14.9 80.9 ± 16.1 
Min-max 53-132 52-130 
BMI (kg/m2) 30.8 ± 5.4 30.8 ± 5.4 
Min-max 19-48 19-48 
BF%* 42.0 ± 5.7 43.4 ± 6.0 
Min-max 25-59 22-58 
GF%* 44.0 ± 6.8 49.6 ± 5.7 
Min-Max 22-62 28-63 
AF%* 52.9 ± 5.9 50.6 ± 6.9 
Min-max 32-66 28-64 
A:G Ratio* 0.71 ± 0.09 0.49 ± 0.08 
Min-max 0.61-1.02 0.23-0.60 
VF%* 24.15± 1.3 2.76 ± 1.3 
Min-max 0.15-8.11 0.04-14.7 
*Mean ± standard deviation (SD), (Maximum – Minimum), BMI–Body mass index, BF%  Total 
Percent body fat, GF%- Percent Gynoid Fat, AF%-Percent android fat, A:G Ratio- 














*p < or = 0.05 indicates statistical significance, Homeostatic Model of Assessment-Insulin 
Resistance – HOMA-IR, Homeostatic Model of Assessment-Beta Cell – HOMA-β 


































































*p < or = 0.05 indicates statistical significance, HDL – High Density Lipoprotein, LDL – Low 
Density Lipoprotein 






























































   
*p < or = 0.05 indicates statistical significance, BP – Blood Pressure 

















































Table 4-3 Comparison of Metabolic Markers Between AGR Top Quartile and BMI, 
Age Matched Control Group 
 
AGR ratio Top 
Q Control 
 n=235 n=235 
Insulin*        98.5 75.7 
HOMA-IR*     3.61 2.61 
HOMA-β      153.9 137.3 
Glucose*      5.56 5.25 
TG*         1.67 1.25 
HDL*        1.34 1.45 
LDL             3.42 3.29 
TC *          5.56 5.34 
SBP*         130 125.5 
DBP            84.4 83.6 
*p<0.05, TG=triglycerides, HDL-High density lipoprotein 
LDL -Low density lipoprotein, TC-Total cholesterol           


















Obesity is defined as a chronic condition characterized by excessive body fat which can 
lead to poor health outcomes and the specific way in which excess fat is distributed 
throughout an individual’s body is more telling of current and future health risks [58-60]. 
Gynoid or “pear shaped” obesity which is often observed in women is frequently 
associated with a decreased risk of CVD and other co-morbidities, however, some women 
also develop android or “apple shaped” obesity which is more prevalent among men [61-
64]. While many studies have made efforts to better understand the effects of android 
obesity in women, there are still gaps in our knowledge that have not been properly 
addressed. An investigation of a comprehensive panel of metabolic characteristics in a 
large general population, including all those necessary for the diagnosis of MetS, would 
significantly advance the understanding of the consequences that upper body obesity 
plays in the health and well-being of women. Furthermore, performing a study of this 
nature with the use of advanced imaging technology which we have done using DXA 
scanning, would add another layer of accuracy to such findings.  
We analyzed a wide range of metabolic and physical characteristics of over 2000 women 
from the general NL population and obtained detailed x-ray images of each participant to 
assess body fat distribution, VF included. Our primary finding from this investigation was 
that MetS risk was 2.4x higher in a group of 235 women exhibiting android obesity when 
compared to 235 BMI matched women of similar age (p<0.001, 95% CI 1.64-3.46) 
However, after controlling for VF percent, the differences between these groups for all 





suggest subcutaneous fat stores have more of an impact on metabolic health than VF 
stores [65]. While there are numerous studies in other populations, including a small 
sample of normal weight women (n=22) and the elderly, that have found android fat to be 
independently associated with both insulin resistance and MetS [7, 24], these studies were 
not able to control for VF mass or percentage. A significantly larger study of a healthy 
cohort (n=3399) has also noted the relationship between abdominal obesity and insulin 
resistance in women, however, this was an association study and no direct comparisons 
were made between women exhibiting android obesity or gynoid obesity [66]. Another 
past study found that the difference between metabolically healthy and unhealthy obese 
women was largely due to VF mass with abdominal subcutaneous fat playing no 
significant role [67]. While it is possible that subcutaneous fat stores may contribute to 
metabolic disturbance, many studies simply do not have the means of accurately 
measuring VF and therefore unable to control for it. Trunk and android fat regions exhibit 
very strong correlations with VF which may, at least partially explain why they are often 
observed to have such strong independent associations with various metabolic markers. 
Our findings suggest that, while acknowledging the role of subcutaneous fat in 
metabolism, VF appears to account for much of the variance observed in insulin 
resistance and lipid profiles between individuals with different patterns of body fat 
distribution. This is in agreement with a recently published longitudinal study on 1964 
subjects from a healthy Asian population which included a 5 year follow up, that found 
that VF was significantly associated with the incidence of MetS but subcutaneous fat was 





subcutaneous abdominal fat and VF stores according to the ATP III criteria, however, this 
was in a sample of elderly men and women aged 70-79 [69]. The lack of significant 
difference we observed in some markers such as LDL and TC lines up with past research 
as a study on aerobic fitness and metabolic characteristics in women found that these two 
same measures exhibited no relationship with aerobic health [70]. It is possible that 
changes in LDL and TC are simply less sensitive to differences in subcutaneous BFD and 
environmental factors and perhaps are more attributable to genetic variation or VF mass. 
To the best of our knowledge, this marks the first time such a complete panel of 
metabolic and anthropometric characteristics have been compared between women from a 
general population measured using DXA scanning. Our results support the 
recommendation of an increased focus on an individual’s VF stores when assessing health 
risks and further emphasis on actions to decrease VF in women as it can have serious 
long-term impacts on their well-being.  
There were several additional findings also yielded by this study. A comparison of 
women grouped by tertiles for AGR revealed that, while all groups were significantly 
different from one another for most markers, only the top tertile was significantly higher 
than the two bottom tertiles for measures of insulin resistance, HOMA-IR, and HOMA-β. 
HOMA measures were not significantly different between the bottom and middle tertiles. 
Lipid profiles worsened as android fat increased which was to be expected, however, the 
fact that HOMA measures did not differ significantly between the lowest and middle 





obesity on insulin sensitivity considerably worsen. These findings concur with past 
studies on the relationship between abdominal fat with insulin resistance and lipid profiles 
[70, 71]. Interestingly, measures of insulin resistance did not significantly worsen 
between the lowest and middle tertile while LDL and TC levels did. One study found that 
increased LDL levels interact with abdominal obesity to exasperate insulin resistance and 
diabetes risk [72]. Many clinicians still opt to use BMI to assess an individual’s risk of 
CVD but based on these findings, it may be in a patient’s best interest to have a more in-
depth analysis of overall body shape, how they can carry excess weight, and as previously 
noted, VF percentage. 
Overall, we have accomplished our goal of improving our understanding of the effects of 
android obesity and BFD on the health of women from a general population, but our 
study was still subject to some limitations. Our BMI matched sub-group was only 470 
women since some of the most severely centrally obese women had to be excluded as 
there BMI reached into the ’40s and no control match was available in our population. 
While AGR exhibits strong correlations with MetS and many of the markers we studied, 
the android region does not include the entirety of upper body fat such as the arms and 
upper portion of the torso which may also be responsible for free fatty acid contribution 
in circulation and subsequent metabolic disturbance. While the goal of our study was to 
investigate the body type specific to excess android fat accumulation, future studies may 
benefit from using total upper body fat to total lower body fat ratio. It may also be of 





inflammatory cytokines and appetite hormones. A study measuring metabolic 
characteristics between women with android or gynoid obesity before and after an 
exercise intervention could also further elucidate the connection between metabolic 
characteristics in relation to BFD. 
This comparative study of specific BFD patterns in women has succeeded in highlighting 
some of the important metabolic implications and health risks in women with excessive 
android fat or “apple shaped” obesity in participants from a general population, although 
our findings suggest that this may be more so attributed to the strong correlation between 
“apple shaped” BFD and VF. It is the first to study a full-scale panel of metabolic and 
anthropometric characteristics in a general population, including all those necessary for 
the diagnosis of MetS with the added accuracy of DXA scanning. This study strengthens 
the proposal that the use of BFD measures and tools such as DXA or MRI capable of 
generating highly accurate data regarding fat stores would be more beneficial to 
individuals than simply relying on BMI. As noted in this study, women with similar BMIs 
can have vastly different health outcomes, especially as it pertains to MetS and therefore, 
CVD and diabetes risk. The information produced by this research is especially beneficial 
to the women of Newfoundland and Labrador, who, as previously noted exhibit a high 
rate of obesity and obesity comorbidities [2, 73, 74]. This research reaffirms the urgent 
need for more detailed assessments of obesity, BFD, and VF measurements in women so 
that clinicians and public health workers can better prioritize resources to those most at 
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Chapter 5. Conclusions, 











The rate of obesity has rapidly soared over the last 30 years and it is predicted that it will 
continue to increase for the foreseeable future. Given the impact the obesity epidemic is 
having on the health and quality of life of so many people, combined with the immense 
economic burden due to healthcare expenditure and lost working hours, it is vital that we 
increase our understanding of obesity etiology. There is growing evidence concerning the 
role of addictive eating tendencies as a contributing factor to obesity and obesity-related 
comorbidities such as T2D. The goal of this thesis was, primarily, to investigate the 
association of FA and its symptoms with various forms of obesity defined by certain BFD 
patterns as well as the metabolic consequences of FA. The secondary objective was to 
better quantify the impact of BFD, specifically android fat, on metabolism and MetS risk 
in adult women. This would provide an improved understanding of how addictive eating 
behaviours contribute to android adiposity and the health outcomes of this particular BFD 
pattern. 
My thesis consists of three manuscripts that explore the role of FA in BFD and metabolic 
health. The role of BFD in metabolic health is expanded upon in a subsequent manuscript 
on android obesity in women. To the best of my knowledge, all studies are the first of 
their kind and all findings are unique.  
In the first manuscript titled “The Association Between an Addictive Tendency Towards 
Food and Metabolic Characteristics in the General NL Population” we found that, in adult 





inversely associated with HDL. Amongst women, those who were pre-menopausal 
exhibited no significant correlation between YFAS symptoms and metabolic 
characteristics while post-menopausal women displayed a significant association between 
YFAS symptoms and TG. Additionally, a comparison of age and BMI matched 
individuals with food addiction revealed that males with food addiction had significantly 
lower HDL levels than females with food addiction. This would suggest that men may be 
subject to a greater risk of metabolic disturbance as a result of addictive eating 
behaviours. The reason for this is yet to be discovered but it may be at least partly 
attributable to common BFD differences between men and women. Men’s propensity to 
accumulate VF and women’s tendency to accumulate gynoid fat, which may exert 
protective effects, might account for some of the sex-related differences observed in this 
study. BFD distribution may also partially explain differences observed between pre and 
post-menopausal women, as post-menopausal women tend to have lower levels of 
estrogen which can lead to greater fat accumulation in the android region and VF stores. 
There is very little comparable research in this regard. One of the few other studies to 
even investigate the correlation between YFAS symptoms and metabolic markers 
compared a group of individuals with T2D to a healthy control group. They reported that 
those who met the criteria for FA had less favourable metabolic characteristics such as 
higher glucose levels, higher TG, and lower HDL. We observed that YFAS symptoms 
were correlated with similar variables in our general population so the report that FA is 
more common among those with T2D is consistent with our findings. This group did not 





also analyzed all men and women together, so they were unable to observe any 
differences due to the sex of their participants and they did not adjust for body fat 
percentage as we did [193]. 
Our findings would suggest that a holistic approach to treating obesity or diabetes should 
account for individuals eating behaviours as addictive eating behaviours may make it 
more difficult to follow dietary guidelines that might improve health, thereby worsening 
the condition. 
Based on the findings from the study mentioned above and the suggestion that the sex and 
menopausal related differences that were observed may be partially mediated by BFD, 
my next paper investigated the association between YFAS symptom counts and various 
measures of BFD in men and women of a general NL population. We reported that both 
men and women shared highly significant correlations between YFAS scores with a 
number of BFD measures including trunk fat, android fat, gynoid fat, and VF stores. 
Correlation coefficients did not differ much across the board with the exception of gynoid 
fat mass (women: r=0.30, men: r=0.23) and gynoid fat percent (women: r=0.24, men: 
r=0.15). We also performed a comparative analysis of FAO, NFO, and a control group, 
matched for sex. This revealed no significant difference in the BFD measures between the 
FAO and NFO group. FA remains far more prevalent among obese individuals and our 
analysis revealed that, even after controlling for sex, age, physical activity, and calories, 
symptoms of FA still account for a notable share of variance attributed to various body fat 





android fat in men and 10.9% of the variance in android fat in women. While there are 
several studies that report on the relationship between obesity status, BMI, and FA, very 
little research concerning the relationship between FA and regional BFD, particularly VF, 
is limited. One study, though limited in comparison to our cohort, investigated the 
relationship between VF and YFAS scores in a small group of young women [184]. 
While this study also demonstrated a significant correlation between YFAS scores and 
BAI measured VF, it was only performed in a group of 93 women with an average age of 
24. Much more research is needed in this regard in far more populations consisting of 
different ethnicities and nationalities to confirm whether the relationship between FA and 
VF holds true for cohorts that may have vastly different diets.  
These findings support the previously stated premise, that the protective effects of gynoid 
fat in women, may also somewhat mitigate the metabolic effects of addictive eating 
tendencies. Also, screening for FA or YFAS symptoms in individuals seeking obesity 
treatment and dealing with these addictive symptoms appropriately rather than the 
consequences of them could prove beneficial to the patient. 
The final manuscript of my thesis explores the relationship between android adiposity in 
women, performing a direct comparison between adult women with varying degrees of 
android fat percent. This study was comprised of 2323 women who were first divided into 
tertiles based on AGR. This revealed that women in the lowest, middle, and top tertile of 
AGR differed significantly in levels of insulin, glucose, TG, HDL, LDL, TC, systolic BP, 





highest tertile and the bottom two tertiles for HOMA-IR and HOMA-β. An additional 
comparison of women from the top DGR quartile with a BMI and age-matched control 
group revealed that women of similar age and BMI were 2.4x more likely to have MetS if 
they carried higher levels of android fat, independent of VF. The relationship between 
AGR ratio and metabolic markers has been investigated by other groups as well. A study 
that consisted of 685 women with an average age of 35 reported that in women, AGR was 
significantly correlated with fasting glucose, TG, and negatively correlated with HDL 
[94]. While this study also employed the use of DXA, VF was not accounted for. Another 
study which consisted of 10,770 women and 8324 men investigated the relationship 
between MetS and BFD. This study used BAI as a means of measuring body composition 
and WHR as an index of AGR. While WHR was associated with an increased risk of 
MetS at a level body of body fat between 20% and 40% in each sex, the impact of WHR 
on the relationship between body fat and MetS was much more pronounced in women 
[254]. Again, this study was unable to measure and control for VF and WHR has many 
limitations which have been discussed so while it does highlight the importance of BFD 
as a factor of MetS, particularly among women, conclusions should be made cautiously.  
Our findings suggest that android adiposity alone can be indicative of serious metabolic 
disorders in women and reinforce the need for thorough assessments of women’s BFD, as 
opposed to relying solely on BMI, to evaluate their risk of developing metabolic issues 
such as CVD and T2D. The accurate measurement of VF is not obtainable for many 





measurements of VF is still somewhat new. Hopefully, in the coming years, those with 
the requisite technology will produce more research on the importance of BFD and health 
outcomes while being able to discern whether visceral or subcutaneous fat stores are the 
risk factor. 
In conclusion, this thesis provides new insights into the role of FA and FA symptoms as a 
contributing factor to obesity, especially central obesity and metabolic disturbance in an 
otherwise healthy general population. It also serves to better quantify the importance of 
BFD in metabolic health in adult women. The major strengths of this thesis include the 
large sample of individuals from a general population used for each manuscript, the use 
of advanced imaging technology (i.e. DXA), and the large amount of behavioural, 
endocrine, and dietary data collected on each participant which allowed us to not only 
answer our initial research questions but control for important confounding factors as 
well. 
5.2 Limitations 
Despite the unique and interesting findings presented in this thesis, like all research 
efforts, certain limitations must be accounted for. While many of these limitations are 
discussed in each manuscript’s discussion section, there are a few additional limitations 
that warrant mentioning or additional elaboration. First and foremost, this was a cross-
sectional study, meaning all data collected and presented was based on each research 
volunteer’s health or behaviours at their time of participation. This can make it difficult at 





Another possible limitation was the substantially smaller sample size of men compared to 
women. We have observed that there are male-specific associations between FA, BFD, 
and metabolic characteristics but a larger group of men would certainly help in assessing 
the true magnitude of these sex-specific effects. 
Finally, it is worth reiterating that data on food intake, physical activity, and eating 
behaviours are self-reported which is, of course, always somewhat vulnerable to self-
reporting or possible re-call bias among our participants. Measuring physical activity by 
way of questionnaire may be the most practical means of measurement in large cohorts 
but it is not without its inadequacies. Physical activity levels can vary greatly based on the 
season or even the day of the week. These variations are not accounted for in the Baecke 
questionnaire and although this questionnaire can be useful for categorizing individuals 
and as active or inactive, it does not measure energy expenditure. While occupational 
activity may remain relatively constant for many people, leisure time and sports-related 
activity can vary greatly based on the time of year. For example, someone may spend 
more leisure time walking during the summer and far less during the winter or someone 
who participates in seasonal sports may be very active during that season only for 
physical activity to reduce significantly once the season is over. It is for these reasons that 
we must also be wary of recency bias when individuals are self-reporting physical activity 
levels (ex. physical activity levels may be underestimated if the questionnaire is 
completed during a particular sports offseason or vice versa). It has been reported that the 





expenditure in men than women and is more likely to misclassify women’s level of 
physical activity, particularly among older women as household chore related activity is 
not accounted for. It also appears to better assess high intensity and low intensity activity 
than moderate levels [255, 256]. Regarding the FFQ, it is worth mentioning that it deals 
with the frequency of consumption and not portion size. This can lead to a great deal of 
variability as an individual’s portion sizes for some foods, whether it be pasta, rice, or 
snacks such as potato chips can be quite different. It can also lack accuracy among people 
or populations that regularly consume mixed dishes composed of many different types of 
ingredients.  
5.3 Future Directions 
The results generated from this research have opened the door to a number of future 
projects. Eventually converting the CODING study into a longitudinal, as opposed to a 
cross-sectional study, could help us better understand cause and effect relationships 
between the variables observed and observe how aging modifies some of these measures.  
In the future, it would also be helpful to measure energy and appetite-regulating 
hormones in a greater number of individuals to evaluate their role in FA and metabolic 
health. If this data was available for all 3000+ CODING study participants we could 
conduct valuable research on the relationship of these hormones with sex, age, medication 
usage, obesity status, and many other variables. Additional data on other disordered 





could also go a long way in understanding FA and its place in the spectrum of substance 















































Appendix 2 Baecke Physical Activity 
Questionnaire 
Physical Activity Form 
 
Date: (        /        /2005) (day/month/year) 
 
Identification # =  
 
Name:  Family                                        Middle                                      First                                      
 
Data Entry 1 Initial                       Data Entry 2  Initial    
 
To be completed by the participant. 
 
Note This assessment instrument has been modified from the Physical Activity 
questionnaire used in the NIH supported Atherosclerosis Risk in Community 
study (ARIC). 
 
Note Blanks allowed on QS # 18, 22 only if No is checked for Qs # 17, 21. 
 
1. What is your main occupation? 
2. At work I sit: 
never / seldom / sometimes / often / always 
3. At work I stand: 
never / seldom / sometimes / often / always 
4. At work I walk: 
never / seldom / sometimes / often / always 
5. At work I lift heavy loads: 
never / seldom / sometimes / often / always 





never / seldom / sometimes / often / always 
7. At work I sweat: 
never / seldom / sometimes / often / always 
8. I n comparison with others of my own age I think my work is physically: 
much heavier / heavier / as heavy / lighter / much lighter 
 
9. Which sport or exercise do you do most recently? 
 
 
10. How many hours a week do you do this activity? 
 
1  less than 1                                             4         At least 3 but not quite 4 
 
2  At least 1 but not quite 2                      5         At least 4 but not quite 5 
 
3  At least 2 but not quite 3 
 
11. How many months a year do you do this activity? 
 
1         less than 1                                             4          At least 7 up to and including 9 
 
2         At least 1 but not quite 4                      5         More than 9 
 




12. Do you do other exercise or play other sports? 
 
1            Yes                  2           No 
 
     If NO, DO NOT COMPLETE QUESTIONS 13-23. CONTINUE WITH QUESTION 24. 
 
 
13.What is your second most frequent exercise or sport?  
 





14. How many hours a week do you do this activity or sport? 
 
1         less than 1                                             4         At least 3 but not quite 4 
 
2         At least 1 but not quite 2                      5         At least 3 but not quite 4 
 
3         At least 2 but not quite 3 
 
 
15. How many months a year do you do this activity? 
 
1         less than 1                                             4          At least 7 up to and including 9 
 
2         At least 1 but not quite 4                      5         More than 9 
 
3         At least 4 but not quite 7 
 
 
16. Do you do other exercise or play other sports? 
 
1            Yes                  2           No 
 
   IF NO, DO NOT COMPLETE QUESTIONS 17-23. CONTINUE WITH QUESTION 24. 
 
17. What is third most frequent exercise or sport? 
 
 
18. How many hours a week do you do this activity? 
 
1         less than 1                                             4         At least 3 but not quite 4 
 
2         At least 1 but not quite 2                      5         At least 3 but not quite 4 
 
3         At least 2 but not quite 3 
 
19. How many months a year do you do this activity? 
 
1         less than 1                                             4          At least 7 up to and including 9 
 
2         At least 1 but not quite 4                      5         More than 9 
 






20. Do you do other exercise or play other sports? 
 
1            Yes                  2           No 
 
   IF NO, DO NOT COMPLETE QUESTIONS 21-23. CONTINUE WITH QUESTION 24. 
 
21. What is your fourth most frequent exercise or sport? 
 
 
22. How many hours a week do you do this activity? 
 
1         less than 1                                             4         At least 3 but not quite 4 
 
2         At least 1 but not quite 2                      5         At least 3 but not quite 4 
 
3         At least 2 but not quite 3 
 
23.  How many months a year do you do this activity? 
 
1         less than 1                                             4          At least 7 up to and including 9 
 
2         At least 1 but not quite 4                      5         More than 9 
 
3         At least 4 but not quite  
24.  In comparison with others of my own age, I think my physical activity during leisure    
       time is:  
 
1         Much less                                              4         More 
 
2         Less                                                       5         Much more 
 
3         The same 
 
25. During leisure time, I sweat: 
 
1         Never                                                    4         Often 
 
2         Seldom                                                 5         Very often 
 
3         Sometimes 
 






1         Never                                                    4         Often 
 
2         Seldom                                                 5         Very often 
 
3         Sometimes 
 
27.  During leisure time, I watch television: 
 
1         Never                                                    4         Often 
 
2         Seldom                                                 5         Very often 
 
3         Sometimes 
 
28. During leisure time, I walk: 
 
1         Never                                                    4         Often 
 
2         Seldom                                                 5         Very often 
 
3         Sometimes 
 
29. During leisure time, I bike: 
 
1         Never                                                    4         Often 
 
2         Seldom                                                 5         Very often 
 
3         Sometimes 
 
30. How many minutes do you walk and/or bike to and from work? 
 
1         less than 5                                            4          At least 30 up to and including 45 
 
2         At least 5 but not quite 15                   5           45 or more 
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